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Human cytomegalovirus (HCMV) regulates the unfolded protein response, including specifically inducing
the ER chaperone BiP. The increase in BiP protein during infection is the result of promoter activation by the
HCMV MIEPs and La autoantigen activation of the internal ribosome entry site of BiP mRNA. To determine
the effects of BiP on HCMV replication, BiP was depleted using the SubAB subtilase cytotoxin or short
hairpin RNAs. Depletion of BiP had little effect on viral protein synthesis. However, progeny virion formation
was significantly inhibited, suggesting that BiP is important for virion formation. Electron microscopic
analysis showed that infected cells were resistant to the toxin and showed none of the cytotoxic effects seen in
uninfected cells. However, all viral activity in the cytoplasm ceased. During infection, BiP localizes in two
cytoplasmic structures, regions of condensed ER near the periphery of the cell and the viral cytoplasmic
assembly compartment, where it interacts with the viral proteins pp28 and TRS1. Depletion of BiP causes the
assembly compartment to dissociate and the cytoplasm to return to a more normal morphology, indicating
that BiP is important for assembly compartment integrity and confirming its role in viral cytoplasmic activity.
Furthermore, depletion of BiP and the corresponding disruption of assembly compartment integrity results in
the loss of virally-induced nuclear lamina rearrangement and a decrease in lamin phosphorylation. These
results are due to an interaction between BiP and pUL50. Thus, BiP depletion affects both nuclear and
cytoplasmic viral activity. These data and the following observations support an intricate link between vial
nuclear and cytoplasmic activity. The inhibition of the molecular motor dynein results in the loss of both
assembly compartment integrity and the nuclear morphology characteristic of an HCMV infection.
Furthermore, the nuclear periphery is dramatically altered adjacent to the assembly compartment, where the
nuclear lamina is rearranged, the outer nuclear membrane is altered, and the nucleus becomes permeable to
large molecules. The perinuclear space is also enlarged, a result of decreasing the SUN proteins during
infection. These results support a model for a highly integrated assembly-egress continuum, linking viral
nuclear and cytoplasmic activity.
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ABSTRACT  
 
THE ROLE OF THE UNFOLDED PROTEIN RESPONSE REGULATOR BIP IN HCMV 
VIRION ASSEMBLY AND EGRESS 
 
NICHOLAS J. BUCHKOVICH 
ADVISOR: JAMES C. ALWINE, Ph.D. 
 
Human cytomegalovirus (HCMV) regulates the unfolded protein response, 
including specifically inducing the ER chaperone BiP.  The increase in BiP protein during 
infection is the result of promoter activation by the HCMV MIEPs and La autoantigen 
activation of the internal ribosome entry site of BiP mRNA.  To determine the effects of 
BiP on HCMV replication, BiP was depleted using the SubAB subtilase cytotoxin or short 
hairpin RNAs.  Depletion of BiP had little effect on viral protein synthesis. However, 
progeny virion formation was significantly inhibited, suggesting that BiP is important for 
virion formation. Electron microscopic analysis showed that infected cells were resistant 
to the toxin and showed none of the cytotoxic effects seen in uninfected cells. However, 
all viral activity in the cytoplasm ceased.  During infection, BiP localizes in two 
cytoplasmic structures, regions of condensed ER near the periphery of the cell and the 
viral cytoplasmic assembly compartment, where it interacts with the viral proteins pp28 
and TRS1. Depletion of BiP causes the assembly compartment to dissociate and the 
cytoplasm to return to a more normal morphology, indicating that BiP is important for 
assembly compartment integrity and confirming its role in viral cytoplasmic activity.  
Furthermore, depletion of BiP and the corresponding disruption of assembly 
compartment integrity results in the loss of virally-induced nuclear lamina rearrangement 
v 
and a decrease in lamin phosphorylation.  These results are due to an interaction 
between BiP and pUL50.  Thus, BiP depletion affects both nuclear and cytoplasmic viral 
activity.  These data and the following observations support an intricate link between vial 
nuclear and cytoplasmic activity.  The inhibition of the molecular motor dynein results in 
the loss of both assembly compartment integrity and the nuclear morphology 
characteristic of an HCMV infection. Furthermore, the nuclear periphery is dramatically 
altered adjacent to the assembly compartment, where the nuclear lamina is rearranged, 
the outer nuclear membrane is altered, and the nucleus becomes permeable to large 
molecules.  The perinuclear space is also enlarged, a result of decreasing the SUN 
proteins during infection. These results support a model for a highly integrated 
assembly-egress continuum, linking viral nuclear and cytoplasmic activity. 
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CHAPTER 1: Introduction 
 
Viruses are obligate intracellular parasites that require the assistance of their 
host cells to undergo processes critical for producing viral progeny: transcription, 
translation, genome replication and virion assembly.  The increased metabolic activity in 
the cell due to viral activity exhausts vital cellular resources.  This leads to the activation 
of key cellular stress responses; the activation of which restores cellular homeostasis.  
As a result of stress signaling, key metabolic processes are shut down and quality 
control mechanisms are activated to conserve resources until the cell can return to more 
favorable growth conditions.  While shutting down key cellular processes is detrimental 
to viral replication, the induction of quality control machinery can be either detrimental or 
beneficial.  Thus, it is expedient that viruses modulate stress responses to their 
advantage. 
 Endoplasmic reticulum (ER) stress is one type of cellular stress induced by many 
viruses.  One of these viruses, human cytomegalovirus (HCMV), encodes several 
proteins that traverse the ER to be processed and receive post-translational 
modifications.  The additional protein load in the ER activates the ER stress response, 
also referred to as the unfolded protein response (UPR).  Like other stress responses, 
UPR activation has both beneficial and detrimental effects on viral replication.  Studies 
have shown that HCMV does regulate the UPR to take advantage of these beneficial 
effects, while inhibiting the detrimental ones (136).  For example, while HCMV prevents 
the induction of the UPR transcriptional regulators, beneficial factors like the ER 
chaperone immunoglobulin binding protein (BiP), also called glucose regulated protein 
78 (GRP78), are still induced.  The hypothesis tested herein is that HCMV specifically 
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induces the ER chaperone BiP independently of the UPR transcription factors because 
BiP plays an important role during an HCMV infection.    
 
Human cytomegalovirus 
 Human cytomegalovirus, also referred to as human herpesvirus 5 (HHV-5), is a 
member of the Herpesviridae virus family.  Members of this family share similar virion 
structural elements: an icosahedral nucleocapsid that houses its genome, a tegument 
layer surrounding the nucleocapsid and an outer lipid bilayer envelope studded with 
virally-encoded glycoproteins (Figure 1) (291).  Like other herpesviruses, HCMV 
undergoes both a lytic and a latent infection. 
Herpesviridae family members are divided into three subfamilies: 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae. There are 26 core 
open reading frames shared among the different families (3).  HCMV is the 
representative member of the subfamily Betaherpesvirinae.  Other members of the 
Betaherpesvirinae subfamily include HHV-6 and HHV-7. Betaherpesviruses share a core 
set of 70 to 80 conserved open reading frames (269).  Several characteristics common 
among family members during infection include a long replication cycle, restricted host 
range and induction of cytomegaly in infected cells (291).   
 HCMV is universally present in human populations with a large number of 
seropositive individuals (269).  Developed countries show a lower incidence of infection 
due to an increase of hygiene, leaving a larger number of individuals susceptible to a 
primary infection (235).  During an acute infection HCMV has a broad tropism, infecting 
a variety of cell types and organs.  Infections have been reported in both mononuclear 
and polymorphonuclear leukocytes, macrophages, epithelial cells, endothelial cells, 
smooth muscle cells, glial cells, neurons, mesenchymal cells and hepatocytes  
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(21, 128, 324, 386).  Following primary infection, a latent infection occurs preferentially in 
several cell types, including smooth muscle cells, endothelial cells and myeloid lineage 
cells (138, 139, 368).   A large number of an infected individual’s T-cell repertoire is 
directed against HCMV-encoded antigens, on average 10% but as high as 40% in some 
individuals (310, 338).   
HCMV infections in children and healthy adults are usually asymptomatic; 
however, it has been attributed to approximately 8% of all cases of mononucleosis (160).  
In contrast to an infection in immunocompetent individuals, infection of the 
immunocrompromised is often symptomatic.  Clinical manifestations of an infection 
depend on the site of primary infection, often resulting in pneumonitis, retinitis, 
myocarditis, hemolytic anemia, hepatitis, encephalopathy and/or peripheral 
polyradiculopathy and neuropathy (177).   Recent literature reviews have also focused 
on the role of HCMV in atherosclerosis, coronary artery restenosis, transplant vascular 
sclerosis and cancer (229, 332, 335).  In addition to causing symptoms in the 
immunocompromised, a congenital HCMV infection can have severe effects for 
newborns.  It is considered to be the leading cause of sensorineural deafness and the 
leading infectious cause of brain damage in children (84, 235).  HCMV remains a 
significant clinical problem in these subsets of patients. 
 
HCMV replication cycle  
Characteristic of the family Betaherpesvirinae, HCMV undergoes a long 
replication cycle that progresses slowly in culture.  The cycle begins upon attachment to 
cellular receptors and is completed upon release of infectious virions from the cell.  As is 
the case for all Herpesviruses, synthesis of viral deoxyribonucleic acid (DNA) and 
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nucleocapsid assembly occurs in the nucleus and a productive viral infection results in 
the destruction of the host cell (291). 
Viral entry into cells is mediated by attachment and fusion of its envelope 
glycoproteins to cellular receptors (55).   Viral attachment and penetration are pH-
independent and occur rapidly in both permissive and non-permissive cell types, 
suggesting a post-entry mechanism for determining tropism (325).  The ability of HCMV 
to enter such a wide range of host cells suggests that the cellular receptor must be 
broadly expressed and/or multiple receptors may play redundant roles in HCMV entry 
(54).  Cellular receptors that have been implicated thus far in HCMV attachment and 
entry are heparin sulfate proteoglycans (HSPG), the integrins αVβ3, α2β1, α6β1 and the 
epidermal growth factor receptor (EGFR) (79, 373, 374).  However, the involvement of 
EGFR in entry is controversial (134, 374).  A weak interaction between the viral 
glycoprotein complex gM/gN or gB with the HSPGs is responsible for initial viral 
attachment; however this interaction is not sufficient for entry (54, 55). Viral fusion and 
entry are mediated by interactions between the viral glycoprotein complex gH/gL/gO or 
gB and cellular receptors.      
 
HCMV gene expression and DNA replication 
 After entry, the viral nucleocapsids proceed quickly to the nucleus to begin viral 
gene expression, which is divided temporally into three stages: immediate early, early 
and late.  Immediate early expression begins one to four hours post infection and does 
not require the expression of previous viral genes.  Viral immediate early proteins 
prepare the cell for infection by modulating the immune response, inhibiting apoptosis 
and activating transcription from many viral and cellular promoters (145, 235). Early 
gene expression requires the immediate early genes and is divided into two categories, 
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early and delayed early.   Early gene products are mainly involved in viral DNA 
replication (for example, UL44, UL112/113, UL54) and immune evasion (US2, US11, 
US28) (235).  The last viral genes expressed during infection are the late genes, also 
divided temporally into early late and late genes.  Microarray data suggest that the 
majority of HCMV proteins are late proteins (41).  Late proteins are mainly structural 
proteins and proteins involved in virion assembly and maturation (177).   Late gene 
expression requires the presence of both immediate early and early genes, as well as 
the initiation of viral genome replication (83).   
 The HCMV genome is greater than 230 kilobases, the largest of the human 
herpesviruses.  For the most part, HCMV encodes its own replication machinery.  This 
includes a polymerase, single-stranded DNA binding protein,  helicase-primase complex 
and processivity factor; however, unlike other herpesviruses, HCMV does not encode 
deoxyribonucleotide synthesis enzymes, relying instead on the host cell for nucleotide 
production (46, 177).  Before DNA replication can initiate, the input genome must 
circularize. This can occur as early as 4 hours post infection (hpi); however, replication 
does not begin until 16 hpi.  Replication initially begins from a single origin and proceeds 
in a bidirectional manner.  Concatamers are eventually formed and replication continues 
by a rolling circle mechanism (222). Nascent genomes are inverted and cleaved before 
being packaged into preformed, empty nucleocapsids. 
 
HCMV nucleocapsid formation and nuclear egress  
 HCMV nucleocapsids are 100 nanometer (nm) icosahedrons consisting of 162 
capsomer shells that form a T=16 lattice (36).  Nucleocapsids consist of four viral 
proteins, the major capsid protein (MCP) and the minor capsid protein (mCP), encoded 
by UL86 and UL85 respectively, UL46 (minor capsid binding protein, mC-BP) and the 
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smallest capsid protein (SCP) encoded by UL48.5 (12, 36, 93, 94, 133).  The MCP is the 
major protein in nucleocapsid pentamers and hexamers.  mCP and mC-BP form 
triplexes in a 2:1 ratio that interdigitate the hexamers and pentamers. SCP is found on 
hexon tips and is believed to direct tegumentation.  Additionally, UL80 encodes three 
viral proteins associated with nucleocapsid assembly, the most abundant being 
assembly protein (AP).  AP is a scaffolding protein that is associated with capsid 
intermediates and noninfectious enveloped particles, but not mature virions (133).   
Once assembled, nucleocapsids must migrate from the nucleus to the cytoplasm 
to finish virion maturation and egress from the cell.  To do this, the nucleocapsids must 
access the inner nuclear membrane (INM), which requires them to overcome barriers 
such as heterochromatin and the nuclear lamina that block access to the INM.  This 
involves the viral nuclear egress complex, which consists of two viral proteins, pUL50 
and pUL53, that recruit both viral and cellular proteins to the nuclear membrane (38).  
This complex includes two kinases, the virally encoded kinase UL97 and the cellular 
kinase protein kinase C (PKC), which are responsible for phosphorylating the nuclear 
lamina, leading to their rearrangement and providing nucleocapsids access to the INM 
(107, 231).  A similar egress function has been described for homologues of pUL50 and 
pUL53 in both herpes simplex virus-1 (HSV-1) and in mouse cytomegalovirus (MCMV) 
(244, 267, 290).  An alternative mechanism for phosphorylating the lamins has been 
suggested in which the viral kinase UL97 is recruited by the cellular protein p32 (218).  
Phosphorylation of the lamina creates a novel binding motif for the peptidyl-prolyl 
cis/trans isomerase Pin1, which may promote the conformational modulation of the 
lamina (232).  The rearrangement of the nuclear lamina allows for infoldings of the 
nuclear membrane (35, 65, 95, 263, 296, 311, 312).  The current model of nuclear 
egress suggests that nucleocapsids egress from these infoldings by acquiring a 
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temporary envelope from the inner nuclear membrane by budding into the perinuclear 
space.  This membrane is lost upon fusion with the outer nuclear membrane, releasing 
naked nucleocapsids into the cytoplasm (327).   
 
HCMV assembly compartment, cytoplasmic maturation and egress 
Once in the cytoplasm, the nucleocapsid acquires its tegument layer and final 
envelope.  This process involves the perinuclear cytoplasmic assembly compartment, 
visualized by electron microscopy in Figure 2A.  This structure is nestled against the 
concave surface of the enlarged, kidney-like nucleus characteristic of HCMV infection.  It 
is located at the microtubule organizing center (MTOC) (Figure 2B), which is necessary 
for compartment integrity (302).  The assembly compartment consists of a reorganized 
secretory apparatus, as shown by immunofluorescence in Figure 2C, with an early 
endosomal core (detected by early endosome antigen 1 (EEA1)), surrounded by 
consecutive rings of trans-Golgi network (TGN) (p230, TGN46, TGN38, Golgin 97) and 
Golgi network (mannosidase II, GM130, p115) (68).  The ER is found at the periphery of 
the assembly compartment, as shown by antibodies that detect the KDEL ER-
localization signal (Figure 2C).  A three-dimensional model of the assembly 
compartment proposes that the assembly compartment is composed of these organelle-
specific vesicles which form nested cylinders that make up ordered layers of the 
assembly compartment (68).  Each layer is proposed to contain a specific set of 
tegument proteins which are transferred to the developing virions as nucleocapsids 
successively move from the outside to the center of the assembly compartment.   
Defining the exact origin of this compartment has been complicated by the 
observation of specific organellar markers in and around the compartment, while other 
markers of the same organelle are not detected. For example, immunofluorescence  
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Figure 2.  HCMV cytoplasmic assembly compartment 
 
(A) Electron microscopic analysis of viral cytoplasmic activity at 96 hpi showing the 
perinuclear cytoplasmic assembly compartment.  (B)  Higher magnification of viral 
assembly compartment depicting viral activity radiating from central microtubule 
organizing center (MTOC).  (C) Immunofluorescence analysis of HCMV assembly 
compartment at 96 hpi showing concentric rings of cellular organelles.  Antibodies 
against p230, EEA1, and the ER-localization signal KDEL were used to detect 
respective organelles.  The Golgi was detected by expression of Mannosidase II-GFP 
(MannII).  
.  
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examination localizes the early endosomal marker EEA1 at the center of the assembly 
compartment (67, 68); however, Rab4 and Rab5, other early endosomal markers, were 
not detected (122).  This suggests that the virus recruits and relocalizes specific cellular 
factors to form the assembly compartment.   
In addition to the cellular markers, many viral proteins exist in the assembly 
compartment.  These include both tegument proteins (pp28, pp65 and pp150) and 
glycoproteins (gB, gO, gH, gL, gM, gN and gp65) (302, 343).   It is proposed that as the 
nucleocapsid progresses through the rings of the assembly compartment, it acquires its 
tegument layer and final envelope before egressing from the cell (68).  Although the 
origin of the final envelopment is still being elucidated, a recent study has shown the 
presence of both TGN and early endosome markers in the final envelope (40).  After 
acquiring a final envelope, infectious viral particles travel in cellular vesicles to the 
plasma membrane where they are released into the extracellular space (236).  Little is 
understood about the process of virion transport by cellular vesicles and their release 
from cells.  
 
HCMV and the induction of stress responses 
One characteristic of HCMV and the betaherpesviruses, as mentioned above, is 
a long replication cycle that progresses slowly in cultured cells.  During this cycle, 
beginning as early as viral attachment, the virus alters cellular signaling pathways to 
optimize conditions for replication.  Some of the pathways that the virus modulates are 
stress response pathways that are activated as a result of increased demand for 
nutrients, energy, nucleic acids and amino acids during a viral infection (6).  These 
stress responses could both benefit and inhibit viral replication.  The virus must evolve to 
overcome detrimental signaling results while taking advantage of the beneficial ones. An 
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example of a stress response with both beneficial and detrimental effects is the unfolded 
protein response. 
 
Unfolded protein response 
The unfolded protein response (UPR) is a response pathway activated by 
conditions that perturb ER homeostasis.  Three ER transmembrane proteins, inositol-
requiring enzyme 1 (IRE1), activating transcription factor 6 (ATF6) and PKR-like ER 
kinase (PERK) act as ER stress sensors (19, 315).  IRE1, ATF6 and PERK all bind to 
BiP in their inactive states (19, 315).   BiP is the master regulator of UPR activation; 
overexpressing BiP prevents UPR activation during ER stress (238).  In addition, an 
abnormally high level of any protein that binds BiP can activate the UPR, while 
accumulation of misfolded proteins that do not bind BiP have no effect on UPR activation 
(100, 249).  One model is that unfolded proteins compete with UPR sensors for BiP 
binding, titrating away BiP and allowing the sensors to become activated (19).  However, 
during ER stress BiP is actively dissociated from ATF6, suggesting that activation of at 
least one UPR sensor may have additional complexity than the simple competition 
model predicts (317).  When activated, the UPR sensors initiate a complex signaling 
cascade that optimizes cellular conditions for alleviating ER stress (Figure 3).   
 
Inositol-requiring enzyme 1 (IRE1) 
IRE1 was first identified in yeast as the sole ER stress sensor and UPR activator 
(58) and subsequently cloned in mammalian cells as one of three stress sensors (348, 
375).  It is a transmembrane protein that contains an ER stress-sensing luminal domain 
and a cytoplasmic domain with both kinase and endoribonuclease activity (199, 348).  
During ER stress, IRE oligomerizes and recruits X-box binding protein 1 (XBP1) 
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Figure 3.  Unfolded protein response signaling. 
 
During ER stress, BiP binds misfolded proteins and dissociates from the ER stress 
sensors IRE1, ATF6 and PERK.  These sensors become activated and initiate a 
complex signaling cascade that ultimately results in an inhibition of global translation 
initiation, cell cycle arrest, ER expansion and the transcription of chaperones, 
degradation factors, and antioxidant genes.  Prolonged UPR signaling results in 
apoptosis.  See text for detailed explanation and abbreviations. 
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mRNA (9, 164).  The cytoplasmic domain of IRE1 then excises a 26-nucleotide intron 
from the XBP1 mRNA, producing an mRNA that encodes a highly active transcriptional 
form of XBP1 (37, 404).  XBP1 is essential for the induction of the ER-associated 
degradation (ERAD) factors:  ER degradation-enhancing α-mannosidase-like protein 
(EDEM), HMG-CoA reductase degradation 1 (HRD1), Derlin-2 and Derlin-3, the DnaJ 
containing proteins ERdj3, ERdj4 and p58IPK , protein disulfide isomerase-5 (PDI-5) and 
ribosome-associated membrane protein 4 (RAMP4) (146, 181, 253, 403).  Other genes 
can be induced by XBP1, but are not absolutely dependent on it since expression of 
these genes can be induced in XBP1-/- cells (37, 181), suggesting compensatory 
mechanisms of induction.  These include the molecular chaperones BiP and GRP94, 
Herp, Armt, AW124040, β-interferon and XBP1 itself. The autoinduction of XBP1 allows 
for sustained activation of target genes in response to prolonged stress (37, 181, 403).  
XPB1 is also involved in ER expansion during stress, inducing the synthesis of the 
primary phospholipid of the ER membrane, phosphatidylcholine (PtdCho) (330).  In 
addition to splicing XBP1, the endonuclease activity of IRE1 is involved in reducing the 
incoming load of protein to the ER by cleaving a subset of ER-localized mRNAs (121) 
and by cleaving the 28S ribosomal RNA to repress translation (137).   
IRE1 also activates c-Jun amino-terminal kinases (JNKs), alternatively called 
stress-activated protein kinases (SAPKs), to help regulate both autophagy and apoptosis 
(18, 361).  Autophagy is an important process for recovery from ER stress; excess ER 
produced by UPR activation and the misfolded proteins associated with it are degraded 
by autophagosomes (18).  In addition to promoting survival, JNK activation by IRE1 is 
involved in promoting apoptosis;  ER-stress induced apoptosis is reduced in IRE1- 
deficient cells (361). IRE1’s utilization of JNK for both pro-survival and pro-apoptotic 
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signaling illustrates the complex balance between survival and death signals generated 
by UPR activation. 
 
Activating transcription factor 6 (ATF6) 
The second activator of the UPR is the 90 kilodalton (kD) protein ATF6 (418).  
ATF6 contains a transmembrane domain with its N-terminus facing the cytoplasm (116).  
During ER stress, ATF6 is transcriptionally induced in an IRE1 dependent manner (377) 
and undergoes several stress-dependent alterations.  ATF6 becomes underglycosylated 
(124) and exposes two Golgi-localization signals (GLS) (315).  Upon exposure of the 
GLS, ATF6 migrates to the Golgi (256) where it is sequentially cleaved by Site-1 
protease (S1P) and Site-2 protease (S2P), releasing its 50 kD N-terminal cytoplasmic 
domain (115, 400).  This domain translocates to the nucleus and acts as a transcription 
factor (115).  ATF6 interacts with other transcription factors associated with the 
endoplasmic reticulum stress elements (ERSEs), including CCAAT-binding 
factor/nuclear factor-Y (CBF/NF-Y) through the CBF/NF-YC subunit (406) and Yin Yang-
1 (YY1) (194).  ATF6 binds to the CCACG sequence of the ERSE, but only when 
CBF/NF-Y is bound to the CCAAT sequence nine nucleotides upstream (405).  ATF6 is 
the stress-inducible factor responsible for transcriptional complex assembly at the ERSE. 
Similar to XBP-1, ATF6 is involved in transcriptional activation of both molecular 
chaperones, such as BiP (402), and degradation factors, such as Herp (210).  ATF6 is 
also involved in ER expansion by upregulating PtdCho, although its upregulation of 
PtdCho occurs differently and independently of PtdCho regulation by XBP1 (25).  
Another similarity between ATF6 and XBP1 is the upregulation of XBP1 (185, 404).  The 
interconnection between the two signaling arms and redundancy in target activation may 
allow for temporal regulation of UPR signaling.  The cleavage of pre-existing ATF6 can 
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occur rapidly in response to stress and result in immediate activation of target genes, 
including XBP1.  In contrast, XBP1 requires translating mRNA that must first be 
transcribed and spliced. Its autoregulation, however, may allow for sustained activation 
of its targets during prolonged stress.   
Other functions have been attributed to ATF6 during ER stress.  ATF6 is involved 
in the regulation of calcium.  Maintaining calcium levels are important for protein folding 
and ER homeostasis. In response to stress, ATF6 upregulates the calcium pump 
sarco/endoplasmic reticulum calcium ATPase-2 (SERCA2) to help maintain proper 
calcium levels (346).  ATF6 also contributes to apoptosis by upregulating the 
transcription factor C/EBP-homologous Protein (CHOP, also called growth arrest and 
DNA damage gene (GADD)153) (209). In addition to activating target genes during ER 
stress, ATF6 has a repressional function as well.  ATF6 represses both cholesterol and 
lipid synthesis by inhibiting the sterol-regulating element binding protein 2 (SREBP2) 
(411).  Inhibiting these two metabolic pathways conserves energy resources required to 
withstand ER stress. 
 
PKR-like endoplasmic reticulum kinase (PERK)  
The third UPR sensor, PERK, contains an ER luminal domain for sensing stress 
and an active cytoplasmic kinase domain (111, 199, 319).  A major consequence of 
PERK activation during ER stress is the repression of global translation initiation.  PERK 
phosphorylates eukaryotic initiation factor 2α (eIF2α) at serine 51 (110, 111).  eIF2α is 
part of the heterotrimeric eIF2 complex that forms a ternary complex with guanosine 
triphosphate (GTP) and methionyl-initiator tRNA (Met-tRNAi).  Binding of this ternary 
complex to the 40S ribosomal subunit promotes translation initiation (190).  After 
initiation, GTP is hydrolyzed to guanosine diphosphate (GDP) and the eIF2-GDP 
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complex is released (352).  In order to reinitiate translation, the GDP of the eIF2 complex 
needs to be exchanged for GTP. Another initiation factor, eIF2B, is responsible for this 
exchange.  When eIF2α is phosphorylated, eIF2B cannot exchange GDP for GTP, and 
initiation of translation is repressed as the available pool of eIF2-GTP is depleted (220).  
Prolonged repression of translation initiation would be detrimental to production of UPR 
transcription factors and ER stress recovery.  To terminate PERK phosphorylation at the 
later stages of UPR induction and promote normal initiation of translation, p58IPK, a 
negative regulator of PERK, is upregulated (397).  Additionally, GADD34 is induced by 
ER stress and interacts with the protein phospatase 1 complex (PP1) to direct the 
dephosphorylation of eIF2α and restore normal translational initiation (57, 252). 
During ER stress, PERK-dependent repression of translation results in both cell 
cycle arrest and an increase in ATF4 translation.  Cell cycle arrest occurs because of the 
inhibition of cyclin D1 translation (29).  The increase in ATF4 translation is a result of an 
increase in ribosome activity at a downstream open reading frame (ORF) due to the 
reduced initiation of translation (109).  The decrease in available eIF2-GTP creates a 
delay in translation initiation that allows the ribosome to read through the inhibitory 
uORF2 and reinitiate translation at the ATF4 ORF (205, 364).  ATF4 is a transcription 
factor that, similar to ATF6, can activate BiP (207), the ERAD factor Herp (210) and 
CHOP (78, 109).  ATF4 also regulates the UPR through its activation of ATF3 (140), and 
upregulates genes involved in amino acid import, glutathione biosynthesis and oxidative 
stress resistance (112). 
In addition to translational repression and ATF4 activation, activated PERK also 
phosphorylates the transcription factor NF-E2-related factor-2 (Nrf2).  Phosphorylation of 
Nrf2 releases it from its cytoplasmic inhibitor Kelch-like ECH-associated protein 1 
(Keap1), allowing it to escape ubiquitin-dependent proteolysis and migrate to the 
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nucleus where it activates transcription from promoters containing antioxidant response 
elements (61, 62).  PERK regulates other signaling pathways as well, including the 
phosphoinositide-3 kinase (PI3K)/Akt pathway (152), indicating a potential role for 
preparing cells for recovery from ER stress (257). 
  
UPR-induced apoptosis 
Prolonged ER stress and sustained activation of the UPR can indicate 
irreparable conditions, resulting in UPR-induced apoptosis.  All three stress sensors 
activate both pro-survival and pro-apoptotic pathways, although the stimulus that triggers 
the shift from survival to apoptosis is not well understood and evidence shows that both 
protective and apoptotic signaling pathways are activated at the same time (120, 297).  
The balance between survival and apoptosis may depend on a balance between the 
pro- and anti-apoptotic Bcl2 family members.  Several Bcl2 family members and other 
apoptotic factors are upregulated during UPR signaling, including the pro-apoptotic 
factors Bim, p53-upregulated modulator of apoptosis (PUMA) and Noxa (192, 280, 289).  
During ER stress, Bim is protected from proteasomal degradation and becomes 
phosphorylated by JNKs to promote Bax-mediated apoptosis (186, 279, 280).  Another 
pro-apoptotic factor, CHOP, is a target of ATF4 and ATF6 (209, 257, 376).  CHOP is 
required for UPR-induced apoptosis (420), but the exact mechanisms of CHOP-induced 
apoptosis are still under investigation.  CHOP upregulates pro-apoptotic factors such as 
death receptor 5 (DR5) and tribbles homolog 3 (TRB3) (255, 396), suggesting that 
CHOP may induce apoptosis through transcriptional activation.  CHOP has also been 
shown to downregulate the anti-apoptotic factor Bcl-2, resulting in decreased cellular 
glutathione levels and increased oxidative stress (221).  Furthermore, CHOP promotes 
the translocation of Bax from the cytosol to the mitochondria, a critical step for apoptosis 
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(98).  Understanding the mechanisms of ER-induced apoptosis and the balance 
between survival and apoptosis during UPR activation is important, particularly for a viral 
infection, as premature apoptosis would be an example of a UPR effect detrimental to 
viral infection. 
 
Unfolded protein response and viruses 
Successful modulation of the different signaling arms of the UPR is a critical 
event for the completion of many viral replication cycles, as many viruses activate UPR 
signaling. Viruses have adopted different regulation strategies for modulating the UPR.  
For example, many viruses require the cellular machinery for translation and must 
overcome the UPR-induced repression of translational initiation; some viruses 
accomplish this by inhibiting phosphorylation of eIF2α, while others have developed 
translational mechanisms that don’t require eIF2α (Figure 4A) (49, 129, 151, 239, 241, 
358, 367).  The human immunodeficiency virus type 1 (HIV-1) tat protein activates the 
UPR by deregulating calcium signaling, an event that has been shown to be critical for 
the neuropathogenesis of HIV-1 (251).  Another viral protein, the latent membrane 
protein 1 (LMP1) of Epstein-Barr virus (EBV) can activate all three arms of UPR 
signaling (183).  The UPR is also activated during a human t-lymphotrophic virus (HTLV-
1) infection, as shown by increased expression of BiP, CHOP, EDEM and XBP1 (168).  
Viruses such as these that activate the UPR must ensure that UPR signaling does not 
adversely affect viral replication. 
 
Virus modulation UPR-induced block in translation initiation  
Activation of the PERK pathway by viruses would result in an inhibition of 
translation initiation.  To circumvent this, viruses have adopted several distinct strategies 
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(Figure 4A).  HSV-1 encodes several viral proteins to counteract eIF2α phosphorylation.  
One viral protein, γ134.5, recruits the cellular phosphatase complex PP1 to 
dephosphorylate eIF2α (49).  Another HSV-1 protein, US11, directly inhibits eIF2α 
phosphorylation late in infection, suggesting the evolution of two temporally distinct 
mechanisms to control the cellular inhibition of translation during HSV-1 infection (241).  
Despite these two mechanisms, it was reported that additional viral proteins are required 
to completely overcome the translational inhibition by phospho-eIF2α during an HSV-1 
infection (240).  One of these proteins has been identified as the viral glycoprotein gB, 
which interacts with PERK to resist PERK’s activation (239).  Additionally, similar to the 
HSV-1 γ134.5 protein, the human papillomavirus E6 protein associates with the PP1 
complex to dephosphorylate eIF2α (153).  The cowpox virus CP77 protein suppresses 
eIF2α phosphorylation; although the exact mechanism of its suppression is still 
undetermined (129). Instead of inhibiting eIF2α phosphorylation, the Dengue viruses 
types 1 and 2 (DEN-1, DEN-2) overcome activation of PERK and eIF2α phosphorylation 
by upregulating GADD34, which is responsible for dephosphorylating eIF2α (358).   
Rather than overcoming the translational inhibition by PERK, some viruses have 
developed translational mechanisms that allow them to circumvent the need for eIF2α.  
Two alphaviruses, Semliki Forest virus and Sindbus virus, have developed a 
translational mechanism that bypasses the requirement of functional eIF2α by using a 
hairpin downstream of the initiation codon to stall the ribosome at the correct initiation 
site (367).  Evolving a mechanism to overcome the block in translation is important for 
the progression of viral infection, as demonstrated by the vesicular stomatitis virus (VSV).  
Cells infected with VSV require the PERK-induced block in translation as a host defense 
mechanism; VSV replicates to higher titers in PERK-deficient cells (13).  The virus is  
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Viral regulation of UPR 
 
(A) To overcome the inhibition of translation by UPR signaling, viruses must regulate the 
level of phospho-eIF2α or promote the eIF2α-indepenent initiation of translation.  (B) 
Viruses that activate the UPR must account for UPR-induced apoptosis.  Viruses that 
benefit from apoptosis can promote the induction of apoptotic factors.  Conversely, 
viruses that need to inhibit apoptosis must prevent these factors. See text for more 
information on viral regulation of UPR signaling. 
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able to generate more viral progeny in the absence of PERK, because cells cannot 
phosphorylate eIF2α and inhibit translation of viral proteins. 
 
Viruses and UPR-induced apoptosis 
A second result of UPR signaling that would directly affect viral replication is the 
induction of apoptosis.  Although premature apoptosis could potentially halt viral 
replication, viruses could also use apoptosis as an effective way to spread infectious 
virions once their replication has been completed.  Several viruses adapt the latter 
strategy and use the UPR to induce apoptosis (Figure 4B).  The bovine viral diarrhea 
virus (BVDV), which uses the ER as the primary site for envelope glycoprotein 
biogenesis, genomic replication, and particle assembly, activates the UPR and ultimately 
induces CHOP, leading to viral-induced apoptosis (143). A related virus, BVDV-2, has 
similarly been shown to induce apoptosis through ER stress signaling (213).  Other 
viruses that induce apoptosis via CHOP and UPR induction include the Japanese 
encephalitis virus (JEV) (336) and respiratory syncytial virus (22).  Similarly, the gPr80env 
proteins of two related viruses, the Maloney murine leukemia virus (MoMuLV) and mink 
cell focus-forming murine leukemia virus (MCF MLV), accumulate in the ER and activate 
the UPR (203, 247).  Interestingly, this CHOP-dependent UPR-induced apoptosis by 
MoMuLV and another mouse retrovirus, FrCasE, is a significant contributor to their 
neuroimmunodegenerative phenotype (72, 156, 203).  This phenotype is lost in a related 
avirulent mouse retrovirus, F43, that has a different envelope protein, one that does not 
initiate ER stress (72, 73).  Thus, the ability of mouse retroviruses to induce ER-stress 
dependent apoptosis is required for virulence. 
Apoptosis, however, would not be beneficial for all viruses.  The African swine 
fever virus (ASFV) has been shown to inhibit the production of CHOP during infection 
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(Figure 4B), even under conditions, such as thapsigargin addition, that normally cause 
ER stress and upregulate CHOP (248).  Since ASFV replicates on the cytoplasmic side 
of the ER and uses the ER cisternae for envelopment, potentially causing ER stress, 
inhibiting the induction of CHOP prevents premature apoptosis and ensures a productive 
viral infection.  This is not the case for West Nile virus (WNV).  The non-structural 
proteins of WNV induce apoptosis by increasing CHOP protein levels.  Inducing 
apoptosis via CHOP limits the amount of virus produced, as the virus replicates to higher 
titers in CHOP -/- cells (223).  Although it appears that the host cell uses CHOP-induced 
apoptosis as a defense mechanism, WNV-induced apoptosis plays a key role in viral 
pathogenesis, resulting in apoptosis of infected neurons and leading to paralysis and 
encephalitis.  Although CHOP-induced apoptosis prevents the virus from replicating to 
its full titers, WNV uses it as a mechanism for viral dispersal.  Interestingly, a closer 
examination of a WNV infection shows that all three signaling branches of UPR signaling 
are activated.  ATF6 is rapidly targeted for degradation by the proteasomes and 
although XBP1 is spliced, it is dispensable for infection and has no effect on viral growth 
(223).  WNV has prevented the transcriptional activity of these UPR molecules, most 
likely to avoid an increase in ERAD.  Importantly however, the ER chaperones BiP, PDI, 
calreticulin, calnexin and GRP94 are all still upregulated (223), illustrating careful 
modulation of the UPR by WNV to promote beneficial outcomes while inhibiting 
detrimental ones. 
Another virus, Borna disease virus (BDV), induces apoptosis in infected neurons, 
contributing to the susceptibility of the host to neurodegeneration and neonatal Borna 
disease. Interestingly, the virus exhibits differential regulation of apoptosis depending on 
the cell type infected; Purkinje cells undergo apoptosis but astrocytes are resistant.  All 
three UPR sensors are activated during infection in both cell types, resulting in the 
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induction of the pro-apoptotic factor CHOP; however levels of the pro-survival UPR 
targets BiP and PDI are increased only in the apoptotic resistant astrocytes (388).  This 
demonstrates cell type specificity in the evolution of the virus that has led to the selective 
ability to overcome the pro-survival signaling arm of the UPR. 
 
Viral regulation of UPR transcriptional signaling and ER chaperones 
Several viruses have been reported to regulate the transcriptional arm of the 
UPR and induce ER chaperones.  BiP and GRP94 are both transcriptionally induced by 
the rotavirus nonstructural protein 4 (NSP4) (394).  BiP is also upregulated by Rous 
sarcoma virus, paramyxovirus, New Castles disease virus and DEN-2 (53, 272, 334, 
379).  The induction of BiP by DEN-2 is required for viral antigen production (379).  The 
hepatitis B virus X protein activates both ATF6 and IRE1 (191) and the E5 protein of 
canine papillomavirus induces splicing of XBP1 mRNA (56).  XBP1 is also upregulated 
by the flaviviruses, JEV and DEN-2 (197).  The number of viruses that upregulate ER 
chaperones either independently of, or through, UPR signaling is indicative of the 
important role chaperones play during infection. 
 
Viruses adapt UPR molecules to benefit viral replication 
Additional roles adapted by UPR proteins during a viral infection may provide 
further incentive for regulating the UPR.  Despite its role in repressing translation, 
activating PERK would be beneficial for a virus as PERK is involved in the 
phosphorylation-dependent ubiquitination and degradation of the interferon alpha 
receptor 1 subunit (IFNAR1), inhibiting type I interferon signaling and antiviral defenses 
(202).  In HTLV-1, XBP1 encoded by both the spliced and unspliced forms of mRNA 
have been reported to bind and activate transcription from the tax-responsive element of 
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the long terminal repeat of HTLV-1 (336).   Further, BiP appears to play a role in the 
pathogenesis of HSV-1.  The neuroinvasive strains of HSV-1, SP7 and 490, induce BiP 
levels during infection; however, the attenuated strain KOS does not (216).  Another 
virus, coxsackievirus A9, uses BiP as a coreceptor for entry (353).  These data suggest 
that viruses can induce additional roles for UPR signaling molecules to further benefit 
viral replication. 
 
Modulation of the UPR by specific viruses 
Studies have elucidated regulation of UPR signaling by viruses through a variety 
of mechanisms.  Extensive studies on the hepatitis C virus (HCV) reveal how a single 
virus selectively modulates the various arms of UPR signaling for the advantage of its 
replication.  The viral envelope E2 protein selectively binds and inhibits two eIF2α 
kinases, PERK and protein kinase R (PKR), an interaction that is sufficient to overcome 
the repression of translation (271, 342).  E2 also induces the transcription of both BiP 
and GRP94 (197).  This induction is a result of an interaction between E2 and BiP, which 
may sequester it from the UPR sensors and allow for UPR activation.  Along with E1, E2 
induces CHOP via a PERK-dependent mechanism and activates XBP1 mRNA splicing 
by IRE1 (43). IRE1 activation and XBP1 mRNA splicing are also induced by the viral 
nonstructural protein 4B (NS4B), which interacts with ATF6 and promotes its cleavage 
and transcriptional activity (195, 350, 416).  Expression of the complete HCV genome 
results in ATF6 cleavage, transcriptional activation of its target gene BiP and activation 
of translation from BiP’s internal ribosome entry site (IRES) (340).  Expression of the 
HCV genome also activates IRE1, resulting in the splicing of XBP1 mRNA; EDEM is not 
however induced, suggesting viral regulation of the UPR to prevent the production of 
degradation factors (339, 416).  An interesting observation from studies with HCV is that 
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the JFH1 strain, the first HCV strain to replicate in culture, exhibits differential regulation 
of PERK.  This suggests both a potential role for PERK in in vitro replication of HCV, as 
well as strain variations among viruses in UPR regulation (326).   
Similar to HCV, two viral proteins of severe acute respiratory syndrome virus 
(SARS) selectively modulate the UPR.  The S protein activates PERK resulting in eIF2α 
phosphorylation; however, it does not induce ATF6 transcription or splicing of XBP1. 
Despite repression of XBP1 and ATF6, transcription of BiP, GRP94 and CHOP is still 
induced by the S protein (42).  BiP and GRP94 are also upregulated by the SARS-CoV 
protein 8ab, which is likely a result of ATF6 activation since 8ab only activates the ATF6 
pathway and not IRE1 or PERK (17).  Work on another coronavirus, mouse hepatitis 
virus (MHV), also shows selective modulation of the UPR.  ATF6 is cleaved and XBP1 is 
spliced, but the target genes ERdj4, EDEM and p58IPK are not upregulated (17).  
Although eIF2α is highly phosphorylated and GADD34 expression is suppressed, halting 
cellular translation, preferential translation of viral transcripts occurs in an eIF2α-
independent manner.  This is another example of a virus counteracting a detrimental 
effect of UPR signaling (17). 
 
HCMV modulation of the UPR 
HCMV also activates and selectively regulates all three arms of UPR signaling. 
PERK is activated during infection as indicated by an increase in phospho-PERK levels; 
consequently, levels of  phospho-eIF2α increase as well (136).  Interestingly, HCMV 
modulates this pathway so that the increase in phospho-eIF2α levels does not result in a 
repression of translation in infected cells, although the mechanism of this regulation is 
not yet known.  However, since HCMV significantly increases the total level of eIF2α, the 
ratio of unphosphorylated to phosphorylated eIF2α is high.  This may account for 
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HCMV’s ability to overcome the inhibition of translation initiation by phospho-eIF2α.  This 
also suggests that the viral infection affects translational mechanisms, since ATF4 
expression is increased during infection even though translation is not repressed (136).  
ATF4 is normally only expressed during the eIF2α-dependent repression in translation.  
Recently, the HCMV protein UL38 has been shown to affect ATF4 expression (395). 
 Another ER stress sensor, ATF6, is not cleaved during HCMV infection; 
although the stress-dependent shift in glycosylation can be detected, suggesting  that 
transport to the Golgi for cleavage may be blocked (136).  Additionally, the splicing of 
XBP1 mRNA is severely reduced during infection, demonstrating that, similar to ATF6 
and PERK, IRE1 is also regulated by HCMV.  Accordingly, the levels of the XBP1 target 
gene EDEM are not increased (136). Further regulation of IRE1 by HCMV is 
demonstrated by the ability of HCMV UL38 to suppress the IRE1-mediated 
phosphorylation of JNK and its UPR-induced cell death (395).  Interestingly, despite the 
suppression of ATF6 and IRE1, levels of two ER chaperones, BiP and GRP94, are 
upregulated during infection.  Thus, HCMV appears to utilize an alternative method to 
induce these chaperones, both of which would be beneficial for viral replication.  
Furthermore, the upregulation of these proteins allows HCMV to utilize them in novel 
ways to aid in viral replication.  During infection, BiP interacts with two HCMV proteins, 
US2 and US11; this interaction is critical for downregulating the major histocompatibility 
complex 1  (MHC1), contributing to HCMV’s well-developed immune evasion strategy 
(117, 259, 349).  In this thesis it will be shown that HCMV also induces an alternative 
function of BiP that is important for virion assembly and egress. 
 
Immunoglobulin heavy chain binding protein  
A 78 kD protein that was independently identified and given the names glucose  
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regulated protein 78 (GRP78) (321) and immunoglobulin heavy chain binding protein 
(BiP) (104) was later shown to be the same protein (243).  It is an ER resident member 
of the heat shock protein 70 (HSP70) molecular chaperone family (320, 410)  with 61% 
homology to its cytosolic family member Hsp70 (243).  BiP promotes the proper folding 
and assembly of peptides by binding aberrantly glycosylated and misfolded proteins (91, 
118, 149), participating in complexes with other ER chaperones (173, 225, 226, 341, 
414). BiP contains a cleavable leader sequence that directs BiP to translocate to the ER 
and a C-terminal KDEL sequence that retains BiP’s ER localization (Figure 5A) (243). 
Although primarily located in the ER, reports have also associated BiP with the plasma 
membrane (354), nucleus (219), mitochondria (337), and most recently the cytosol (208).  
It is essential for cell and organismal survival, as mice deficient for BiP exhibit early 
embryonic lethality (193).  In addition to BiP’s role in development, it is required to 
maintain ER integrity and for stress-induced activation of cellular autophagy (193). 
 
Structure and function of BiP 
Structurally, the HSP70 family members consist of an N-terminal adenosine tri-
phosphate (ATP)-ase domain (44) and a C-terminal peptide or substrate binding domain 
(372) (Figure 5A).  The substrate binding domain of BiP recognizes stretches of seven 
amino acids with a preference for aliphatic and aromatic amino acids, although it can 
tolerate polar and charged residues (24, 82).  The crystal structure of the ATPase 
domain of BiP has recently been published, and closely resembles the ATPase domain 
of other Hsp70 family members (389).  Structural studies on HSP70 family members 
revealed a mechanism in which ATP hydrolysis in the ATPase domain causes a 
significant conformational change in the substrate binding domain (80, 141, 419).  This 
conformational change increases the affinity of the substrate binding domain for peptides, 
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as substrates have a higher affinity for the adenosine di-phosphate (ADP)-bound state of 
HSP70 family members (262, 305).  Accordingly, peptide binding to the substrate 
binding domain increases ATP hydrolysis rates of the ATPase domain (103). This 
suggests a mechanism in which peptides bind HSP70 family members in the ATP-bound 
state, stimulate ATP hydrolysis and then become “locked” to the chaperone until ADP is 
exchanged for ATP and the substrate is released (81, 101, 243, 261).  The exchange of 
ADP for ATP on HSP70 family members is done by nucleotide exchange factors.  Two 
ER-localized co-chaperones, BiP-associated protein (BAP) (52) and GRP170 (382), 
have been identified as nucleotide exchange factors for BiP.  In addition to the 
nucleotide exchange factors, other co-chaperones known as DnaJ domain containing 
proteins can bind and stimulate BiP’s ATPase activity through their J domains.  These 
include the ER-localized DnaJ Homologues 1-5 (ERdj1 or Mtj1/HTJ1 (166), ERdj2 or 
hSec63 (329), Erdj3 or HEDJ (407), ERdj4 (318), ERdj5 or JPDI (63, 126)) and p58IPK 
(298).  Conversely, the ATPase activity of BiP is negatively regulated by the FK506-
binding protein 23 (FKBP23) (414). 
In addition to its role in protein folding and assembly, BiP is also involved in 
protein translocation; although studies suggest that the mammalian BiP may not play as 
big as role in protein translocation as its yeast homologue Kar2 (71, 159, 250). One 
study suggests that mammalian BiP can be lowered by 10,000 fold without adversely 
affecting protein translocation (97).  Despite this report, a definitive role for mammalian 
BiP has been established in protein translocation.  BiP binds incoming and newly 
translocated proteins, in part to ensure unidirectional import of the nascent polypeptides 
(356).  BiP also seals both the luminal end of actively translocating pores and inactive 
translocons to maintain the ER membrane permeability barrier (105, 108).  This is an  
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Figure 5.  BiP protein and promoter organization 
 
(A) Schematic of BiP showing domain organization, localization signals and SubAB 
cleavage site.  Ribbon diagrams of the ATPase domain of BiP and the peptide binding 
domain of the BiP homologue DNAK are shown above.  Ribbon diagrams of BiP ATPase 
domain and DNAK peptide binding domain taken from http://www.thesgc.org/structures/ 
structure_description/3IUC/ and http://people.cryst.bbk.ac.uk/~ubcg16z/hsplec.html, 
respectively.   (B) Organization of the BiP promoter with ERSE’s, ATF/CREB site, TATA 
box and five CCAAT elements.  The transcriptional complex that forms in response to 
ER stress and ATF6 cleavage is shown assembled at the ERSE. 
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ATP hydrolysis-dependent mechanism, similar to the mechanism used by BiP to bind 
and release unfolded peptides (4).   
BiP also plays a role in the reverse process of ER translocation, ERAD, and the 
targeting of misfolded proteins for export out of the ER.  BiP is one component of an ER 
quality control scaffold involved in ERAD (127).  Depletion of BiP increased the half-life 
of the alpha chain of the T-cell receptor, a model for ERAD, confirming a role for BiP in 
ERAD (179).  BiP’s role in ERAD is dependent on both its concentration and an intact 
peptide binding domain (144), and requires the co-chaperone function of several of the  
ERdj proteins (76, 362).  Despite utilizing many of the same proteins as ER protein 
translocation, BiP-mediated export is mechanistically distinct from import (31).  Since 
ERAD targets are determined by a protein’s confirmation, not primary sequence 
information, BiP must maintain a delicate balance of maintaining proteins in a foldable 
state and targeting them for degradation (161, 328).   
 
Transcriptional control of BiP 
BiP is ubiquitously expressed as an abundant ER luminal protein in all cells 
during unstressed conditions.  Basal expression of BiP, in at least some cell lines, is 
dependent on growth factors like IL-3 and CSF-1 (28).  The BiP promoter is 
constitutively depleted of nucleosomes (88) and contains five CCAAT elements, a TATA 
box and two potential binding sites for SP1 (347) (Figure 5B). There are also three 
ERSEs with the consensus sequence CCAAT(N9)CCACG, which are critical for the 
stress-induction of BiP (402).  Many transcription factors involved in activating the BiP 
promoter have been identified, including YY1 (196), CBF/NF-Y(294), CAAT-binding 
transcription factor-nuclear factor 1 (CTF-NF1) (390), transcription factor II-I (TFII-I) 
(268), cAMP response element binding protein 1 (CREB1), ATF1, ATF4 (207), ATF6 
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(402), XBP-1 (404), GATA4 (215), c-Myb (285), Sp1, Sp3 and Sp4 (1).  In many cases 
these appear to be cell type and stress-dependent.  GATA4 interacts with YY1 to induce 
BiP transcription only in the embryonic heart (215) and c-Myb is associated with BiP’s 
promoter only in cancer cells (285).  In contrast to activation of the BiP promoter, the 
cellular E2 transcription factor 1 (E2F1) represses BiP transcription (283).  
Several transcription factors are involved in the stress-induction of BiP. The BiP 
promoter contains an upstream ATF/cAMP response element (CRE) site that is 
activated during stress by ATF4 in conjunction with CREB1 and ATF1 (207).   
Downstream of this site, CBF/NF-Y constitutively binds to the proximal CCAAT element 
(295) and interacts with ATF6 during stress (406).  ATF6 also interacts with TFII-I (268), 
which during stress gets phosphorylated by the c-Src tyrosine kinase (123) and binds 
the promoter in the intermediate nine nucleotides of the ERSE (293).  This complex has 
also been shown to bind Sp1, Sp3 and Sp4 (1). YY1 also acts as a cofactor for ATF6 (15) 
and interacts with protein arginine methyltransferase 1 (PRMT1) to enhance the BiP 
promoter during stress (15).  Another chromatin modifier, the histone deacetylase p300, 
is also present at the BiP promoter during ER stress (15).  The stress-induced complex 
that forms during ER stress is depicted in Figure 5B.   
A number of conditions and treatments have been reported to increase BiP levels.  
Many of these perturb protein processing and increase the presence of malfolded 
proteins in the ER (165), ultimately activating the UPR and increasing BiP.  Alterations in 
protein glycosylation induce BiP, including glucose deprivation (276) and treatment with 
glucosamine, 2-deoxyglucose, castanospermine (380) or tunicamycin (258).  Perturbing 
calcium levels by adding calcium free media (175) and calcium modulators ionomycin 
(391), A23187 (383) and thapsigargin (277) also upregulate BiP. Inhibiting protein 
transport by treatment with brefeldin A or the trimeric G-protein inhibitor Aif4
-  (148, 277) 
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also increase BiP levels.  Other inducers include insulin (148), β-mercaptoethanol, low 
pH (385), nitric oxide (162), the amino acid analogue azetidine (380), homocysteine (306) 
and exposure to anaerobic conditions (306).  BiP is also upregulated by a variety of drug 
treatments including cisplatin (201), iodoacetamide (201), the non-steroidal anti-
inflammatory indomethacin (392), methylseleninic acid (47), valproate (26, 314), lithium 
(314), and the antidiabetics rosiglitazone and troglitazone (214).  The variety of stimuli 
that increase BiP production is indicative of the important role BiP plays in restoring ER 
homeostasis and protecting cells from damage. 
 
Post-transcriptional control of BiP 
In addition to transcriptional mechanisms for inducing BiP, evidence also 
suggests post-transcriptional regulation.  In some cell types brefeldin A induction of BiP 
occurs at the transcriptional level, while in others it is post-transcriptional (200).  Similarly, 
both treatment with dexamethasone (174) and expression of a mutant mouse mammary 
tumor viral glycoprotein pr74 (357) increase BiP protein levels without increasing mRNA 
levels.  Furthermore, artificially increasing BiP levels during unstressed conditions does 
not result in BiP protein production, suggesting a stress-dependent regulation of BiP 
translation (102).  During ER stress induction, BiP translation efficiency increases 
independently of transcript levels (102).  A similar observation has also been reported for 
BiP in plants (344) and chicken HSP70, in which protein levels are increased by 
regulating protein elongation (345).  Human HSP70 is also regulated post-
transcriptionally; however, it appears to be due to an increase in mRNA half-life (345).  
One feature that may allow for the unique translational regulation of BiP mRNA is the 
IRES in its 5’ untranslated region (UTR) that allows for internal ribosome binding (211).  
This element is regulated by NS1-associated protein 1 (NSAP1), La autoantigen (also 
33 
called Sjogren syndrome antigen B, SSB), p50 and p95 (51, 158, 398).  The multiple 
methods of upregulating BiP demonstrate that maintaining levels of BiP is critical for cell 
homeostasis.   
BiP is also regulated post-translationally by both phosphorylation and ribosylation 
(39, 383).  BiP can be phosphorylated on serine and threonine residues in the peptide 
binding domain, by either autophosphorylation or an unidentified ER kinase (89, 189).  
This phosphorylation does not occur on BiP that is associating with misfolded proteins, 
thus phosphorylation may be inhibitory to BiP’s chaperone function (119).  The 
ribosylation of BiP is reversible and is not present on the majority of BiP in stressed cells 
(119, 187, 188).  These results suggest a role for post-translational modifications in 
regulating the function of BiP.  This was confirmed by a study identifying the different 
cellular states of BiP.  BiP actively functions as a chaperone in the monomeric form, 
while unassociated BiP exists as either an unmodified monomer or in an aggregate 
modified by both phosphorylation and ribosylation (85).   
Another post-translational regulator of BiP is calcium (Ca2+).  Ca2+ has been 
linked to both the induction and proper function of BiP.  BiP’s amino terminal nucleotide 
binding domain is enriched for glutamic and aspartic acid, creating an acidic, Ca2+ -
binding domain (182).  Accordingly, BiP was verified as an ER-resident Ca2+ -binding 
protein (212) and as participating in ER Ca2+ storage (198). The role of BiP as a 
meaningful player in ER Ca2+ storage has since been disputed and it has instead been 
shown that Ca2+ binding to BiP alters its affinities for ATP and ADP (176).  This 
observation could explain the necessity of Ca2+ for proper protein folding (204).  
However, too much Ca2+ is detrimental to protein folding as high concentrations of Ca2+ 
ions inhibits BiP’s ATPase activity (150).  Other roles connecting BiP with Ca2+  include 
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regulation of GRP94 phosphorylation (284) and Ca2+ signaling from ER to mitochondria 
through an interaction between BiP and the sigma-1 receptor (114). 
 
BiP’s role in disease 
Ongoing studies of BiP have implicated it in a variety of disease.  Recent studies 
have shown elevated levels of BiP in many different cancers (20, 66, 322, 371, 393), 
although the effects of elevated BiP vary greatly.  BiP can provide some cancerous cells 
with a survival advantage (34, 64, 86, 87, 234, 286, 287, 313, 401), while in others be 
pro-apoptotic (34).  Depending on the cancer type, elevated BiP levels can represent 
either a negative (66, 96, 184, 233, 275, 413) or a positive (130, 178, 304, 360) 
prognosis.  BiP is strongly associated with drug resistance in cancer cells (14, 45, 75, 
154, 163, 228, 275, 281, 287, 299, 316, 355, 370, 409, 412, 421),  but also shows 
promise as a tool for cancer therapy (10, 48, 90, 157).  Other diseases associated with 
BiP and ER stress include two neurodegeneration diseases, Alzheimer’s disease (125, 
172, 408, 415) and Marinesco-Sjogren neurodegenerative disorder (8, 307).  BiP also 
plays a protective role in atherosclerosis (381, 384).  Due to BiP’s critical role in 
maintaining cellular homeostasis, deregulating BiP may sensitize cells to disease.   
BiP’s critical role in maintaining cellular homeostasis and promoting cell survival 
makes it a target for several natural compounds.  Prunustatin A isolated from 
Streptomyces violaceoniger 4521-SVS3 downregulates BiP expression (359), and both 
the soy protein genistein and the macrocyclic compound versipelostatin inhibit the 
transcription of BiP (266, 417). Epigallocatechin gallate (EGCG) from green tea and the 
plant signaling molecule salicylic acid, from which aspirin is derived, both bind BiP and 
inactivate it by altering its ATPase activity (69, 77).   Another naturally produced 
molecule, the cholera toxin, upregulates BiP and other ERAD factors to aid in its 
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retrotranslocation from the ER to the cytoplasm (74).  The cholera toxin is only one AB5 
toxin that regulates BiP.  
 
Subtilase cytotoxin 
The AB5 toxins consist of the cholera toxin, pertusis toxin, and the shiga toxins 
and related Escherichia coli heat labile enterotoxins.  The AB5 toxins are named for their 
subunits, a single A subunit and a pentamer of B subunits.  Generally, the B subunits are 
involved in entry and the A subunit is responsible for toxicity by disrupting a key cellular 
process.  A recently identified AB5 toxin, subtilase cytotoxin (SubAB), selectively cleaves 
and inactivates BiP (270).   It consists of a 35 kD subtilase-like serine protease A subunit 
and five 13 kD B subunits.  SubAB cleaves BiP quickly in culture, within 1 to 2 hours 
post treatment.  An inactive derivative of SubAB is made by mutating a serine to alanine 
in a key catalytic triad of the A subunit at amino acid 272 (SubAA272B ).  Alternatively, to 
produce a toxin-resistant BiP that retains chaperone activity, amino acid 416 at the toxin 
cleavage site can be mutated from a leucine to aspartic acid (270).  These properties of 
SubAB make it a good experimental tool for inactivating BiP.   
 
The experiments described in this dissertation investigate the regulation of BiP 
and its role during an HCMV infection.  They first examine the kinetics of BiP expression 
at both the mRNA and protein level and the mechanisms used by HCMV to regulate BiP.  
They also aim to identify a role for BiP in infection, including any effects it might have on 
a viral infection and the processes required to produce infectious virions.  The 
localization of BiP during infection and any infection-specific interactions between BiP 
and viral or cellular proteins is also investigated.  Interestingly, although depleting BiP 
did not alter the steady state levels of viral proteins as might be expected for a molecular 
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chaperone, it did halt the production of infectious virions.  The results show that BiP is 
required to maintain viral cytoplasmic activity and has an important role in the intricate 
relationship that occurs between the cytoplasm and nucleus during infection. 
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CHAPTER 2: Materials and Methods 
 
Cell lines, reagents and plasmids 
Cells and cell culture: Lifetime extended-human foreskin fibroblasts (LE-HFF) (27) 
were cultured at 37 degrees (ο) Celsius (C) and 5% carbon dioxide (CO2) in Dulbecco’s 
Modified Eagle Medium with 10% fetal calf serum, 100 units/ milliliter (ml) penicillin, 100 
micrograms (µg)/ml streptomycin and 2 millimolar (mM) GlutaMAX (DMEM10).  All cell 
culture reagents were Gibco brand, purchased from Invitrogen (Carlsbad, CA).  For 
experimentation, fibroblasts were used between passages 3 and 13.  293T cells are a 
variation of the HEK293 cell line  that express polyomavirus large T antigen and were 
used for lentivirus production (99). 293T cells were cultured as described previously for 
LE-HFF.   
To generate stable cell lines expressing luciferase under control of either the 
wildtype BiP promoter or the BiP promoter with mutations in the ERSEs, LE-HFF were 
electroporated with plasmids containing the respective promoters in the pGL4.17 
plasmid backbone (cat# E6721, Promega, Madison, WI). Electroporation was performed 
using program U-023 of the Nucleofector Device (cat# AAD-1001, Lonza, Basal, 
Switzerland ) following the manufacturer’s instructions.  Briefly, the cells were released 
from the culture plate with trypsin (cat# 25300-054, Invitrogen) and centrifuged at 1200 
revolutions per minute (rpm) (~250 x g) and 4οC in a Sorvall RT7 table top centrifuge 
(Thermo Scientific, Waltham, MA) .  The cell pellet was resuspended in DMEM10, 
alliquotted into microcentrifuge tubes (1 X 106 cells per tube) and centrifuged at 1000 
rpm (61 x g) and 4οC in a Beckman-Coulter Microfuge 22R Centrifuge with a S241.5 
rotor (Brea, CA).  The cell pellets were resuspended in 100 microliters (µl) Basic 
Nucleofector Solution for Mammalian Fibroblasts from the Basic Nucleofector Kit for 
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Primary Mammalian Fibroblasts (cat# VPI-1002, Lonza) and transferred to a cuvette to 
be electroporated. After electroporation, the cells were transferred to 1 ml DMEM10 and 
plated in pre-warmed media.  Stably electroporated cells were selected by serially 
passaging the electroporated cells in the presence of 1 milligram (mg)/ml G418 (cat# 61-
234-RF, Mediatech Inc.).  After selection, cells were propagated in media containing 200 
µg/ml G418 and then maintained in normal DMEM10.      
 
Reagents: Thapsigargin (cat# 586005) and non-glycosidic indolocarbazole-1 (NGIC-1) 
(cat# 481500) were purchased from EMD Chemicals (Darmstadt, Germany).  
Thapsigargin was used at a concentration of 2 µg/ml.  NGIC-1 was used at a 
concentration of 0.5 micromolar (µM).  SubAB and SubAA272B (270) were generously 
provided by James and Adrian Paton (University of Adelaide) at stock concentrations of 
1.49 µg/ml and 0.97 µg/ml, respectively, and diluted in DMEM10 to a working dilution of 
100 nanograms (ng)/ml.  Tetramethylrhodamine (TRITC)-conjugated dextran with an 
average molecular weight of 155 kD was purchased from Sigma-Aldrich (cat# T1287) 
and used at a concentration of 10 mg/ml.  The control siRNA against green fluorescent 
protein (GFP) was purchased from Qiagen (cat# 1022064, Germantown, MD).  The 
sense (GGUUAUCAGUGUAAUGAAG) and antisense (CUUCAUUACACUGAUAACC) 
siRNA sequences that have been previously shown to target IE72 (131)  were custom 
generated by Thermo Scientific (formerly Dharmacon, Lafayette, CO).  The siRNA 
against La autoantigen (cat# D-006877-01-0005) and the scrambled control (cat# D-
001210-03-05) was also purchased from Thermo Scientific. 
 
Antibodies: All antibodies against BiP are commercially available and are summarized 
in Table 1.  The two antibodies against TRS1, SD2 and ZH3, were generously provided  
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Table 1.  Summary of commercially available BiP antibodies. 
 
AAs, amino acids; Mono, monoclonal; Poly, polyclonal; IF, immunofluorescence; IP, 
immunoprecipitation; W, Western  
Name Type Source 
Cat# 
Epitope 
(AAs) 
Assay 
BiPA  Rabbit Poly Abgent 
(AP1335a) 
1-654 IF 
BiPB Mouse 
Mono 
BD Bioscience 
(610978) 
525-628 W 
BiPC Goat Poly Santa Cruz  
(C-20, sc-1051) 
20AAs 
within 
600-654 
IF, W 
BiPD Mouse 
Mono 
R&D Systems 
(MAB4846) 
1-654 IF 
BiPH Rabbit Poly Santa Cruz  
(H-129, sc-13968) 
525-654 IF 
BiPN Goat Poly Santa Cruz 
(N-20, sc-1050) 
20AAs 
within 
1-50 
IP 
BiPR Rabbit Poly Sigma 
(GL-19, G8918) 
636-654 IF  
BiPS Rabbit Poly Sigma 
(ET-21, G9043) 
71-91 IF 
BiPY Rabbit Poly Abcam 
(ab21685) 
600-654 IF, IP 
KDEL 
BiP K 
Mouse 
Mono 
MBL 
(SR-827F) 
KDEL 
(649-
654) 
IF, IP 
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by Thomas Shenk (Princeton University) (292).  The rabbit polyclonal anti-ex2/3 
antibody, which recognizes the common exons 2 and 3 of the HCMV major immediate 
early proteins (MIEPs), was previously produced for this laboratory by Cocalico 
Biologicals (Reamstown, PA) (113).  An antibody that recognizes the HCMV viral protein 
produced from the UL50 ORF was produced in rabbits and affinity purified using a 
peptide containing amino acids 152-170 (GPENEGEYENLLRELYAKK) of pUL50 by 
Open Biosystems (Huntsville, AL) for this laboratory.  The anti-phospho lamin A/C serine 
22 antibody was purchased from Cell Signaling Technology (cat# 2026, Beverly, MA).  
The monoclonal antibody against pp28 used for immunofluorescence (IF) and 
immunoprecipitation (IP) assays was from Abcam (cat# ab6502). The pp28 monoclonal 
antibody used for Western blot analysis was from Santa Cruz Biotechnology (5C3, cat# 
sc-56975, Santa Cruz, CA). Other antibodies purchased from Santa Cruz include the 
polyclonal antibodies against phosphofructosekinase-1 (PFK-1) (K-15, cat# sc-31712), 
PDI (H-160, sc-20132), lamin B (C-20, sc-6216) and lamin A/C (N-18, cat# sc-6215), the 
monoclonal antibody against UL44 (p52) (CH13, cat# sc-69745), and the normal rabbit 
IgG (cat# sc-2027).  Antibodies against p230 (cat# 611280) and EEA1 (cat# 610456) 
were purchased from BD Biosciences (San Jose, CA).  The SUN1 (cat# HPA008346) 
and SUN2 (cat# HPA001209) antibodies were from Sigma-Aldrich (St. Louis, MO).  The 
antibody against the HCMV protein pp65 (c9100-25) was from US Biological 
(Swampscott, MA).  The antibody against SSB/La autoantigen (cat# H00006741-M01) 
was purchased from Novus Biologicals (Littleton, CO).  The anti-gB monoclonal antibody 
was purchased from East Coast Bio (cat# CA005, North Berwick, ME) and the anti-actin 
monoclonal antibody (cat# MAB1501) was from Chemicon International (Temecula, CA).   
All horseradish-conjugated secondary antibodies for Western analysis were 
purchased from Thermo Scientific (formerly Pierce Biotechnologies, Rockford, IL): goat 
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anti-rabbit IgG (H+L) pre-adsorbed with human serum (cat# 31462), goat alpha-mouse 
IgG (H+L)  pre-adsorbed with human, horse and bovine serum (cat# 31432), and rabbit 
anti-goat IgG (H+L) (cat# 31402).  All secondary antibodies used for 
immunofluorescence were purchased from either Santa Cruz: pre-adsorbed donkey anti-
rabbit IgG TRITC-conjugated (cat# sc-2095) or FITC-conjugated (cat# sc-2090), pre-
adsorbed isotype-balanced donkey anti-mouse IgG TRITC-conjugated (cat# sc-2300) or 
FITC-conjugated (cat# sc-2099), pre-adsorbed donkey anti-goat IgG TRITC-conjugated 
(cat# sc-2094) or FITC-conjugated (cat# sc-2024); or Invitrogen: donkey anti-goat IgG 
(H+L) Alexa Fluor 594 pre-adsorbed with rabbit, rat, mouse and human serum (cat# A-
11058), donkey anti-mouse IgG (H+L) Alex Fluor 594 (cat# A-21203), donkey anti-rabbit 
IgG (H+L) Alexa Flour 594 (cat# A-21207), donkey anti-goat IgG (H+L) Alexa Fluor 647 
pre-adsorbed with rabbit, rat, mouse and human serum (cat# A-21447), donkey anti-
mouse IgG (H+L) Alex Fluor 647 (cat# A-31571) and donkey anti-rabbit IgG (H+L) Alexa 
Flour 647 (cat# A-31573)  
 
Plasmids:  The  luciferase reporter plasmids with the wildtype and mutant BiP 
promoters in the pGL3 backbone were a gift from Kazutoshi Mori (Kyoto Research Park) 
(402).  For stable cell line generation described above, promoter sequences were cut 
from the pGL3 backbone using the restriction sites Kpn1 (cat# R0142S) and HindIII (cat# 
R0104S) and inserted into pGL4.17.  All restriction enzymes used for cloning were 
purchased from New England Biolabs (Ipswich, MA).  The pDL-N dual-luciferase 
plasmid has been described previously and was a gift to the lab (366).  The BiP 5’ UTR 
region containing the BiP IRES was PCR amplified from the pSVCAT/BiP/Luc plasmid 
(211) provided generously by Maria Hatzoglou using the following forward 
(CGCTGCAGAGGTCGACGCCGG) and reverse (CGGGTACCCTTGCCAGCCAGTTG 
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G) primers.  The PCR product was cloned into pDL-N using the restriction enzymes KpnI 
and PstI (cat# R0140).   
Plasmids expressing the viral proteins IRS1 (292), TRS1 (292), pp65 (12) and 
pp71 (12) were gifts from Thomas Shenk.  Plasmids pRL43a (274) and pSVH (70), 
containing HCMV MIEP genomic DNA, were obtained from Gary Hayward (Johns 
Hopkins University) and Richard Stenberg (Eastern Virginia Medical School), 
respectively.  The MIEP genomic DNA expressing plasmid pCD-MIE was made by 
Yongjun Yu in a two step cloning process in which the genomic region of pRL43a was 
inserted into pcDNA3.  First, a 1.4 kb XhoI/SalI blunt fragment from pRL43a replaced the 
XhoI/BsmI piece in pCDNA3; then, a 3.8 kb NdeI/XhoI fragment from pRL43a replaced 
NdeI/XhoI piece in the plasmid made in the first step.  The IE1 and IE2 cDNA expressing 
plasmids pRSV72 (92), pRSV86 (92), pIE72 (333) and pIE86 (333) were all obtained 
from Richard Stenberg.   Plasmids expressing the viral protein products UL69 and UL84 
were created by Yongjun Yu by cloning the respective PCR products into pcDNA3 using 
the restriction sites BamHI (cat# R0136S) and XhoI (cat# R0146S) or EcoR1 (cat# 
R0101S) and EcoR5 (cat# 10667145001, Roche), respectively.  All PCR products were 
verified by sequencing at the University of Pennsylvania DNA Sequencing Facility.    
The GFP expressing plasmid pMAX-GFP is from Lonza and provided as part of 
the Basic Nucleofector Kit for Primary Mammalian Fibroblasts.  The CC1-mCherry 
plasmid was generously provided by Erika Holzbaur (University of Pennsylvania).  
Plasmids expressing the proteins tagged with fluorescent markers used for live-cell 
analysis, pp28-red fluorescent monomeric protein (DsRed) (308) and lamin A-GFP were 
gifts from Bill Britt (University of Alabama-Birmingham) and Robert Kalejta (University of 
Wisconsin), respectively.   
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Plasmids encoding short hairpin RNAs (shRNAs) against BiP (cat# RHS3979-
9569448, 449, 451, Open Biosystems) and GFP (plasmid# 12273, Addgene, Cambridge, 
MA) in the lentiviral packaging plasmid pLKO.1-puro were purchased from their 
respective companies.  The third generation lentiviral packaging plasmids pMDL-RRE, 
pRSV-Rev and pCMV-VSVg necessary for lentiviral production were a gift from Eric 
Brown (University of Pennsylvania).   
 For plasmid DNA replication, the plasmids were transformed into 50 µl 
Subcloning Efficiency DH5α chemically competent cells (Invitrogen, cat# 18265-017).  
The plasmid DNA was incubated with the competent cells on ice for 30 min, followed by 
a 1 minute heat shock at 42οC.  After two minute incubation on ice, 450 µl Luria-Bertani, 
Miller broth (LB) (cat# 244620, BD Biosciences) was added and the cultures were 
incubated for 90 minutes at 37οC.  The cultures were then plated on LB agar (cat# 
244520, BD Biosciences) plates containing the appropriate antibiotic, 30 µg/ml 
Kanamycin or 50 µg/ml Ampicillin, and the plates were incubated at 37οC overnight.  
One colony from each plate was inoculated in 100 ml LB media containing the 
appropriate antibiotic and shaken overnight at 37οC and ~225 rpm.  Plasmids were 
extracted from bacteria using Qiagen Plasmid MaxiKit (cat# 12163, Qiagen) according to 
the manufacturer’s instructions.  Briefly, overnight cultures were pelleted by 
centrifugation at 10,000 rpm (15,180 x g) and 4οC in a SLA-1500 rotor and Sorvall RC-
5B Refrigerated Superspeed Centrifuge.  The pellets were resuspended and lysed, and 
the cellular debris was precipitated using Qiagen buffers 1, 2 and 3.  The precipitated 
material was cleared from the lysate by subsequent centrifugation steps at 13,000 rpm 
(20,199 x g) and 4οC in a SS-34 rotor for 30 and 15 minutes.  The supernatant 
containing the plasmid DNA was applied to a Qiagen column, and the bound DNA was 
washed and eluted with Qiagen buffers QC and QF.  The eluted plasmid DNA was 
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precipitated in isopropanol and washed with 70% ethanol.  After the precipitation and 
wash steps, DNA was pelleted by centrifugation in a SS-34 rotor at 11,500 rpm (15,806 
x g) for 30 and 10 minutes, respectively. The final DNA pellet was dried and 
resuspended in distilled deionized water (ddH2O) and stored at -20
οC.  The 
concentration of the plasmid DNA was acquired by reading absorbance at 260 and 280 
nanometers on a DU800 spectrophotometer (Beckman-Coulter). 
 
Virus preparation and titration 
HCMV preparation and stocks: All experiments were done with the Towne strain of 
HCMV (cat# VR-977, American Type Culture Collection (ATCC), Manassas, VA).  Some 
experiments were done with a Towne strain of HCMV expressing GFP under the control 
of the SV40 promoter.  The GFP insert replaces a region of non-essential genes from 
US1–US11 (217).  For experiments with HCMV, LE-HFF were infected at a multiplicity of 
infection (MOI) of 3 plaque forming units (pfu)/cell.  For infection, the virus was thawed in 
a 37°C water bath, sonicated 10 times with a one second pulse in a Bransonic 200 
Ultrasonic Cleaner (Branson, Danbury, CT) and vortexed.  The virus was diluted in an 
appropriate amount of DMEM10 and added to plates containing LE-HFF, which were 
then incubated at 37°C.  After the absorption phase of infection, (~2 hpi), the plates were 
refed with fresh DMEM10 and returned to 37°C.  For experiments with UV-inactivated 
HCMV, virus was exposed to short wavelength, 254 nanometer, ultraviolet (UV) light 
administered in a UV Stratalinker 1800 (Stratagene, La Jolla, CA) for 5 minutes in a 35-
millimeter uncovered tissue culture dish.  Cells were then infected as described above.  
HCMV was propagated in LE-HFF plated in 15-centimeter (cm) plates and 
infected in 10 ml DMEM10 at a very low MOI, 0.01 - 0.1 pfu/cell.  After appearance of 
cytopathic effects (CPE) in 80-90% of cells, an additional 10 ml DMEM10 was added to 
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each plate.  Virus was harvested 3-4 days post media addition by scraping cells into the 
media and pooling the media/cell mixture from each plate for centrifugation at 4000 rpm 
(3313 x g) in a Sorvall RT7 table top centrifuge for 30 min at 4οC. After centrifugation, 
the supernatants were pooled and stored at 4οC.  The cell pellets were resuspended in a 
small amount of DMEM10, distributed in 500 µl aliquots to microcentrifuge tubes, 
sonicated 10 times with a 1 second pulse, vortexed 15 seconds and spun down at 
13,000 rpm (10,268 x g) for 2 minutes in a Microfuge 22R Centrifuge with a S241.5 rotor.  
The supernatant was added to the previously pooled supernatant and the cell pellets 
were resuspended in 500 µl DMEM10.  The sonication, vortex and centrifugation steps 
were repeated and the supernatant was again added to the previously pooled 
supernatants.  The pooled media was then alliquotted into polyclear ultracentrifuge tubes 
(cat# 7052, Seton, Los Gatos, CA).  A 7 ml D-sorbitol cushion (20% sorbitol, 50mM Tris-
HCl (hydrochloric acid), pH 7.2, 1mM MgCl2, 100 µg/ml Bacitracin (cat# B0125, Sigma-
Aldrich)) was applied beneath the medium using a sterile 10 cm steel needle and syringe.  
The medium was then centrifuged, after being weighed and counterbalanced, at 19,000 
rpm (47,700 x g) for 1 hour at room temperature (RT) using a SW28 rotor and L8-80M 
ultracentrifuge.  The media and sorbitol cushion were removed from the pellet by 
vacuum aspiration and the virus was resuspended in DMEM and alliquotted into 
cryovirals to be flash frozen in liquid nitrogen and stored at -80οC. 
 
HCMV titrations and growth curves:  Virus titers were determined using the 50% 
tissue culture infectious dose (TCID50) method (288).  Serial dilutions of the virus to be 
titered were made as follows: 10-2, 10-3, 10-4, 10-5, 10-6, 10-7 and 10-8.  100 µl of the 
dilutions were added to LE-HFF plated in 1 row (12 wells) of a 96-well plate.   Each 
titration was performed in triplicate plates.  Each plate contained a row of no virus control.  
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After 1 week, the cells were refed media by adding 100 µl DMEM10 to each well of the 
plates. At 14 days, viral titers were read by monitoring the presence of either CPE for the 
non-GFP Towne virus or expression of GFP for the Towne-GFP virus.  Each well with 
CPE or GFP was scored as positive.  The two dilutions after the dilution that scored 12 
positive wells were used to calculate the titer using the TCID50 chart (288).  
 Titration of virus samples for growth curves was performed using the TCID50 
method as described above.  For growth curve samples, cells were washed 3 times in 
DMEM10 following the absorption phase of infection and 2 ml DMEM10 was added to 
each sample. At this time, the input virus sample (~2 hpi) was harvested as described 
below with the exception that the initial volume was only 1 ml, and this sample was 
harvested before washing with DMEM10.  The other viral samples were harvested at the 
indicated times post infection by transferring 1.5 ml of medium to a conical vial on ice.  
The cells were then scraped into the remaining 500 µl of medium and transferred to a 
microcentrifuge tube to be sonicated 10 times with a 1 second pulse, vortexed 15 
seconds and microcentrifuged at 13,000 rpm (16,060 x g) for 1 min at RT in a Sorvall 
Pico Biofuge (Thermo).  The supernatant was added to the previously collected medium 
and the sample was frozen at -80οC.  For BiP depletion growth curves, SubAA272B was 
added at 2 hpi and SubAB was added at either 2 hpi or 12 hours before harvest. 
 
Lentiviral production and harvest: For lentiviral production, four 10-cm plates of 293T 
cells were transfected 24 hours after plating using the following protocol.  For each plate 
to be transfected, 20 µg of either shBiP or shGFP pLKO.1 plasmids, 10 µg pMDL-RRE, 
5 µg pRSV-Rev and 6 µg pCMV-VSVg were combined in a microcentrifuge tube and 
brought to a volume of 500 µl in sterile ddH2O.  Two tubes were prepared for each 
shRNA type.  To each tube, 500 µl of 2X HBS solution (0.27 molar (M) sodium chloride 
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(NaCl), 0.01 M potassium chloride (KCL), 0.001 M sodium phosphate (Na2HPO4), 
0.042M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 0.011 M 
glucose, pH 7.05) and 50 µl of 2.5 M calcium chloride (CaCl2) was added.  After a 25 
minute incubation at RT, the transfection mix was added to 5 ml fresh medium on each 
plate and the plates were placed at 37°C.  After 6 hours, the medium was replaced with 
7.5 ml fresh DMEM10 and the plates were returned to 37°C.  At 48 hours post 
transfection, the medium was collected from each plate and replaced with 7.5 ml fresh 
DMEM10.  The plates were returned to 37°C.  The collected medium from plates 
transfected with the same shRNA were combined and stored at 4°C.  At 72 hours post 
transfection, the cells were scraped into 7.5 ml of medium.  Cells from the plates 
transfected with the same shRNA were combined and spun down at 3000 rpm (1864 x g) 
for 5 min at 4°C in a Sorvall RT7 table top centrifuge.  The supernatant was combined 
with the 15 ml of media collected the previous day.  The cell pellet was resuspended in 4 
ml serum-free medium and alliquotted into 4 microcentrifuge tubes to be sonicated 10 
times with a 1 second pulse.  After sonication the cells were centrifuged at 13,000 rpm 
(10,268 x g) for 5 minutes at 4°C in a Microfuge 22R Centrifuge with a S241.5 rotor.  The 
supernatant was combined to the 30 ml media already collected and the pooled media 
was filtered through a 0.45 µM Steriflip vacuum-driven filtration system (cat# 
SE1M003M00, Millipore, Billerica, MA).  After filtration, the media was weighed, 
counterbalanced and centrifuged for 2 hours at 4°C, 26,000 rpm (89,454 x g) in a SW-28 
rotor, L8-80M ultracentrifuge.  The supernatant was removed and the pellet was 
resuspended in 2.5 ml DMEM10.  The virus was then alliquotted into 10 cryovials in 250 
µl amounts, snap frozen in liquid nitrogen and stored at -80°C.  Virus was used without 
being titrated. 
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Lentiviral infection:  For knockdown of BiP using shRNA, 250 µl of BiP shRNA 
expressing lentivirus was added to 2.25 ml DMEM10 containing 8 µg/ml polybrene (cat# 
107689, Sigma-Aldrich).  Two 6-cm plates with LE-HFF were infected with 1 ml of 
medium containing the BiP shRNA lentivirus.  As a control, 1 plate was infected with 1 
ml GFP shRNA lentivirus.  One plate was left untreated and was not infected with 
lentivirus.  The plates were incubated at 37°C for 6 hours before replacing the medium 
with 4 ml of fresh DMEM10.  At 24 hpi, all 4 plates were infected with HCMV at an MOI 
of 3.  At 96 hours post HCMV infection (120 hours post lentiviral infection), the plates 
were either prepared for electron microscopy or harvested for Western analysis. 
 
Assay protocols  
Protein harvests and quantification:  LE-HFF were plated in either 6-cm plates or 6-
well dishes and infected with HCMV-Towne-GFP at an MOI of 3.  For BiP depletion 
studies, mock- or HCMV-infected LE-HFF were treated with SubAA272B at 2 hpi or with 
SubAB at either 2 hpi or 12 hours before harvest.  For lamin phosphorylation studies, 
cells were treated with NGIC-1 or SubAB at 2 and 72 hpi.    Mock- and HCMV-infected 
samples were harvested for protein at the indicated times post infection by washing one 
time in 1 ml chilled phosphate buffered saline (PBS) (140mM NaCl, 2.7 mM potassium 
chloride, 1.5 mM potassium phosphate monobasic, 8 mM sodium phosphate dibasic).  
Following the wash, 200 – 300 µl radioimmunoprecipitation assay (RIPA) buffer (1% NP-
40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 0.15 M NaCl, 10 mM 
sodium phosphate [ph 7.2], 2 mM ethylenediaminetetraacetic acid (EDTA), 50 mM 
sodium fluoride (NaF), 1 mM phenylmethylsulfonyl fluoride (PMSF), 1.7 µg/ml aprotinin, 
0.2 mM sodium orthovanadate, 1 µg/ml leupeptin) was added and cells were rocked 5 
minutes at 4οC.  Cells were then scraped into the lysis buffer, transferred to a 
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microcentrifuge tube and centrifuged at 13,000 rpm (10,268 x g) for 10 minutes at 4οC in 
Microfuge 22R Centrifuge with a S241.5 rotor. The supernatant was transferred to a new 
tube and frozen at -80οC.   
 Protein lysates were quantified by adding 5 µl protein sample to 995 µl ddH2O 
and 250 µl Bio-Rad Protein Assay Dye Reagent Concentrate (cat# 500-0006, BioRad, 
Hercules, CA) and light absorbance at 595 nm was read on a DU800 spectrophotometer.  
Bovine serum albumin (BSA) dilutions of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 
mg were used as protein standards.   
 
Western analysis: Proteins were prepared for Western analysis by adding 15-30 µg 
protein to 3X SDS loading buffer (187.5 mM Tris-HCl, pH 6.8, 6% SDS, 30% glycerol, 
0.03% bromophenol blue, 467 mM β-mercaptoethanol).  Samples were boiled for 5 
minutes, centrifuged at 13,000 rpm (16,060 x g) for 1 minute at RT in Sorvall Pico 
Biofuge (Thermo), and loaded onto polyacrylamide gels.  Gels were either 8% or 10% 
polyacrylamide, depending on the size of proteins to be investigated. Molecular weight 
standards (cat# P7708S, New England Biolabs) were also run to aid in identification of 
protein band size.   Gels were run in 25 mM Tris, 192 mM glycine, 0.1% SDS (1X 
running buffer) until the desired separation among bands was obtained, as monitored by 
the molecular weight standard.  Following electrophoresis, gels were transferred to 
nitrocellulose membranes (cat# 162-0115, Bio-Rad) under constant current in transfer 
buffer (25 mM Tris, 192 mM glycine, 20% methanol).  Membranes were blocked in 5% 
non-fat dry milk in tris-buffered saline-Tween 20 (TBST) (20 mM Tris pH 7.5, 150 mM 
NaCl, 1% Tween 20) with gentle rocking at RT.  Primary antibodies were diluted in 2% 
BSA-TBST using optimized dilutions based on manufacturer’s recommendations, or 
experience, and rocked gently, usually overnight at 4οC.  Following primary antibody 
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incubation, membranes were washed 3 times in TBST. Secondary antibodies were 
diluted 1:5000 in 5% non-fat dry milk-TBST and rocked gently at RT.  Membranes were 
washed 3 times in TBST before addition of Lumi-Light Western Blotting Substrate (cat# 
12 015 200 001, Roche, Indianapolis, IN) for 5 min.  For bands with low signal, 
membranes were incubated for 1 min with a 1:5 dilution of SuperSignal Femto Substrate 
(cat# 34094, Thermo). Membranes were then exposed to either X-Omat AR-5 non-
interleaved film (cat# 165 1454, Kodak, Rochester, NY) or BlueLite Autrorad Film (cat# 
F-9024-8X10, ISC BioExpress, Kaysville, UT).   
 
Quantitative PCR (polymerase chain reaction):   LE-HFF were plated in 6-cm dishes 
and infected with HCMV-Towne or HCMV-Towne-GFP at an MOI of 3.  At the indicated 
times post infection, RNA was isolated from fibroblasts using the RNeasy Mini Kit (cat# 
74104, Qiagen) according to manufacturer’s instructions as follows.  The cells were 
harvested in Buffer RLT provided by Qiagen, homogenized by passing 5 times through a 
20-guage needle with a 1-ml syringe and applied to a Qiagen column after addition of 
70% ethanol.  After washing with Qiagen buffers RW1 and RPE, RNA was eluted in 50 
µl ddH2O and quantified by reading absorbance at 280 and 260 nanometers on a DU800 
spectrophotometer.   
cDNA was generated from 1-2 µg RNA with Superscript First-Strand Synthesis 
System for RT-PCR (reverse transcriptase-PCR) (cat# 11904-018, Invitrogen) using the 
manufacturer’s instructions.  The RNA was incubated with deoxynucleotide 
triphosphates (dNTPs) and random hexamers for 5 minutes at 65οC and then cooled 1 
minute on ice.  Following addition of Qiagen’s reverse transcriptase buffer, magnesium 
chloride, dithiothreitol and an RNase inhibitor, samples were incubated at RT for 2 
minutes.  Superscript II reverse transcriptase was added and the samples were 
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incubated at RT for 10 minutes, 42οC for 50 minutes and 70οC for 15 minutes.  The 
samples were cooled on ice before addition of RNase H and incubation at 37οC for 20 
minutes. cDNA was stored at -20οC. 
Quantitative-PCR was performed with a 7900 HT system (Applied Biosystems, 
Foster City, CA) using Taqman Universal PCR Master Mix (cat# 4304437) and gene 
expression assays for BiP (Hs00607129_gH) and GAPDH (Hs00266705_g1) from 
Applied Biosystems.  Reactions were incubated for 2 minutes at 50οC and 10 minutes at 
95οC and then cycled 40 times between 15 seconds at 95οC and 1 minute at 60οC.  PCR 
results were analyzed using Sequence Detection Systems software version 2.3 (Applied 
Biosystems). 
 
Luciferase assays: Luciferase reporter plasmids were introduced into LE-HFF by 
electroporation using one of two methods, with 260 volts and 950 µFarad administered 
by Bio-Rad Gene Pulser II or by using program U-023 of the Nucleofector Device as 
described previously.  For luciferase experiments with HCMV samples, cells were 
infected 24 hours post electroporation by Gene Pulser II and harvested at the indicated 
time points.  For experiments not involving an HCMV infection, cells containing 
transfected plasmids were harvested 48 hours post transfection.  To harvest samples, 
cells were washed one time in PBS before addition of 200 µl 1X reporter lysis buffer, part 
of the Luciferase Assay System (cat# E4030, Promega) or 1X Renilla luciferase assay 
lysis buffer, part of the Renilla Luciferase Assay System (cat# E2810, Promega). Cells 
were scraped into lysis buffer, transferred to a microcentrifuge tube and immediately 
frozen at -80οC.   Cells were then thawed, centrifuged at 13,000 rpm (10,268 x g) for 10 
minutes, 4οC in a Microfuge 22R Centrifuge with a S241.5 rotor and quantified as 
described above under protein quantification.  Luciferase assays were performed by 
52 
adding equal amounts of protein, brought to a constant volume with the respective lysis 
buffer, to Luciferase Assay Substrate from either Promega’s Luciferase Assay System or 
Renilla Luciferase Assay System.  Samples were read for 10 seconds on Lumat LB 
9501 Luminometer (PerkinElmer, Waltham, MA) and results were graphed in Microsoft 
Excel (Redmond, WA). 
 
Assembly compartment isolation: LE-HFF plated in 15-cm dishes were either infected 
with HCMV-Towne-GFP at an MOI of 3 or left uninfected.  At 60 hpi, one mock and one 
infected plate were treated with either SubAB or SubAA272B.  Plates were harvested at 
72 hpi by removing all but approximately 10 ml of medium. The cells were scraped into 
the remaining medium, transferred to a 15-ml conical vial and spun down at 1100 rpm 
(~225 x g) at 4οC in Sorvall RT7 table top centrifuge.  After centrifugation, the medium 
was removed and the cell pellet was washed 2 times in 1 ml PBS, using the same 
centrifugation conditions as above to pellet cells after each wash.  After the second wash, 
the cell pellet was resuspended in 1 ml Tris-buffered isotonic saline pH 7.4 containing 5 
mM EDTA and 0.25 M sucrose and passed 20 times through a 27-gauge needle.  The 
samples were then centrifuged for 10 minutes at 4οC at 3500 rpm (744 x g) in a 
Microfuge 22R Centrifuge with a S241.5 rotor.  The supernatant was applied to a 
sucrose step-gradient of 0.5 ml 2 M, 1.5 ml 1.6 M, 2.5 ml 1.4 M, 3.5 ml 1.2 M and 1.5 ml 
0.8 M sucrose.  The gradients were weighed, counterbalanced and centrifuged for 3 
hours at 25,000 rpm (77,175 x g) and 4οC in a SW-41Ti rotor, L8-80M ultracentrifuge.  
Fractions were collected using Piston Gradient Fractionator (BioComp, Fredericton, 
Canada) at 0.3 rpm speed and 2.4 cm distance.  About 30 fractions were collected from 
each sample and frozen at -80οC.        
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Immunoprecipitation (IP) reactions:  Mock- or HCMV-infected LE-HFF were washed 
one time in 1X PBS at 96 hpi before addition of 1% Triton-X buffer (20 mM HEPES pH 
7.5, 150 mM NaCl, 1% Triton-X 100, 10% glycerol, 1 mM EDTA, 10 mM tetrasodium 
pyrophosphate, 100 mM NaF, 17.5 mM β-glycerophosphate, 1 mM PMSF, 8.5 µg/ml 
aprotinin, 1.25 µg/ml pepstatin (cat# 11359053001, Roche)).  Cells were then rocked 5 
minutes at 4οC, scraped into the Triton-X buffer and transferred to a microcentrifuge tube.   
After centrifugation at 13,000 rpm (10,268 x g) in a S241.5 rotor, Microfuge 22R 
Centrifuge, the supernatant was transferred to a new microcentrifuge tube, flash frozen 
in liquid nitrogen and stored at -80οC.  Protein concentrations were determined as 
previously described.   
For IP reactions with pp28, TRS1, KDEL, BiPY and UL50 antibodies, 20 µl of 
Dynabeads protein G (cat# 100-03D, Invitrogen) per sample were washed 2 times in 
wash and bind buffer (0.1 M sodium phosphate buffer, 0.1% Tween 20 pH 8.2).  After 
each wash step and throughout the protocol, beads were separated from the 
supernatant by incubation on MagnaRack (cat# CS15000, Invitrogen) for at least 1 
minute.  Generally, 2 µg of antibody was then added per 20 µl of washed Dynabeads.  
Because the concentration of the TRS1 antibodies was unknown, 10 µl of each TRS1 
antibody was combined with one tube of washed Dynabeads.  The samples were 
brought to an equal volume with wash and bind buffer and then mixed gently on a 
nutator at RT for 30 minutes.  Following three washes in 1X PBS, 150 µg of either mock 
or HCMV protein lysate was added and the samples were gently mixed on a nutator at 
RT for 30 minutes.  The samples were washed 3 times in 1X PBS before addition of 20 
µl 1X SDS loading buffer with 2X β-mercaptoethanol and incubation at 70οC for 10 
minutes.  After collecting the liquid by a quick centrifugation, the samples were 
separated on MagnaRack and transferred to a new tube.  For input samples, 10 µl of 
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mock and HCMV lysates were added to 5 µl 3X SDS loading buffer.   The above IP 
protocol varied depending on the antibodies and antibody lots used. 
For immunoprecipitation reactions involving pUL50, the beads/antibody complex 
was cross-linked after incubation using the following protocol.  The antibody conjugated 
beads were washed twice in conjugation buffer (20 mM sodium phosphate, 150 mM 
NaCl, pH 7.8) before addition of 5 mM BS3 crosslinker (Bis(sulfosuccinimidyl) suberate).  
After incubation with gentle mixing on a nutator at RT for 30 minutes, the BS3 was 
quenched by addition of 1 M Tris-HCl, pH 7.5, and left on nutator for 15 minutes.  The 
beads were then washed 3 times in PBS-0.5% Tween 20 before addition of protein 
lysates and continuation with the IP protocol. 
For analysis of IP, input and IP samples were either subjected to Western 
analysis as described above or analyzed by mass spectrometry.  For mass spectrometry 
analysis, the gel was rinsed two times in ddH20 following gel electrophoresis, and then 
fixed and stained in Coomassie Brilliant Blue (cat# 161-0400, Bio-Rad) diluted in 45% 
methanol and 10% acetic acid overnight at RT with gentle rocking.  The gel was first 
destained at RT with gentle shaking in two washes of 45% methanol and 10% acetic 
acid and then changed to 12% methanol and 10% acetic acid, with periodic changes of 
the destain solution.  Bands of interest were then excised from the gel and subjected to 
nano-reverse phase high performance liquid chromatography tandem mass 
spectrometry for identification.  Peptide results were run against the National Center for 
Biotechnology Information non-redundant database. 
  
Dextran staining:  Mock- and HCMV-infected LE-HFF were loaded with dextran at 48 
hpi.  Cells were removed from the plate by trypsinization and pelleted at 1200 rpm (~250 
x g) for 5 min at 4°C.  The cell pellet was washed one time in PBS and one time in 
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hypertonic buffer (0.5 M Sucrose, 10% polyethylene glycol 1000, 20 mM HEPES pH 7.2) 
(246).  The cells were then incubated 10 min at 37°C in hypertonic buffer containing 10 
mg/ml TRITC-dextran 155 kD. After addition of 80 volumes of DMEM10, the cells were 
incubated an additional 10 minutes at 37°C.   The cells were then washed two times in 
DMEM10 and plated on coverslips.  At 72 and 96 hpi, the cells were stained with 4’6’-
diamidino-2-phenylindole (DAPI), observed by microscopy on a Nikon Eclipse E600 and 
analyzed as described under the Indirect Immunofluorescence section. 
   
Microscopy 
Electron microscopy (EM):  LE-HFF were plated in 6-cm plates and either infected at 
an MOI of 3 with HCMV-Towne-GFP or left uninfected.  For BiP depletion samples, 
SubAB and SubAA272B were added to LE-HFF at 84 hpi and prepared for EM analysis 12 
hours post treatment at 96 hpi.  A description of BiP depletion using shRNA is described 
previously.  These samples were prepared for EM analysis at 96 hours post HCMV 
infection (120 hours post lentiviral infection). To harvest samples for EM, cells were 
washed 1 time with PBS before addition of EM fixative (2.5% glutaraldehyde, 2% 
paraformaldehyde in sodium cacodylate).   Cells were prepared for EM analysis by the 
Penn Biomedical Imaging Core.  Cells were pelleted in microcentrifuge tubes and then 
postfixed with 1% aqueous osmium tetroxide (OsO4) for 1 hour.  The cell pellets were 
dehydrated with ethanol and propylene oxide, embedded in epoxy resin, and 
polymerized at 65οC for 28 hours. Ultrathin (~80 nm thick) sections were cut with a 
diamond knife, mounted on single-slot grids, stained with uranyl acetate and bismuth, 
and examined with an FEI Tecnai T12 transmission electron microscope. 
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Indirect Immunofluorescence (IF):  Coverslips containing either mock-infected LE-HFF 
or LE-HFF infected with HCMV at an MOI of 3 were prepared for IF at the indicated 
times post infection.  For BiP depletion experiments, SubAB and SubAA272B were added 
12 hours before harvest.  For dynein studies, cells were electroporated at 24 hpi using 
Nucleofector device as described above and harvested at 96 hpi.  Cells were prepared 
for IF analysis by washing three times in 1 ml 1X PBS before fixing in 1 ml 4% 
paraformaldehyde at RT for 20 minutes. Cells were then washed three times in 1 ml 
PBS and stored in PBS at 4οC until used for staining.   
Cells were prepared for incubation with antibodies by permeabilizing in PBS 
containing 0.5% Triton X-100 and blocking in PBS containing 5% BSA and 0.5% Tween 
20.  Alternatively, cells were blocked with PBS containing 10% human or goat serum 
(cat# H4522 & G6761, Sigma-Aldrich).  Cells were incubated with primary antibodies 
diluted in blocking buffer; optimal antibody dilutions were determined based on 
manufacturer’s recommendations.  Following primary antibody incubation, cells were 
washed three times for 5 minutes in PBS and then incubated with secondary antibody 
diluted 1:100 in blocking buffer for 30 minutes at RT.  Following three 5 minute washes 
in 1 ml PBS, cells were rinsed in ddH2O and mounted on slides (cat# 12-550-343, Fisher 
Scientific, Pittsburgh, Pa) with Vectashield mounting medium containing DAPI (cat# H-
1200, Vector Laboratories, Burlingame, CA).  Slides were examined on a Nikon Eclipse 
E600 or Leica DM 6000 Confocal microscope.  Micrographs were acquired, processed 
by deconvolution, and analyzed using Image-Pro 6.3 and Autoquant X2 software 
(MediaCybernetics, Bethesda, MD) or Leica Confocal Software (Leica Microsystems, 
Wetzlar, Germany). 
For live-cell microscopy, HCMV-infected cells were electroporated with plasmids 
expressing lamin A fused to GFP and pp28 fused to DsRed at 2 hpi.  Following 
57 
electroporation, cells were plated in Lab-Tek II chambered coverglass slides (cat# 155379, 
Nalgene).  Images were acquired on an Olympus IX71 inverted microscope and analyzed 
using Volocity (PerkinElmer). For BiP depletion experiments, samples were treated with 
100 ng/ml SubAB or SubAA272B immediately before analysis. 
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CHAPTER 3: HCMV upregulates the ER chaperone BiP  
 
As mentioned in Chapter 1, the levels of the ER chaperones BiP and GRP94 are 
increased during HCMV infection.  The experiments in this chapter detail the kinetics of 
BiP induction during infection at the level of both protein and mRNA.  Furthermore, 
during infection the activation of two of the UPR transcription factors responsible for 
inducing ER chaperones in response to stress, XBP1 and ATF6, is inhibited (136).  
Although ATF4, another UPR transcription factor that induces transcription of BiP, is 
expressed during infection, its activation appears to succeed that of BiP (136).  These 
observations suggest that HCMV must use an alternative method for inducing ER 
chaperones such as BiP.  The experiments in this chapter will investigate the 
mechanism of HCMV-mediated expression of BiP. 
 
HCMV increases BiP protein during infection 
To determine the kinetics with which BiP protein is increased during an HCMV 
infection, LE-HFF grown to confluence were infected with HCMV Towne strain at an MOI 
of 3.  Cell lysates were collected from infected cells at 4, 8, 12, 24, 36, 48, 60, 72 and 96 
hpi.  Cell lysates were also prepared from mock-infected cells left untreated or treated 
for 48 hours with thapsigargin, which induces UPR activation and BiP expression.  The 
lysates were analyzed by Western analysis using antibodies that detect epitopes at both 
the N- and C-termini of BiP.  Both antibodies show that BiP protein levels are 
significantly increased as early as 36 hpi, peak at 60-72 hpi, and decrease by 96 hpi 
(Figure 6).  The increase in BiP approaches the level seen after the UPR has been 
robustly activated by treatment with thapsigargin for 48 hours.  To coordinate the  
increase in BiP with the progression of the infection, antibodies against the following viral 
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Figure 6.  HCMV temporally regulates BiP protein levels 
 
Proteins were harvested from mock- and HCMV-infected LE-HFF at the indicated times 
post infection or from uninfected cells treated for 24 h with thapsigargin (Thaps). Thirty 
micrograms of extracted protein from each sample were analyzed by Western analysis. 
BiP was detected using antibodies directed to the C-terminus (BiP-C) and N-terminus 
(BiP-N).  Antibodies directed against the MIEPs (IE86 and IE72), an early protein p52 
(UL44), and a late protein p28 (UL99) were used to monitor viral protein expression.  
Actin was used as a loading control.  Copyright © American Society for Microbiology, 
Journal of Virology, 82, 2008, 32, 10.1128/JVI.01881-07. 
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proteins were used: the HCMV MIEPs (IE72 and IE86), an early protein, p52, and a late 
protein, p28 (Figure 6).  The peak expression of BiP correlates with the expression of 
proteins during the late phase of infection, a time of abundant viral protein synthesis, 
many of which traverse the ER.  
 
HCMV infection increases BiP mRNA levels   
To determine if the HCMV-induced increase in BiP protein involves increased 
BiP mRNA levels, total mRNA was harvested from mock-infected fibroblasts and 
fibroblasts infected with HCMV at 4, 8, 12, 24, 36, 48, 60, 72 and 96 hpi.  Quantitative-
PCR showed an increase in BiP mRNA as early as 8 hpi.  This increase was sustained 
throughout infection, peaking at a level three times greater than mock between 36 and 72 
hpi before decreasing slightly at the later times during infection (Figure 7A).  The 
unexplained decline in BiP RNA at 24 hpi is quite repeatable.   The peak level of BiP mRNA 
during infection corresponds with the peak in BiP protein.  However, the peak level of BiP 
mRNA was much less than after treatment with the UPR inducer thapsigargin for 24 hours, 
which resulted in greater than 100 fold induction (Figure 7B). These data suggest that 
although increased BiP protein levels in HCMV-infected cells correspond to an increase in 
BiP mRNA, other mechanisms may be involved as well. 
 
HCMV activates the BiP gene promoter in an ERSE-independent manner   
During UPR activation, increased BiP transcription results from activation of the BiP 
gene’s ERSE-containing promoter.  Thus, activation of the BiP promoter during infection 
was investigated using luciferase reporter plasmids, where the luciferase gene was under 
the control of either the wild type BiP promoter (wt-BiP-Luc) or a mutant BiP promoter (mut- 
BiP-luc) which lacked the three ERSEs (402).  After electroporation of the reporter plasmids, 
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Figure 7.  HCMV temporally regulates BiP mRNA levels 
 
(A) cDNA was generated from total RNA harvested from mock (M)- or HCMV-infected 
LE-HFF at the indicated times post infection and subjected to quantitative-PCR analysis 
using primers specific for BiP and GAPDH.  BiP mRNA was normalized to GAPDH 
mRNA.  (B)  RNA was harvested from untreated (-) or thapsigargin (Thaps)-treated (+) 
LE-HFF and analyzed as described in A.  Fold activation in A & B is relative to the mock 
sample, which was set to 1.  Graphs show results from one of multiple experiments 
performed in triplicate.  Error bars represent standard deviation of the triplicate samples 
from represented experiment.  
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LE-HFF were infected with HCMV.  Increased luciferase levels from the WT-BiP-Luc 
plasmid is detected between 8 and 12 hpi; by 24 hpi luciferase levels are greatly increased 
(Figure 8A).  The levels of luciferase produced from the mut-BiP-Luc promoter are similar 
to those from the WT-BiP-Luc promoter, suggesting that HCMV-induced activation of the 
BiP promoter does not require the ERSEs.  Importantly, treating electroporated cells with 
thapsigargin, a robust activator of the UPR, increased luciferase levels in cells expressing 
the wt-BiP-Luc plasmid, but not the mut-BiP-Luc reporter (Figure 8A).  This confirms that 
under the electroporation conditions, both reporter plasmids respond as expected to ER 
stress.  It is important to note the discrepancy between the fold activation in BiP mRNA and 
promoter activation, as measured by luciferase assay, in thapsigargin treated samples.  
While the luciferase assay, which is dependent on the protein level of luciferase, is subject 
to the thapsigargin-induced UPR inhibition of translation initiation, the production and 
detection of BiP mRNA is not affected by this block.  The data suggest that during HCMV 
infection the BiP gene promoter is activated by a viral-mediated mechanism that does not 
require the endoplasmic reticulum stress elements. 
 In the HCMV field there is a dogmatic belief that plasmid-borne promoters are 
readily and promiscuously activated by the HCMV MIEPs.  Despite evidence refuting this 
belief, it persists (206).  Thus to ensure the specificity of BiP promoter activation by HCMV, 
stable cell lines expressing the luciferase reporter from either the wildtype or ERSE-mutant 
BiP promoters were generated.  Similar to the transient electroporation results, when LE-
HFF stably expressing the luciferase plasmids were infected, an increase in luciferase is 
detected from both the wildtype and mutant promoters.  Similar to the transient 
electroporation results, activation occurs between 8 and 12 hpi (Figure 8B).  Treatment with 
the UPR inducer thapsigargin confirmed inducibility of the wildtype (WT) BiP promoter, but 
not the mutant promoter in response to ER stress (Figure 8B).  This data confirms that the  
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Figure 8.  HCMV activates the BiP promoter 
 
(A) LE-HFF were electroporated with plasmids expressing luciferase under control of the 
WT BiP promoter (WT-BiP-Luc) or a promoter with mutations in the three ERSEs (mut-
BiP-Luc).  The cells were either infected with HCMV 24 hours post electroporation or 
treated with thapsigargin (Thaps) for 24 hours.  Proteins were harvested at the indicated 
times post infection for luciferase analysis.  Fold activation was determined by normalizing 
luciferase levels in infected/treated samples to levels in mock samples. (B) LE-HFF stably 
expressing WT-BiP-Luc or mut-BiP-Luc were mock-infected, HCMV-infected or treated 
with Thaps and analyzed for luciferase expression as described in A.  Graphs show 
results from one of multiple experiments performed in triplicate.  Error bars represent 
standard deviation of the triplicate samples from represented experiment. 
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BiP promoter is activated during infection and that the activation occurs independently of 
the ERSEs.   
 
The BiP promoter is not activated by incoming virions 
The increase in BiP mRNA levels by 8 hpi suggests that activation may be 
mediated by either proteins that enter with the virions, for example tegument proteins, or 
by the synthesis of immediate early viral proteins.  To test if the BiP promoter is 
activated by incoming viral proteins, LE-HFF stably expressing luciferase under control 
of the BiP promoter were infected with either HCMV or UV-irradiated HCMV.  UV 
irradiation damages the HCMV genome such that the virus can enter cells, release 
tegument proteins and initiate signaling pathways that prepare the cell for infection; 
however no gene expression occurs from the damaged DNA.  Proteins were harvested 
for luciferase assays at 4, 8 and 24 hpi.  UV-inactivation of HCMV was confirmed by 
detecting the HCMV MIEPs in the normal HCMV, but not UV-irradiated lysates at 24 hpi 
(Figure 9).  Luciferase levels are increased in cells infected with normal HCMV at 24 hpi, 
indicative of the BiP promoter activation described above.  In contrast, luciferase levels 
are not increased in cells infected with UV-inactivated HCMV (Figure 9).  Western 
analysis confirmed successful entry of virus, showing equivalent levels of pp65, a 
prominent tegument protein, in cell extracts from both normal and UV-irradiated virus 
infections extracted at 4 hpi (Figure 9).         
 
The HCMV MIEPs activate the BiP promoter 
The above data show that the BiP promoter is activated prior to 24 hpi by newly 
synthesized viral immediate early proteins.  To test this, plasmids expressing an array of 
HCMV immediate early and early proteins, MIEPs, TRS1, IRS1, pp71, pp65, pUL69 and  
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Figure 9.   The BiP promoter is not activated by incoming virions 
 
LE-HFF stably expressing the WT BiP promoter were infected with normal HCMV or 
HCMV irradiated with UV light (UV-HCMV).  Protein samples were harvested for 
luciferase analysis at the indicated times post infection.  Fold activation was determined 
by normalizing luciferase levels in infected samples to levels in mock samples.  Graph 
shows results from one of multiple experiments performed in triplicate.  Error bars 
represent standard deviation of the triplicate samples from represented experiment.  The 
level of the viral MIEPs and tegument protein pp65 were detected by Western analysis in 
lysates from normal HCMV and UV-HCMV samples.  Actin was used as a loading 
control.   
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pUL84, were co-electroporated with the WT-BiP-Luc reporter plasmid into LE-HFF.  Figure 
10A shows that only the MIEPs significantly activated the BiP promoter.  The most 
abundant MIEPs are the 72 kD IE72 (also called IE1) and the 86 kD IE86 (also called IE2); 
therefore, plasmids expressing these proteins individually were co-electroporated with 
either WT-BiP-Luc or mut-BiP-Luc.  Figure 10B shows that increased luciferase activity was 
detected by the introduction of either IE72 or IE86.  Similar analysis using the mut-BiP-Luc 
reporter showed that promoter activation by IE72 and IE86 does not depend on the ERSEs, 
although there is some reduction in activation by IE86.  This may be a result of the 
mutations in the CAAT elements of the ERSE since previous analysis has shown that IE86 
has a preference for CAAT sites (206).  In sum, the data suggest that the HCMV MIEPs 
can activate the BiP promoter by a mechanism that does not require the ERSEs. 
 Since the HCMV MIEPs may be non-specifically activating the reporter plasmids, 
MIEP activation of the BiP promoter was tested in the stable cell line expressing luciferase 
under control of the WT BiP promoter.  Two plasmids expressing MIEP genomic DNA, as 
well as plasmids expressing the cDNA of either IE72 or IE86 were tested.  All increased 
luciferase levels, suggesting activation of the BiP promoter (Figure 10C).  A plasmid 
expressing GFP did not increase luciferase levels, suggesting that activation of the BiP 
promoter was specific for the viral MIEPs.  Western analysis of the electroporated lysates 
confirmed the presence of the MIEP proteins (Figure 10).  The above data suggest that the 
HCMV MIEPs activate the BiP promoter independently of the ERSEs. 
 
Knockdown of IE72 by siRNA impairs BiP promoter activation 
To confirm a role for the MIEPs in inducing BiP promoter activation during 
infection, one of the MIEPs, IE72, was depleted using an IE72-specific siRNA.  The 
stable cell line expressing luciferase under control of the BiP promoter was electroporated 
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Figure 10.  The HCMV MIEPs activate the BiP promoter 
 
(A) A vector control plasmid or plasmids expressing the following viral proteins: MIEPs, 
TRS1, IRS1, pp71, pp65, UL69 and UL84, were co-electroporated into LE-HFF with WT-
BiP-Luc and harvested 48 hours post electroporation for luciferase analysis.  Fold 
activation was determined by normalizing luciferase levels to those of the vector control, 
set at 1.  (B) WT-BiP-Luc  and mut-BiP-Luc were co-electroporated with plasmids 
expressing genomic MIEP DNA or cDNAs for IE72 and IE86 and harvested 48 hours post 
electroporation for luciferase analysis as in A.  (C) LE-HFF stably expressing luciferase 
under control of the WT BiP promoter were electroporated with plasmids expressing 
genomic MIEP DNA or cDNAs expressing IE72, IE86 and GFP.  Protein lysates were 
harvested 48 hours post electroporation for luciferase and Western analyses.  Graphs 
show results from one of multiple experiments performed in triplicate.  Error bars 
represent standard deviation of the triplicate samples from represented experiment.  
Actin was used as a loading control for Western analysis.   
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with siRNA against IE72 or GFP.  Western analysis shows that IE72 was significantly, but 
not completely, depleted in cells containing the siRNA targeting IE72 (Figure 11A).  
Analysis of luciferase levels from protein lysates shows the increase in luciferase levels 
reported earlier that occurs in HCMV-infected cells.  This increase was reduced in cells with 
a depleted level of IE72, when compared to cells treated with the control siRNA against 
GFP (Figure 11A), confirming a role for IE72 in BiP promoter activation.   
To further investigate a role for IE72 in activating BiP, mRNA was harvested from 
mock- or HCMV-infected cells treated with siRNA against IE72 or GFP.  Similar to the 
luciferase results, the level of BiP mRNA is reduced in cells treated with an siRNA against 
IE72 (Figure 11B).  The reduction in BiP mRNA is not as large as the reduction seen in the 
luciferase assay, but the IE72 depletion is less, as shown by Western analysis (Figure 11B).  
The above data confirm a role for IE72 and the MIEPs in inducing BiP transcription during 
infection. 
 
HCMV activates translation from the BiP IRES 
 The level of BiP mRNA is increased during HCMV infection; however the increase 
does not correlate with the significant increase in BiP protein. This suggests that HCMV 
may utilize additional methods for increasing BiP protein.  BiP mRNA contains an IRES in 
the 5’ UTR, a feature HCMV may utilize for increasing BiP protein during infection.  To 
investigate the activation of the BiP IRES by HCMV, a dual luciferase plasmid was 
generated that expresses Renilla luciferase under control of the HCMV promoter and firefly 
luciferase under control of first 221 nucleotides of the BiP transcript, the 5’ UTR of BiP, 
which contains the BiP IRES (Figure 12A).  A stable stem-loop structure inserted after the 
Renilla luciferase ORF reduces activation of firefly luciferase by ribosomal scanning (366).   
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Figure 11.  Depleting IE72 reduces BiP promoter activation and mRNA 
 
 
(A) Mock- and HCMV-infected LE-HFF stably expressing luciferase under control of the 
BiP promoter were electroporated with siRNA against IE72 or GFP at 2 hpi.  Protein 
samples were harvested for Western and luciferase analyses.  Fold activation was 
relative to Mock samples.  (B)  RNA was harvested from HCMV-infected LE-HFF and 
analyzed by quantitative-PCR using primers against BiP and GAPDH.  BiP mRNA was 
normalized to GAPDH mRNA.  Fold increase is relative to Mock sample. Graphs show 
results from one of multiple experiments performed in triplicate.  Error bars represent 
standard deviation of the triplicate samples from represented experiment.  Protein was 
harvested concurrently with RNA for western analysis to monitor knockdown of IE72. For 
western analysis, actin was used as a loading control.   
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LE-HFF were electroporated with the BiP IRES dual-luciferase plasmid, or a vector 
control plasmid that did not contain the BiP IRES.  The cells were mock-infected or infected 
with HCMV 24 hours post electroporation.  Protein was harvested for luciferase analysis at 
8 and 24 hours post infection.  Figure 12B shows the levels of both Renilla and firefly 
luciferase expressed from either the BiP IRES or control plasmid.  Luciferase levels were 
normalized to mock levels, which were set at 1.  The level of Renilla luciferase, 
representing transcript level, was comparable between the two plasmid samples at all time 
points.  In contrast, although the level of firefly luciferase was comparable between the two 
samples at 8 hpi, the level was significantly greater in the presence of the BiP IRES when 
compared to the vector control at 24 hpi.  This is represented graphically in Figure 12C, 
which shows the ratio of firefly to Renilla luciferase for both plasmids in either mock-infected 
samples or HCMV-infected samples at 8 and 24 hpi. This suggests that BiP IRES activity is 
activated during an HCMV infection. The activation of IRES activity by 24 hpi correlates 
with the increase in BiP protein, which also begins to increase by 24 hpi (Figure 6). 
As mentioned in Chapter 1, several cellular proteins bind and regulate the BiP IRES.  
One cellular protein of interest was La autoantigen, also called SSB, due to its activation 
during HCMV infection.  Western analysis shows that SSB is increased beginning at 12 hpi, 
peaks at 24 hpi, and declines slightly thereafter before maintaining a constant level during 
the late times of infection (Figure 12D).  The increase in SSB from 12-24 hpi correlates with 
both the onset of BiP IRES activity and the increase in BiP protein, implicating it as a 
potential regulator of BiP IRES activity during infection. 
To investigate the role of SSB in regulating BiP IRES activity during HCMV 
infection, mock- or HCMV-infected LE-HFF were electroporated with the BiP IRES dual-
luciferase plasmid and either an siRNA targeting SSB, or a scrambled (SCR) non-
specific siRNA.  Proteins were harvested for luciferase assays from the mock- and 
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Figure 12.  HCMV activates translation from the BiP IRES 
 
(A) Schematic of dual-luciferase plasmid generated by inserting the 221 nucleotide 
5’UTR of BiP (BiP IRES) into pDL-N (vector) (B & C) LE-HFF expressing plasmids with 
Renilla luciferase under control of the HCMV promoter and firefly luciferase from either 
the BiP IRES or its vector control were mock- and HCMV-infected. Protein lysates were 
harvested at 8 and 24 hpi.  Results are graphed as luciferase values at each time point 
set relative to Mock samples (B) and as the ratio of firefly to Renilla luciferase for each 
sample (C). (D) Protein from mock (M)- and HCMV-infected LE-HFF were harvested at 
the indicated times post infection.  Western analysis was performed using antibodies 
against SSB and actin (loading control).  (E) Mock- and HCMV-infected LE-HFF were 
electroporated with the dual-luciferase BiP IRES plasmid and siRNA against a control 
scrambled sequence (SCR) or SSB.  Protein was harvested for luciferase and Western 
analysis at the indicated times post infection.  Results are graphed as the ratio of firefly 
to Renilla luciferase for each sample.  Western analysis confirms knockdown of SSB and 
a reduced level of BiP protein.  Actin was used as a loading control.  Graphs in A, C, & E 
show results from one of multiple experiments performed in triplicate.  Error bars 
represent standard deviation of the triplicate samples from represented experiment. 
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HCMV-infected samples at 8 and 24 hpi.  The ratio between Renilla and firefly luciferase is 
comparable between the mock-infected and 8 hpi samples (Figure 12E).  In contrast, the 
ratio of Renilla to firefly luciferase is lower in the samples with reduced levels of SSB, when 
compared to the SCR control samples.  Western analysis confirms both the knockdown of 
SSB and a reduction in BiP protein in the SSB siRNA treated samples (Figure 12E).  Thus, 
the cellular protein SSB is at least one factor that activates the BiP IRES during infection. 
  
The above data show that the ER chaperone BiP is induced during HCMV infection 
at both the level of transcription and translation.  HCMV must specifically upregulate BiP, as 
cellular transcription factors normally responsible for BiP induction are not induced during 
infection.  These results show that HCMV accomplishes this by activating transcription from 
the BiP promoter and by increasing BiP IRES activity.  HCMV utilizes a unique mechanism 
to activate the BiP promoter which does not require the ERSEs or the transcription factors 
that are normally induced to activate transcription from the ERSEs.    For translational 
regulation, HCMV enhances the utilization of the BiP IRES.  At least one mechanism to 
accomplish this involves the upregulation of SSB/La autoantigen, which is induced early in 
infection. 
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CHAPTER 4: HCMV requires BiP for virion assembly. 
 
The data and indicated figures from this chapter are published in the Journal of 
Virology in the following journal articles “Human Cytomegalovirus Specifically Controls 
the Levels of the Endoplasmic Reticulum Chaperone BiP/GRP78, Which is Required for 
Virion Assembly” (33) and “The Endoplasmic Reticulum Chaperone BiP/GRP78 Is 
Important in the Structure and Function of the Human Cytomegalovirus Assembly 
Compartment” (32).   
 
Since HCMV specifically upregulates BiP during infection, the virus may require it 
to complete a successful replication cycle.  BiP levels peak at a period of intense viral 
protein production and the onset of late protein synthesis and virion assembly; many late 
proteins traverse the ER to receive post-translation modifications.  Thus, BiP may 
function in virion protein folding and assembly. To investigate the role of BiP during an 
HCMV infection, BiP was depleted using shRNA against BiP or the SubAB cytotoxin.  
The quick cleavage of BiP by SubAB provides a means to obtain a snapshot of BiP’s 
function at various times during infection.   
 
HCMV steady state protein levels are not altered when BiP is depleted 
LE-HFF were infected with HCMV and samples were harvested for protein 
analysis at 24, 48, 60, 72 and 96 hpi.  At 2 hpi, 100 ng/ml SubAB or SubAA272B were 
added and samples were harvested at 48, 72 and 96 hpi.  Since it was feared that the 
viral infection might not get established in the absence of BiP and that extended BiP 
depletion would be deleterious to cells, a second strategy was utilized in which SubAB  
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Figure 13.  Depletion of BiP does not alter steady state levels of viral proteins. 
  
Proteins were harvested from HCMV-infected LE-HFF that were either left untreated (No 
Treatment) or treated with SubAB (WT Toxin) or SubAA272B (Mut Toxin). The times 
(hours post infection) of toxin addition and protein harvest are given. Proteins were 
analyzed by Western analysis using antibodies that detect BiP or the viral proteins IE72, 
IE86, p52 and pp28 to monitor viral protein expression. Actin was used as a loading 
control.  BCP, the BiP C-terminal cleavage product. Copyright © American Society for 
Microbiology, Journal of Virology, 82, 2008, 33, 10.1128/JVI.01881-07.  
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was added for a 12 hour period before harvest.  Protein lysates following this treatment 
were harvested at 48, 60, 72 and 96 hpi.  
Western analysis of the protein lysates showed a normal infection in the untreated 
samples, as shown by an increase in BiP and the onset of viral immediate-early (IE1 and 
IE2), early (p52) and late proteins (pp28) (Figure 13).  Treatment with SubAA272B did not 
alter steady state levels of BiP or of viral proteins.  In contrast, BiP was cleaved in all 
samples treated with SubAB, whether treated at 2 hpi or for 12 hours before harvest, as 
shown by the disappearance of full-length BiP and the appearance of the 28 kD 
cleavage product (Figure 13).  As anticipated for samples treated with SubAB at 2 hpi, 
both the levels of the major immediate early proteins and the early protein p52 were 
significantly reduced.  The late protein pp28 was not detected, suggesting that the 
infection did not proceed to the late phase in the absence of BiP.  Interestingly, 
treatment with SubAB for 12 hour periods did not significantly reduce the steady state 
levels of the MIEPs, p52 or pp28 (Figure 13).  Therefore, depletion of BiP during an 
established infection does not significantly affect the steady state levels of viral proteins. 
 
 
BiP is required for infectious virion formation  
Although BiP depletion did not alter viral protein steady state levels in an 
established infection, HCMV may induce and require BiP to produce infectious virions.   
To test this hypothesis, a viral growth curve was generated where both cell-free and cell-
associated virus were collected from infected samples that were either untreated, or 
treated with SubAB or SubAA272B as described above.  In the untreated samples, 
production of infectious virions initiated between 24 and 48 hpi.  Viral titers peaked at 72 
hpi before reaching a plateau at the later times during infection (Figure 14A). As 
expected, treatment with SubAA272B did not alter infectious virion production.  In contrast,  
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Figure 14.  HCMV requires BiP to produce infectious virions 
 
 
 (A) LE-HFF were infected with HCMV, and infectious virions were harvested at the 
indicated times post infection (Normal Growth Curve). Virus was also harvested at 48, 
72, and 96 hpi from infected LE-HFF that had been treated with either SubAB (Toxin) or 
SubAA272B (Mutant Toxin) at 2 hpi. Viral titers were determined using the TCID50 method. 
(B) Growth curves were performed as described for panel A, except that SubAB was 
added 12 h before the harvesting of virus at 48, 60, 72, or 96 hpi.  Copyright © American 
Society for Microbiology, Journal of Virology, 82, 2008, 34, 10.1128/JVI.01881-07. 
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no infectious virions were produced at any time during infection when SubAB was added 
at 2 hpi, consistent with the Western analysis that showed late protein synthesis did not 
occur.  BiP depletion is toxic to cells and the inability of cells to produce infectious virions 
may be a consequence of cells not being healthy enough to support a viral infection.  To 
circumvent this, a different treatment strategy was used in which SubAB was added 12 
hours before harvest.  This approach allowed the infection to get established before BiP 
depletion.  Interestingly, infectious viral titers were decreased after addition of SubAB for 
12 hours at any point during an infection (Figure 14B).  This result suggests a role for 
BiP in the production of infectious virions. 
 
BiP is required for the cytoplasmic activity of HCMV 
Since the data indicate that BiP plays a role in virion formation without affecting 
the steady state levels of viral proteins, electron microscopy was performed to further 
analyze BiP’s role during an HCMV infection.  Mock- and HCMV-infected LE-HFF were 
harvested at 96 hpi after treatment with 100 ng/ml SubAB or SubAA272B for 12 hours.  A 
fibroblast treated with SubAA272B appeared normal and was indistinguishable from an 
untreated mock fibroblast (Figure 15A).  In contrast, an uninfected fibroblast treated with 
SubAB showed obvious cytotoxic effects, indicated by the formation of secondary 
lysosomes and autophagic vesicles (Figure 15B&C).  This is predictable since BiP 
depletion has been shown to be deleterious for cells (270).  Similar to what was 
observed with SubAA272B treatment of mock cells, treatment with SubAA272B had no 
effect on HCMV-infected cells (Figure 15D).  The infected fibroblasts treated with 
SubAA272B resembled the infected fibroblasts that were untreated.  An abundance of viral 
cytoplasmic activity was apparent as demonstrated by tegument bodies and maturing 
virions.  Virions that had completed cytoplasmic maturation and had egressed from the  
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Figure 15.  Treatment with SubAB abolishes HCMV cytoplasmic activity 
 
Mock-infected (A to C) and HCMV-infected (D to F) LE-HFF were treated with either 
SubAA272B (mutant toxin) (A and D) or SubAB (WT toxin) (B, C, E, & F) at 84 hpi and 
were harvested at 96 hpi for analysis by EM. White arrows in E & F point to 
nucleocapsids in the nucleus.  Copyright © American Society for Microbiology, Journal of 
Virology, 82, 2008, 35, 10.1128/JVI.01881-07. 
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cell were present in the extracellular space.  Nucleocapsids were also present in the 
nucleus.   
In contrast, treatment with SubAB abolished all of the cytoplasmic and 
extracellular viral activity, suggesting the viral cytoplasmic events involved with virion 
formation cease when BiP is depleted (Figure 15E&F).  This is in accordance with the 
growth curve data which shows that infectious virions are not produced when BiP is 
depleted.  However, nucleocapsids were present in the nucleus, indicating that a viral 
infection had initiated.  Interestingly, the infected cells also did not show the cytotoxic 
effects of SubAB treatment seen in mock-infected cells.  Specifically, the cytoplasm was 
relatively quiet and secondary lysosomes and autophagic vesicles were not present.  
This suggests that the alterations made to the cellular physiology by the viral infection 
protect the cell against the cytotoxic effects of the toxin. 
 To verify that the above results are in fact a phenotype of BiP depletion and not a 
result of a yet unidentified effect of SubAB, an alternative strategy was used to deplete 
BiP during infection.  BiP expression was silenced using a shRNA introduced into 
fibroblasts using a lentiviral vector. shRNAs silence gene expression by forming a tight 
hairpin that is processed by the RNA interference machinery into a 21-nucleotide RNA 
that recognizes target mRNAs (260).  A set of 3 shRNAs targeting BiP were tested for 
BiP knockdown.  LE-HFF were infected with lentivirus expressing the BiP shRNA that 
exhibited the best BiP knockdown, or a control shRNA against green fluorescent protein 
(GFP).  The cells were infected with HCMV 24 hours post lentiviral infection.  Due to the 
long half life of BiP, the peak of BiP knockdown, 10-20% of normal levels, was not 
achieved until 48 to 72 hours after infection with HCMV.  This allowed the viral infection 
to get established before BiP depletion, in contrast to cells treated with SubAB in which 
BiP was depleted almost immediately.  Electron microscopic analysis revealed that  
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Figure 16.   Depletion of BiP by shRNA mimics BiP depletion by SubAB toxin.  
 
LE-HFF were infected with HCMV 24 hours after infection with lentivirus vectors 
expressing shRNA against GFP (control shRNA, A & B) or BiP (C to F). The cells were 
harvested at 96 hours post-HCMV infection for analysis by EM. White arrows indicate 
the presence of nucleocapsids in the nucleus. Copyright © American Society for 
Microbiology, Journal of Virology, 82, 2008, 36, 10.1128/JVI.01881-07. 
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Figure 17.  Nucleocapsids stall outside of the nucleus in the absence of BiP 
 
LE-HFF were infected with HCMV, treated with either SubAB (WT toxin) (A, B, & C) or 
SubAA272B (Mut. toxin) (D & E) at 84 hpi, and harvested at 96 hpi for analysis by EM. 
White arrows in panels A to C show accumulation of virion particles outside of the 
nuclear membrane. White arrows in panels D and E indicate the nuclear membrane.  
Copyright © American Society for Microbiology, Journal of Virology, 82, 2008, 37, 
10.1128/JVI.01881-07. 
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HCMV-infected cells depleted of BiP by shRNA had a similar phenotype to cells 
depleted of BiP by SubAB (Figure 16C,D&F).  The cells had reduced cytoplasmic activity 
and nucleocapids were present in the nucleus.  Importantly, cells infected with the 
control GFP shRNA showed normal viral cytoplasmic activity (Figure 16A&B).  The 
similar phenotype between the BiP shRNA cells and the SubAB treated cells confirms 
that depleting BiP inhibits viral cytoplasmic activity. 
The above results suggest a role for BiP in either nuclear egress or the 
cytoplasmic events of tegumentation, envelopment and egress.  Closer examination of 
the EM sections revealed that in some SubAB-treated cells, depending on how the 
samples were sectioned, cytoplasmic nucleocapsids were lined up just outside the outer  
nuclear membrane (ONM) (Figure 17).  These nucleocapsids appear to have stalled in 
the maturation and egress process.  This heavy concentration of nucleocapsids on one 
side of the nucleus is not detected at any time in cells treated with SubAA272B.  Therefore, 
after egressing from the nucleus in the absence of BiP, and upon the cessation of viral 
cytoplasmic activity, nucleocapsids are stalled outside the nuclear membrane and all 
further cytoplasmic viral progression is halted. 
 
BiP is relocalized to the viral cytoplasmic assembly compartment  
To further investigate BiP’s role during an infection, the localization of BiP was 
examined using indirect immunofluorescence microscopy. Localization of BiP was 
performed with seven different commercially available antibodies (Table 1).  Each 
antibody detected BiP in its normal ER localization in mock-infected cells.  Staining of 
HCMV-infected LE-HFF revealed two distinct BiP localizations (Figure 18).    Antibodies 
directed against epitopes generated from full-length BiP (BiPA), the N-terminus of BiP 
(BiPS) or a large portion of the C-terminus (BiPH, BiPY), detected BiP in a perinuclear,  
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Figure 18.  BiP is localized to two distinct locations during HCMV infection 
 
Mock- or HCMV-infected LE-HFF were prepared for immunofluorescence microscopy at 
96 hpi. BiP (red) was detected using the following antibodies described in Table 1: BiPA 
(A), BiPS (S), BiPH (H), BiPY (Y), BiPC (C), KDEL (BiPK, K) and BiPR (R). Normal 
rabbit IgG (IgG) was used as a control. Nuclei were stained with DAPI (blue).  Copyright 
© American Society for Microbiology, Journal of Virology, 83, 2009, 11423, 
10.1128/JVI.00762-09. 
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cytoplasmic compartment.  The location of the compartment next to the kidney-shaped 
nucleus suggests that this could be the viral cytoplasmic assembly compartment 
described in Chapter 1 (302).   In contrast, antibodies with epitopes at the C-terminus 
(BiPH and BiPY) also detected BiP in a second localization, often found at the periphery 
of the cells.  These regions looked condensed or clumped compared to the cytoplasmic 
localization of BiP in mock-infected cells.  Three additional antibodies, BiPC, BiPR and 
BiPK, detected these BiP-containing structures, but did not detect the perinuclear 
structure.  All three of these BiP antibodies were directed against epitopes to the 
extreme C-terminus.  The failure of these antibodies to detect BiP in the perinuclear 
compartment suggests that the extreme C-terminus of BiP is occluded in this 
compartment.  Since the ER-retention signal is located at the C-terminus, BiP’s 
relocalization from the ER to this structure may occur by blocking this retention signal 
and consequently the epitope for these antibodies. 
Using antibodies to detect the localization of proteins in HCMV-infected cells can 
be problematic since the virus encodes Fc receptors that interact with antibodies, 
particularly of rabbit origin (7).  The antibodies that detect BiP in the perinuclear region 
(BiPA, BiPS, BiPH, BiPY) are all rabbit polyclonal antibodies, raising concern that the 
antibodies are interacting with the Fc receptors and incorrectly localizing BiP to the 
perinuclear structure.  However, one rabbit polyclonal antibody, BiPR, did not detect the 
perinuclear structure.  Furthermore, using equivalent staining conditions and exposure 
times, control normal rabbit IgG also did not detect the perinuclear structure (Figure 18).  
The structure could however be detected by increasing the exposure time and gain 
when examining the normal IgG staining.  However, these controls may not be sufficient 
as HCMV Fc receptors have a higher affinity for some IgG subclasses than others (245).  
The differences in subclasses of the rabbit IgG’s could account for the differences in 
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staining.  To remove the variability of rabbit antibody preparations, a mouse monoclonal 
antibody generated against full length BiP (BiPD) was used to stain mock and infected 
cells.  The antibody was not recommended by the manufacturer for immunofluorescence 
studies, and accordingly, in mock-infected cells, BiP could not be detected in its typical 
ER localization (Figure 19A).  In infected cells, however, staining in a perinuclear 
structure was detected.  The staining was notably different from that seen with the rabbit 
antibodies (Figure 18 & Figure 19A).  BiPD stained a perinuclear ring with a dot in the 
middle.  This ring was similar to the rings of organelles that constitute the assembly 
compartment described in Chapter 1. 
Although the results of staining with both BiPD and the rabbit antibodies suggest 
that BiP is associated with a perinuclear structure, the localization in this perinuclear 
structured differed between the rabbit antibodies and BiPD.   To resolve this discrepancy, 
it was necessary to use the rabbit antibodies under a condition where the Fc receptors 
were blocked before addition of the antibodies.  The previous experiments with the rabbit 
antibodies had been done with bovine serum albumin (BSA) as the blocking reagent, 
which would not be sufficient to block the HCMV Fc receptors.  Previous studies of the 
perinuclear assembly compartment region have used goat serum for blocking HCMV-
infected samples (67, 68, 302).  However, goat IgG has been reported to have very little 
affinity for HCMV Fc receptors (7) and blocking with goat serum did not alter the staining 
of BiP in the perinuclear structure using the rabbit antibodies (Figure 19B).  Since human 
serum binds well to the HCMV Fc receptors, it was utilized for blocking HCMV-infected 
samples.  Interestingly, when blocked with HCMV-negative human serum, the rabbit 
antibody BiPS stained BiP in a perinuclear ring with a dot in the middle; the same 
staining pattern that was observed with the mouse monoclonal antibody BiPD.  Blocking 
with human serum did not change the staining pattern of BiPR, which detected BiP in the  
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Figure 19.  BiP colocalizes with pp28 in perinuclear ring 
 
(A) Mock- and HCMV-infected LE-HFF were prepared for immunofluorescence at 96 hpi 
and stained for BiPD (red), a mouse monoclonal antibody. (B) HCMV-infected LE-HFF 
were prepared for immunofluorescence by blocking with 10% normal goat serum in PBS 
and stained for BiP (red) using BiPH (Table 1) (C) HCMV-infected cells were prepared at 
96 hpi and stained for BiP (red) using BiPS and BiPR antibodies (Table 1) and either 
pp28 or gB (green). Colocalization of BiP and pp28 is indicated in yellow. Nuclei shown 
in panels A and B were stained with DAPI (blue). Comp., composite. Adapted from 
Figure 2 of reference 32. 
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condensed cytoplasmic regions at the periphery of the cell but not in any perinuclear 
region (Figure 19C). This result was similar to what was observed in cells blocked with 
BSA.  Thus, blocking with human serum allows for the use of rabbit antibodies in 
immunofluorescence of HCMV-infected cells. These observations confirm that BiP is 
localized in two distinct regions, one of which is a perinuclear ring resembling a layer of 
the viral cytoplasmic assembly compartment.    
To determine if the perinuclear ring of BiP was in fact part of the assembly 
compartment, infected cells were co-stained for BiP and viral proteins that localize to the 
assembly compartment, pp28 and gB.  BiP did not colocalize with gB, which stained the 
space between the peripheral BiP ring and the central dot (Figure 19C).  The peripheral 
ring of BiP did, however, colocalize with pp28 (Figure 19C).  Not surprisingly, pp28 did 
not colocalize with the condensed cytoplasmic structures recognized by BiPD.  These 
results show that the peripheral ring of BiP is in fact part of the assembly compartment, 
and that BiP colocalizes with the viral tegument protein pp28 in this ring. 
To confirm the microscopic evidence of BiP’s localization to the assembly 
compartment, a non-microscopic approach was taken.  A previous study reported that 
the assembly compartment could be isolated by sucrose gradient centrifugation (302).  
Western analysis showed a significant portion of BiP sedimented with both pp28 and gB, 
confirming the results obtained by microscopy (Figure 20).  A control protein not reported 
to be associated with the assembly compartment, the cellular glycolytic enzyme 
phosphofructosekinase-1 (PFK-1), does not sediment with BiP and viral assembly 
compartment markers.  These results provide further evidence that BiP is associated 
with the assembly compartment of HCMV. 
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Figure 20.  BiP cosediments with pp28 and gB in a sucrose gradient 
 
Lysates were prepared from infected cells treated with SubAA272B (Mutant Toxin) and 
sedimented on a discontinuous sucrose gradient as previously described (302). The 
gradient was fractionated from the top (300 µl/ fraction) and analyzed by Western 
analysis using antibodies against BiP, pp28, gB, TRS1 and PFK-1. AC, assembly 
compartment.  Adapted from Figure 3 of reference 32. 
 
 
89 
A ring of BiP forms concurrently with assembly compartment formation   
  The above observations detected BiP in the assembly compartment late in 
infection at 96 hpi.  To determine at what time during infection BiP enters the assembly 
compartment, coverslips containing LE-HFF were infected with HCMV and fixed in 
paraformaldehyde at 24, 36, 48, 60, 72 and 96 hpi.  In addition to staining for BiP, 
coverslips were co-stained with pp28 to monitor assembly compartment formation 
throughout infection.  Figure 21 shows that early in infection (24-36 hpi), BiP localization 
remains unaltered when compared to staining in mock-infected cells.  At 48 hpi, large 
amounts of pp28 are detected outside the nucleus at what presumably will become the 
site of the assembly compartment (Figure 21).  Although BiP is not yet detected in this 
region, the BiP-containing clumps at the cell periphery are now detectable (Figure 21).  
By 60 hpi, pp28 has coalesced into a round perinuclear structure. A distinct ring of BiP is 
beginning to form around the pp28 structure. At 72 and 96 hpi, the previously described 
ring of BiP with a central dot is present.   
 
 
BiP is localized to condensed ER in infected cells  
In addition to the ring around the assembly compartment, BiP is detected in 
condensed cytoplasmic structures recognized by BiPD.  During an HCMV infection, BiP 
performs important functions in the ER; one of these is the downregulation of MHC1 
through its interaction with the viral proteins US2 and US11 (117, 349).  The cytoplasmic 
clumps of BiP at the periphery of the cell could be condensed ER, as normal organelles 
have been reported to be condensed at the cell periphery (254).  This is likely a result of 
the abundance of viral activity in the cytoplasm; the cytoplasmic clumps don’t appear 
until after late protein synthesis and accumulation in the cytoplasm (Figure 21).  To test if 
BiP colocalized with another ER marker in the condensed cytoplasmic region, HCMV-  
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Figure 21.  Time course staining of BiP during an HCMV infection 
 
At the indicated times post infection, cells were prepared for immunofluorescence 
microscopy and co-stained for pp28 (green) and BiP (red) using an antibody that 
sees BiP in the condensed cytoplasmic regions (BiPY, top panels)  or the 
cytoplasmic assembly compartment (BiPS, bottom panels).  Nuclei were stained 
with DAPI (blue). Comp, composite
91 
 
 
 
 
 
 
 
 
 
Figure 22.  The clumped cytoplasmic regions of BiP are condensed ER 
 
HCMV-infected LE-HFF on coverslips were treated with SubAA272B (Mut Toxin) or 
SubAB (Toxin) at 60 hpi and fixed for immunofluorescence microscopy at 72 hpi. 
Coverslips were stained for BiP (red) and PDI (green).  Nuclei were stained with DAPI 
(blue).  Copyright © American Society for Microbiology, Journal of Virology, 83, 2009, 
11425, 10.1128/JVI.00762-09. 
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infected coverslips treated with SubAB or SubAA272B for 12 hours were prepared for 
immunofluorescence at 72 hpi.  Detection of BiP using the BiPC antibody, which detects 
only the cytoplasmic clumps and not the perinuclear region, colocalized with protein 
disulfide isomerase (PDI), an established ER marker, in the condensed cytoplasmic 
regions (Figure 22). This suggests that these regions are condensed ER.  Furthermore, 
the clumps disappeared in the SubAB treated cells, consistent with the EM data that viral 
cytoplasmic activity is abolished after toxin treatment and that the cytoplasm returns to a 
more normal appearance. 
 
BiP is required for assembly compartment integrity  
Our data show that BiP is induced by HCMV, relocalized to the viral cytoplasmic 
assembly compartment and required for the maintenance of viral cytoplasmic activity. 
These observations suggest that BiP may play an important role in the maintenance 
and/or formation of the assembly compartment.  To test this, HCMV-infected cells that 
were either untreated, or treated with 100 ng/ml SubAB or SubAA272B for 12 hours, were 
stained for the viral assembly compartment markers pp28 and gB.  Intact assembly 
compartments were present in untreated cells or cells treated with SubAA272B, as 
demonstrated by both viral protein markers (Figure 23A).  In contrast, the integrity of the 
assembly compartment was disrupted in cells depleted of BiP by SubAB.  This result 
suggests that BiP is important for maintaining the viral cytoplasmic assembly 
compartment. 
To confirm BiP’s role in maintaining assembly compartment integrity, lysates 
from HCMV-infected cells treated with SubAB were subjected to the same sucrose 
gradient sedimentation described previously for SubAA272B.  The presence of BiP was 
not detected in any gradient fraction, indicating the successful depletion of BiP 
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Figure 23.  BiP is required for maintaining assembly compartment integrity 
 
(A) At 60 hpi, HCMV-infected cells were treated with SubAB (Toxin), SubAA272B (Mutant 
Toxin) or left untreated (No Toxin). At 72 hpi, the cells were prepared for 
immunofluorescence microscopy, and assembly compartment integrity was examined by 
staining for gB or pp28 (green). Nuclei were stained with DAPI (blue).  (B) Lysates from 
HCMV-infected LE-HFF treated with SubAB were subjected to sucrose gradient 
centrifugation and analyzed by Western analysis using antibodies against BiP, gB, pp28 
and TRS1. AC, assembly compartment.  Adapted from Figures 3 & 4 of reference 32. 
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(Figure 23B).  Additionally, less gB and pp28 sedimented in the assembly compartment 
region, consistent with a disrupted assembly compartment structure. These observations 
suggest that BiP is necessary for maintaining the integrity of the assembly compartment, 
consistent with the observation that depleting BiP abolishes viral cytoplasmic activity and 
virion formation.    
In the above experiments, assembly compartment integrity was analyzed after 12 
hours of SubAB treatment.  However, cleavage of BiP by SubAB in Vero cells occurs 
very rapidly, and can be detected as early as 20 minutes post SubAB treatment (270).  
To monitor the integrity of the assembly compartment after BiP depletion by SubAB, 
HCMV-infected LE-HFF were electroporated with plasmids expressing lamin A fused to 
GFP and pp28 fused to DsRed.  At 96 hpi, samples were treated with 100 ng/ml SubAB 
or SubAA272B.  Assembly compartment integrity was monitored by live-cell imaging using 
an Olympus IX71 inverted microscope.  Micrographs were acquired every 10 minutes for 
220 minutes.   
In cells treated with SubAA272B, the assembly compartment remained intact 
throughout the entire period of observation (Figure 24).  In contrast, the integrity of the 
assembly compartment in cells treated with SubAB was rapidly lost.  At 30 minutes post 
SubAB treatment, pp28 was detected in a perinuclear location, although it was not in the 
compact assembly compartment observed in SubAA272B treated cells, indicating that the 
assembly compartment integrity was already compromised.  By 220 minutes post 
treatment, pp28 had spread throughout the cytoplasm and a perinuclear region 
resembling an assembly compartment was no longer detectable.  Interestingly, as 
assembly compartment integrity was lost, the HCMV-induced curvature to the nucleus, 
visualized by lamin A, was also lost and the nucleus appeared to return to a more 
normal morphology.  The rapid onset of assembly compartment disruption represented  
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Figure 24. BiP depletion leads to rapid disruption of assembly compartment  
 
HCMV-infected LE-HFF were electroporated with plasmids expressing lamin A (green) 
and pp28 (red) tagged with the fluorescent markers GFP and DsRed, respectively.  
Micrographs were acquired on an Olympus IX71 inverted microscope every 10 minutes 
for 220 minutes. 
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in the above sample was variable among cells, which is likely dependent on the variation 
in the uptake of SubAB from cell to cell.  However, in all cells monitored, assembly 
compartment disruption began within the observed 220 minute window.  These data 
show that HCMV assembly compartment integrity is rapidly lost upon depletion of BiP 
and confirms a role for BiP in maintaining assembly compartment integrity.  
 
BiP interacts with the viral proteins pp28 and TRS1  
BiP is present in the viral cytoplasmic assembly compartment where it 
colocalizes with pp28 and is important for maintaining assembly compartment integrity.  
To determine if BiP and pp28 interact in the assembly compartment, 
immunoprecipitation assays were performed.  Lysates from mock- and HCMV-infected 
LE-HFF were prepared at 96 hpi.  Immunoprecipitations were done with antibodies 
against BiP, using BiPY or BiPK, and pp28.  Western analysis showed an interaction 
between pp28 and BiP, detected by both the BiPY and pp28 immunoprecipitations 
(Figure 25A&B).  The interaction between BiP and pp28 was also detected by others 
(Nat Moorman and Tom Shenk, personal communication).  Interestingly, an antibody 
directed against BiP’s KDEL ER-localization signal, BiPK, did not precipitate pp28.   
Since BiPK does not detect BiP in the assembly compartment or coprecipitate pp28, the 
KDEL ER-localization sequence may be blocked when BiP is in the assembly 
compartment ring.  This could potentially occur through an interaction with a viral protein, 
such as pp28.  It is reasonable to propose that this signal becomes blocked during 
infection, allowing BiP to leave the ER and progress further down the secretory pathway 
into the assembly compartment.   
 A second viral protein also coimmunoprecipitated with BiP.  An interaction 
between BiP and TRS1 was first detected by mass spectrometry and then confirmed by  
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Figure 25.  BiP associates with pp28 and TRS1 during infection. 
 
(A) Lysates from mock (M)- and HCMV (V)-infected LE-HFF were prepared at 96 hpi for 
immunoprecipitation with BiPY, an antibody that detects BiP in the assembly 
compartment, and the KDEL antibody, which does not detect BiP in the assembly 
compartment. Following immunoprecipitation, reactions were analyzed by Western 
analysis using antibodies against BiP, TRS1, and pp28. Western analysis of 20% of the 
input is also shown (Input). (B and C) Similar lysates from mock- and HCMV-infected 
cells were immunoprecipitated with anti-pp28, and analyzed by Western analysis for BiP 
(B) or TRS1 (C). A cross-reaction with light chains by the pp28 antibody is shown (LC) in 
panels B and C.  Copyright © American Society for Microbiology, Journal of Virology, 83, 
2009, 11426, 10.1128/JVI.00762-09. 
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Western analysis (Figure 25A).  This interaction was interesting because both 
immunofluorescence and electron microscopy data show that cells infected with a TRS1-
deficient HCMV and infected cells depleted of BiP show a similar intracellular phenotype 
(2, 23).  Specifically, TRS1-deficient HCMV-infected fibroblasts have a disrupted 
assembly compartment and a lack of viral cytoplasmic activity.  In sucrose gradient 
fractions, a small fraction of TRS1 is present in the assembly compartment region  
 (Figure 20).  Since TRS1 performs several functions during infection (2, 50, 106, 265, 
292, 331), it is possible that only a fraction is dedicated to function with BiP.  
Alternatively, since the amount of TRS1 sedimenting with the assembly compartment 
fraction is less than what would be expected from the immunoprecipitation data, the 
various components of the assembly compartment may have different affinities and 
some may have been dissociated during purification and sedimentation.  A suitable 
TRS1 antibody for immunoprecipitation was not available to confirm the interaction 
between BiP and TRS1, but TRS1 did coimmunoprecipitate with a pp28 antibody (Figure 
25C).  Overall, these data provide evidence for complexes containing BiP, pp28 and 
TRS1 in the assembly compartment.  This complex is likely involved in maintaining 
assembly compartment integrity and viral cytoplasmic activity. 
 
 The experiments in this chapter show that the ER chaperone BiP, which is 
upregulated by HCMV, is required for a productive HCMV infection. Although BiP 
depletion does not affect the steady state levels of viral protein, infectious virions are not 
produced.  In addition to its normal ER localization, BiP is also localized to the viral 
cytoplasmic assembly compartment, a key center of viral cytoplasmic activity.  The 
integrity of this compartment is rapidly disrupted upon depletion of BiP, suggesting a key 
role for BiP in the cytoplasmic progression of immature virions.  This is confirmed by EM 
99 
analysis, which shows that viral cytoplasmic activity ceases in the absence of BiP.  The 
role of BiP in the assembly compartment is likely dependent on its interaction with the 
viral proteins pp28 and TRS1; the depletion of which exhibit similar phenotypes to BiP 
depletion. These experiments demonstrate a key role for BiP during HCMV virion 
maturation. 
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CHAPTER 5: HCMV-induced alteration of the nuclear architecture 
 
The data from this chapter were submitted for publication to the Journal of 
Virology.   
 
The assembly and egress of HCMV virions requires significant morphological 
alterations of both nuclear and cytoplasmic architecture.  The relationship between the 
curvature and enlargement of the nucleus and the assembly compartment is unknown.  
However, they may be intricately connected since perturbation of the perinuclear 
placement of the assembly compartment results in the nucleus regaining normal shape 
(11, 107, 278).  These same conditions abolish cytoplasmic viral activity.  The previous 
experiments have shown that BiP is required for HCMV viral cytoplasmic activity and 
assembly compartment integrity.  During BiP depletion, nucleocapsids either remain in 
the nucleus or are stalled just outside of the nucleus (Figure 17).  This provides another 
example where perturbation of viral cytoplasmic activity affects activity in and around the 
nucleus.  These observations suggest that factors involved with viral activity in the 
cytoplasm must communicate with factors involved in viral nuclear activity, such as the 
nuclear egress complex, setting up a highly interconnected assembly-egress continuum.  
Evidence for an interconnected assembly-egress continuum and factors that link 
the assembly compartment to the nucleus was provided by live-cell imaging.  Two hours 
after infection with HCMV, LE-HFF were electroporated with plasmids expressing lamin A 
fused to GFP and the viral protein pp28 fused to DsRed.  At 54 hpi, samples were 
subjected to live-cell analysis using an Olympus IX71 inverted microscope.  Pictures were 
taken every 15 minutes over a 20 hour time period.  From 54 to 60 hpi, pp28 is found in a 
perinuclear region representing the nascent assembly compartment which is shared  
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Figure 26.  Assembly compartment remains localized next to nucleus 
 
HCMV-infected LE-HFF were electroporated with plasmids expressing lamin A (green) 
and pp28 (red) tagged with the fluorescent markers GFP and DsRed, respectively.  
Micrographs were acquired on an Olympus IX71 inverted microscope every 15 minutes 
for 20 hours. 
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between two nuclei.  At 60 hpi, the nuclei begin to migrate apart from each other.  The 
distance between the nuclei gradually increases until 74 hpi, the last observed time point. 
Interestingly, as the nuclei migrate apart from each other, the assembly compartment 
maintains a constant association with each nucleus.  This results in an elongated or 
stretched assembly compartment (Figure 26).  The constant association between the 
assembly compartment with each nucleus provides further evidence of an intricate 
relationship between factors involved in viral cytoplasmic and nuclear activity.  Since BiP is 
located in an outer ring of the assembly compartment, it is possible that BiP may be a factor 
involved in the crosstalk between the assembly compartment and nucleus during an HCMV 
infection.  
 
BiP interacts with the nuclear egress factor pUL50  
To investigate if BiP interacts with a component of the nuclear egress complex, 
an immunoprecipitation reaction was performed using an antibody against the N-
terminus of BiP, which detects BiP in the assembly compartment.  BiP was precipitated 
from mock- and HCMV-infected lysates and the precipitated proteins were separated by 
polyacrylamide gel electrophoresis.  Protein bands were cut from the gel and identified 
by liquid chromatography tandem mass spectrometry.  One protein identified was the 
viral protein expressed by the HCMV UL50 ORF (Figure 27A).  pUL50 is an inner 
nuclear membrane protein responsible for recruiting other nuclear egress factors, which 
form a complex to phosphorylate and rearrange the nuclear lamins in preparation for 
nuclear egress, as described previously in Chapter 1. 
Confirmation of an interaction between BiP and pUL50 was complicated by the 
lack of availability of an antibody against pUL50 suitable for IP and Western analyses.  
To overcome this, a polyclonal antibody against pUL50 was generated in rabbits and  
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Figure 27. BiP interacts with nuclear egress factor pUL50 
 
(A) Mass spectrometry results identifying a potential interaction between BiP and pUL50.  
Protein score is based on the calculated probability that the observed match between the 
experimental data and the database sequence is a random event. A score of 70 with at 
least 2 peptides is considered significant.  (B) Proteins were harvested from mock (M)- and 
HCMV-infected LE-HFF at the indicated times post infection and analyzed by Western 
analysis using the newly generated antibody that detects pUL50. Actin was used as a 
loading control.  (C) Mock (M)- and HCMV-infected lysates harvested at 96 hpi were 
subjected to immunoprecipitation (IP) analysis using antibodies that detect BiP or pUL50 
and analyzed be Western analysis. Input represents 20% of protein lysates used for IP 
analysis. 
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affinity-purified using a peptide containing amino acids 152-170 of pUL50 (GPENEGEYE 
NLLRELYAKK).  The antibody was tested in Western analysis on protein lysates from 
mock- and HCMV-infected samples harvested at 4, 8, 12, 24, 36, 48, 60, 72 and 96 hpi.  
A 43 kD band is detected beginning at 24 hpi and increases in intensity throughout 
infection (Figure 27B).  This band is consistent with the predicted molecular weight of 
pUL50.  The induction of pUL50 by 24 hpi suggests that UL50 is an expressed 
temporally in infection as an HCMV early gene. 
To confirm an interaction between BiP and pUL50, mock- and HCMV-infected 
protein lysates were subjected to immunoprecipitation and analyzed by Western analysis.  
Immunoprecipitation was performed using the newly generated antibody against pUL50 
and an antibody against BiP, BiPY.  Western analysis confirms the interaction between 
BiP and pUL50 (Figure 27C).  BiP coprecipitates with the pUL50 antibody in the HCMV-
infected lysate, but was not present in the mock-infected precipitate.  Conversely, pUL50 
coprecipitated with the BiPY antibody in HCMV-infected lysates.  The interaction 
between BiP and pUL50 has since been detected by another laboratory (Don Coen, 
Harvard University, personal communication).  BiP’s interaction with both pUL50 of the 
nuclear egress complex and pp28 of the assembly compartment suggests that it could 
be a potential candidate for a factor that is involved in intricately connecting viral 
cytoplasmic and nuclear activity. 
 
Lamins are not rearranged when BiP is depleted 
 During infection, nuclear egress is believed to occur at sites of nuclear 
membrane infoldings (35, 65, 95, 263, 296, 311, 312).  A major function of pUL50 and 
the nuclear egress complex is to rearrange the rigid nuclear lamina during infection, 
which gives the nuclear membrane the flexibility necessary to form membrane infoldings 
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and allow nucleocapsids to gain access to the inner nuclear membrane for egress (38).  
To visualize this lamin rearrangement, HCMV-infected LE-HFF on coverslips were 
prepared for immunofluorescence by using antibodies that detect lamin B and pp28.  
Slides were examined by confocal microscopy on a Leica DM 6000 Confocal 
microscope.  Figure 28A shows the maximum projection Z-axis stack of the 
rearrangement of the nuclear lamins from the nuclear rim to a lamin structure set back 
into an interior plane of the nucleus.   Importantly, the lamin rearrangement does not 
occur uniformly around the nuclear rim, but rather occurs only at the point of the nucleus 
in immediate proximity to the assembly compartment, visualized by staining for pp28.  
The panel on the far right is slightly enlarged and rotated forward and to the left to 
provide an alternate view of the lamin layers and emphasize their position set back from 
the nuclear periphery. 
Since BiP interacts with pUL50, BiP may be involved in the rearrangement of the 
nuclear lamina.  To test if lamin rearrangement occurs when BiP is depleted, HCMV-
infected LE-HFF on coverslips were treated at 84 hpi with 100 ng/ml SubAB, 100 ng/ml 
SubAA272B or left untreated.  Samples were prepared for immunofluorescence at 96 hpi 
and lamin rearrangement was visualized by two-dimensional widefield fluorescence 
microscopy using a Nikon Eclipse E600.  In mock-infected cells, lamin B staining is 
unaltered by treatment with SubAB or SubAA272B (Figure 28B).  In HCMV-infected cells, 
rearrangement of lamin B is detected in cells left untreated or treated with SubAA272B.   
Furthermore, an intact assembly compartment is present in both of these samples as 
visualized by staining for pp28 (Figure 28B).  In contrast, the assembly compartment 
integrity in cells treated with SubAB is disrupted, as described previously.  Interestingly, 
the rearrangement of the nuclear lamina is also lost in SubAB treated cells.  Thus, the 
presence of either BiP and/or an intact assembly compartment is required to maintain  
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Figure 28.  Nuclear lamins are not rearranged with BiP is depleted 
 
(A) HCMV-infected LE-HFF were prepared for immunofluorescence at 96 hpi and 
stained for pp28 (green) and lamin B (red).  Slides were examined by confocal 
microscopy.  The far right panel was enlarged and rotated as indicated by the white 
arrow.  (B) Mock- or HCMV-infected LE-HFF were treated with SubAB (Toxin), 
SubAA272B (Mut.Toxin) or left untreated (No Toxin) at 84 hpi and prepared for 
immunofluorescence analysis at 96 hpi by staining with pp28 (green) and lamin b (red). 
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lamin rearrangement.  This provides further evidence for a relationship between viral 
nuclear and cytoplasmic activity.   
 
BiP is involved in the phosphorylation of the lamins  
The rearrangement of the nuclear lamina in HCMV-infected cells is largely 
thought to be the result of lamin phosphorylation by two kinases, the viral kinase pUL97 
and the cellular kinase PKC.  Recently, serine 22 of lamin A and C has been shown to 
be phosphorylated during infection by the viral kinase pUL97 (107).  This residue and 
the equivalent residue on lamin B, serine 16, are also important for lamin breakdown 
during mitosis (273, 378).  To investigate the phosphorylation of lamins during infection, 
mock- and HCMV-infected protein lysates harvested at 4, 8, 12, 24, 36, 48, 60, 72 and 
96 hpi were subjected to Western analysis using antibodies that detect total lamin A and 
C or lamin A and C phosphorylated on serine 22.  Lamin A and C was used for the 
phosphorylation studies instead of lamin B, which was used in immunofluorescence, 
since a reliable antibody against phosphorylated serine 16 of lamin B is not available.  A 
detailed time course shows that lamin A and C levels remain constant during infection 
(Figure 29A).   This agrees with published data that show lamin levels late in infection 
are not increased when compared to mock-infected cells (38).  In contrast, 
phosphorylation of serine 22 on lamin A and C is drastically increased during infection.  
This increase begins early, at 4 hpi, peaks at 24 hpi and shows a slow decrease until 96 
hpi.  Despite decreasing after 24 hpi, the level of phosphorylated lamin A and C late in 
infection is greatly increased compared to the mock-infected sample (Figure 29A).  The 
early increase in phosphorylation of lamins A and C was surprising, especially 
considering the induction of pUL50 as an early protein (Figure 27B) and pUL53 as a late 
protein (65).  One possibility is that a nuclear egress complex-independent 
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phosphorylation of lamin A and lamin C precedes the pUL50/pUL53 dependent lamin 
phosphorylation.  Alternatively, pUL50, pUL53 and pUL97 have all been detected in 
purified virions and may function upon entry with incoming virions (65, 363).  
Since BiP interacts with pUL50 and is required for lamin rearrangement, BiP may 
be involved in the phosphorylation of the lamins.  To test BiP’s role in lamin 
phosphorylation, mock- and HCMV-infected samples were treated with 0.5 µM NGIC-1, 
100 ng/ml SubAB or left untreated at 2 hpi and harvested for protein at 24 hpi.  To study 
lamin phosphorylation at later times during infection, HCMV-infected samples were 
treated as described above at 72 hpi and harvested for protein at 96 hpi (Figure 13).  
NGIC-1 has been shown to inhibit both kinases implicated in lamin phosphorylation 
during infection, PKC and pUL97.  
Western analysis using an antibody that detects phospho-serine 22 of lamin A 
and C shows the increase in the phosphorylation of serine 22 described previously at 
both 24 and 96 hpi (Figure 29B).  As expected, treatment with the kinase inhibitor NGIC-
1 significantly reduces this phosphorylation at both time points.  Interestingly, the 
depletion of BiP with SubAB does not reduce phosphorylation of serine 22 at 24 hpi.  
This is not surprising as immunofluorescence of BiP at this point in infection shows that 
BiP remains in its typical ER localization (Figure 21).  Late proteins, which include viral 
assembly compartment markers like pp28 or the nuclear egress factor pUL53, have not 
yet been synthesized.  In contrast, the phosphorylation of serine 22 of lamins A and C is 
reduced in both the NGIC-1 and SubAB treated samples harvested at 96 hpi.  Thus, 
depletion of BiP late in infection reduces phosphorylation of lamins A and C.  At this time 
point during infection, BiP interacts with both pp28 and pUL50, is located in the 
assembly compartment and is required to maintain viral cytoplasmic activity.  As is the  
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Figure 29.  Depletion of BiP alters nuclear lamin phosphorylation 
 
(A)  Proteins were harvested from mock- and HCMV-infected LE-HFF at the indicated 
times postinfection and analyzed by Western blot analysis using antibodies that detect 
total lamin A and C and lamin A and C phosphorylated at serine 22.  Actin was used as 
a loading control. (B) Proteins were harvested from mock- and HCMV-infected samples 
treated with SubAB (Toxin) or NGIC-1 and analyzed by Western analysis using 
antibodies that detect total lamin A and C, lamin A and C phosphorylated at serine 22, 
BiP and pUL50.  Antibodies directed against the MIEPs, an early protein p52, and a late 
protein pp28 were used to monitor viral protein expression.  Actin was used as a loading 
control.  * Lighter exposures were used in these panels to maintain band integrity.
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case with lamin rearrangement, lamin phosphorylation is dependent on BiP and/or an 
intact assembly compartment. 
 
Dynein is required for assembly compartment integrity and nuclear enlargement 
The early phosphorylation of the nuclear lamins during infection without the 
rearrangement of the nuclear lamina suggests that nuclear lamin phosphorylation alone 
is not sufficient for the rearrangement of the lamins during HCMV infection.  Studies 
investigating the disassembly of the nuclear lamina during mitosis have similarly shown 
that lamin phosphorylation is not sufficient for nuclear lamina breakdown, but that 
breakdown of the nuclear envelope requires the molecular motor dynein.  Dynein 
attaches to the nuclear membrane and moves toward the centromere, generating 
tension on the nucleus and folds in the inner nuclear membrane (16, 301).  Thus, a 
modified version of nuclear envelope breakdown may be adapted by HCMV in which 
dynein is recruited to bind the nucleus and move toward the microtubule organizing 
center, located at the center of the assembly compartment, creating tension on the 
nucleus and causing the concave nuclear shape and membrane infoldings from which 
nucleocapsids egress.  Intriguingly, dynein interacts with the HSV-1 protein UL34, the 
homologue of pUL50 (399).  Furthermore, dynein is involved in protein trafficking and 
maintenance of the secretory system and may play a role in assembly compartment 
formation and/or maintenance.  The previously described roles for dynein make it an 
intriguing factor to investigate in the relationship between viral nuclear and cytoplasmic 
activity.  
In order to perform many of its cellular functions, dynein requires an interaction 
with dynactin via dynactin’s p150Glued subunit (147, 365).  Overexpression of a p150Glued 
construct containing amino acids 217-548, termed CC1, affects a variety of motility 
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functions.  CC1 lacks two N-terminal microtubule binding domains, but contains the 
binding domain for the dynactin intermediate chain.  It is therefore believed that CC1 
binds dynein directly and acts as a competitive inhibitor for the interaction between 
dynein and intact dynactin (282). To test if dynein has a role in the HCMV-induced 
nuclear alterations or in assembly compartment maintenance, HCMV-infected fibroblasts 
were electroporated with CC1 fused to the mCherry fluorescent tag at 24 hpi.  Cells were 
prepared for immunofluorescence at late times during infection, 72 or 96 hpi.  Antibodies 
against pp28 and gB were used to visualize the assembly compartment and nuclei were 
visualized with DAPI.  In cells not expressing CC1, intact assembly compartments are 
present next to enlarged nuclei as shown with both pp28 and gB, typical of HCMV-
infected cells (Figure 30).  In contrast, cells expressing CC1-mCherry do not have an 
intact assembly compartment.  Both gB and pp28 are dispersed throughout the 
cytoplasm in small speckles (Figure 30).  Thus, dynein is required to maintain assembly 
compartment integrity.  Furthermore, the nuclei of cells expressing CC1-mCherry are 
round and not enlarged; indicating that dynein and/or an intact assembly compartment is 
required for the viral-induced alteration to nuclear morphology during infection.  Similar 
to what was observed in cells depleted of BiP, the loss of assembly compartment 
integrity was accompanied by the loss of viral-induced nuclear alterations.   
Interestingly, one cell can be observed in Figure 30 in which expression of CC1-
mCherry appears to be expressed at a low level.  This cell contains an enlarged nucleus, 
even in the presence of CC1-mCherry.  Furthermore, gB is not dispersed throughout the 
cytoplasm in clumps as seen in other cells, but is kept in proximity to the nucleus, 
although not in the typical assembly compartment ring.  Since CC1-mCherry acts as a 
competitive inhibitor, it is reasonable to speculate that the lower expression of the 
inhibitor allows for some functional dynein to be present.  The functional dynein  
112 
 
Figure 30. Dynein is required to maintain assembly compartment integrity 
 
HCMV-infected LE-HFF electroporated with CC1-mCherry (red) were prepared for 
immunofluorescence at 72 or 96 hpi. White arrows show an uninfected cell, an infected 
cell expressing CC1 and an infected cell not expressing CC1, as indicated.  Assembly 
compartment integrity was monitored using antibodies that detect pp28 or gB (green).  
Nuclei were stained with DAPI (blue). 
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complexes appear to keep gB in a perinuclear location, however they are not sufficient 
for maintaining the ring structure of the assembly compartment.  Interestingly, the 
residual perinuclear viral activity appears to be sufficient to maintain the relationship 
between viral and cytoplasmic activity, resulting in an enlarged nucleus and allowing for 
viral-induced nuclear morphological changes to occur.    
 
The nuclear periphery is altered in proximity to the assembly compartment 
 To further investigate the relationship between viral cytoplasmic and nuclear 
activity, mock- and HCMV-infected LE-HFF were prepared for electron microscopy at 96 
hpi.  The nucleus of the mock-infected cell shows a relatively uniform periphery around 
the nucleus, with the nuclear membrane backed by a darker region that is likely to 
represent the lamina and heterochromatin (Figure 31A).  The periphery of the infected 
cell nucleus is however more varied.  The darker region at the nuclear periphery is 
present around most of the nucleus.  However, this dark region is absent from the 
membrane area adjacent to the assembly compartment, which appears thinner and 
likely represents an area of only nuclear membrane (Figure 31B).  These data suggest 
that the nuclear periphery adjacent to the assembly compartment is significantly altered, 
probably by removal of heterochromatin and rearrangement of the lamina as seen by 
immunofluorescence (Figure 28A).  Such thinning of the nuclear periphery adjacent to 
the assembly compartment provides further evidence of an intricate relationship between 
viral cytoplasmic activity and virus-induced nuclear alterations. 
Closer examination of the nuclear membrane reveals additional differences 
between mock- and HCMV-infected nuclei.  The inner and outer nuclear membranes in 
mock-infected cells are distinct and the perinuclear space between them is relatively 
uniform (Figure 31C).  In infected cells, the membrane appears to lose its integrity.  The  
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Figure 31.  HCMV alters the nuclear periphery next to the assembly compartment 
 
Mock- (A, C) and HCMV-infected LE-HFF (B, D, E) were prepared for EM analysis at 96 
hpi.  (A) A mock-infected cell showing the nucleus with a uniform nuclear periphery. (B) 
HCMV-infected cell showing an altered nuclear periphery (white arrow) in proximity to 
the assembly compartment (AC).  (C) High magnification micrograph of a mock-infected 
cell highlighting the inner (INM) and outer (ONM) nuclear membrane (white arrows). (D) 
The ONM and INM (thick white arrows) of an HCMV-infected cell with the region of 
indistinct ONM (area between thin white arrows) (E) The perinuclear space of HCMV-
infected cells is inconsistent and exhibits areas with large gaps between the INM and 
ONM (INM and ONM shown by white arrows). 
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outer nuclear membrane becomes indistinct and seems to disappear with the 
appearance of vesicles and nucleocapsids that have recently exited the nucleus, as 
seen in Figure 31D between the two thin white arrows.  Additionally, the space between 
the inner and outer nuclear membranes is variable, with occasional large bulges (Figure 
31E). 
To document the increase in the perinuclear space, the distance between the 
inner and outer nuclear membranes in mock- and HCMV-infected samples was digitally 
measured in high magnification micrographs of the nuclear membrane.  Using the 
micrographs in Figure 32, thirty measurements were obtained from regions of the nuclei 
where the inner and outer nuclear membranes could be readily detected.  It is important 
to note that in infected cells, the regions containing an intact outer nuclear membrane 
may be minimally altered by infection and the increase in the perinuclear space may be 
underestimated.  In mock-infected cells, the perinuclear space was measured to be 32 
nm with a standard deviation of 7 nm (Figure 32).  This space is increased in HCMV-
infected cells to 44 nm with a standard deviation of 8 nm.  The observed alterations in 
the nuclear membrane of infected cells and the increase in the perinuclear space may 
be necessary to provide the nuclear membrane with the flexibility required to form the 
membrane infoldings for nucleocapsid egress.       
 
HCMV downregulates the SUN-domain containing proteins 
 In order to increase the perinuclear space, HCMV must regulate the cellular 
machinery involved in maintaining a constant distance between the inner and outer 
nuclear membranes.  The Sad1/UNC84 homology (SUN) and Klarischt, Anc-1, Syne 
homology (KASH) domain containing proteins are involved in maintaining the perinuclear 
space by keeping the outer nuclear membrane in place around the inner nuclear 
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Figure 32. HCMV increases the perinuclear space 
 
Mock- or HCMV-infected LE-HFF were prepared for EM analysis at 96 hpi.  Thirty 
measurements of the perinuclear space were digitally taken on high magnification 
micrographs of the nuclear membrane. 
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membrane.  In mammalian cells, two nuclear envelope SUN-domain proteins have been 
identified, SUN1 and SUN2.  Both SUN proteins are inner nuclear membrane proteins 
that form homo- and heterodimers (59).  The C-terminal domains are located in the 
perinuclear space and interact with the KASH-domain of the nesprin family of proteins.   
The nesprin proteins, recently reviewed by Wilhelmsen et al. (387), are very large 
proteins, up to a megadalton in size, that extend from the outer nuclear membrane into 
the cytoplasm where they interact with the cytoskeleton directly or through adaptor 
proteins via their N-terminal domains.  Nesprins require the interaction with the SUN 
proteins to maintain outer nuclear membrane localization (59).  Depletion of the SUN 
proteins is sufficient to alter the perinuclear space, creating large gaps between the inner 
and outer nuclear membranes (59).  In the context of an HCMV infection, removal of the 
SUN proteins may be required to allow for the increase in perinuclear space and the 
formation of the nuclear membrane infoldings necessary for nucleocapsid egress.   
 To monitor the level of SUN proteins in HCMV-infected cells, protein was 
harvested from mock- or HCMV-infected LE-HFF at 4, 8, 12, 24, 36, 48, 60, 72 and 96 
hpi and subjected to Western analysis using antibodies against SUN1 or SUN2.  Figure 
33A shows that during infection, SUN2 levels remain constant throughout the early times 
during infection until 24 hpi.  By 36 hpi, SUN2 levels begin to decrease and continue 
until almost no SUN2 remains at 96 hpi.  The decrease in SUN2 correlates with the 
onset of late protein synthesis and the beginning stages of assembly compartment 
formation (Figure 21).  Western analysis of SUN1 shows that similar to SUN2, the level 
of SUN1 protein is also decreased by HCMV.  SUN1 is not decreased as much as SUN2 
and the decrease in SUN1 begins later in infection, between 48 and 60 hpi (Figure 33A).  
Therefore, HCMV decreases both SUN1 and SUN2 levels during infection and this  
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Figure 33.  HCMV downregulates SUN proteins during infection 
 
 
(A) Proteins were harvested from mock (M)- and HCMV-infected LE-HFF at the 
indicated times postinfection and analyzed by Western blot analysis using antibodies 
that detect SUN1 and SUN2.  Actin was used as a loading control. (B) Mock- and 
HCMV-infected LE-HFF were prepared for immunofluorescence at 96 hpi and examined 
for SUN2 localization (green). 
119 
  
decrease correlates temporally with the formation of the assembly compartment and 
presumably, nucleocapsid egress.   
Immunofluorescence analysis of SUN2 in mock- or HCMV-infected LE-HFF at 96 
hpi also shows a reduction in SUN2 staining, confirming a decrease in SUN2 levels 
during infection.  In mock-infected cells, SUN2 staining is present at the nuclear 
periphery in all cells.  In HCMV-infected cells, this staining is lost in most cells (Figure 
33B).  Interestingly, in HCMV-infected cells that retain SUN2 staining, SUN2 is found at 
the site of lamin rearrangement.  This suggests that when present, SUN2 may be 
rearranged with the nuclear lamina, removing it from the nuclear periphery and the inner 
nuclear membrane.  Therefore, HCMV regulation of SUN1 and SUN2 correlates with the 
increase in the perinuclear space during infection. 
  
Nuclear membrane permeability is altered during an infection 
HCMV alters the nuclear periphery proximal to the assembly compartment by 
rearranging the rigid lamina layer and increasing the perinuclear space.  These 
alterations, which may be necessary for nucleocapsid egress, would alter the rigidity of 
the nucleus and may affect nuclear properties such as permeability.  To study nuclear 
permeability during infection, dextran labeled with TRITC was introduced into mock- or 
HCMV-infected cells.  Dextran is a complex, branched polysaccharide made of glucose 
molecules.  Dextran can be used for a variety of biomedical applications, including 
monitoring the permeability of cellular structures.  Permeability is monitored by tracking 
the location of dextran polysaccharides of varying sizes under different cellular 
conditions.  Dextran polysaccharides of 155 kD are excluded from the nucleus and were 
used to study the permeability of the nuclear membrane during infection.   
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Figure 34.  HCMV alters nuclear membrane permeability 
 
(A) Mock- and (B) HCMV-infected LE-HFF were loaded with dextran-TRITC (green) at 
48 hpi. Cells were examined for the presence of nuclear dextran at 72 and 96 hpi.  (C) At 
96 hpi, z-axis slices were taken of an infected cell.  Z-axis slices from top to bottom are 
shown left to right.  The z-axis nuclei were stained with DAPI (blue).
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Mock- or HCMV-infected cells were loaded with 155 kD dextran at 48 hpi.  The 
status of nuclear dextran was investigated at both 72 and 96 hpi.  In mock-infected cells, 
dextran is clearly excluded from the nucleus (Figure 34A). In HCMV infected cells, 
dextran also appears to be excluded from the majority of the nucleus.  However, nuclear 
dextran can be detected in the region of lamin rearrangement next to the assembly 
compartment (Figure 34B).  Thus, dextran can enter the nucleus proximal to the 
assembly compartment, suggesting the permeability of the nucleus is altered in this 
region. 
It is not clear from the 2D pictures whether the dextran is really within the nucleus 
or concentrated above or below it.  To clarify this, a Z-axis series was taken through an 
HCMV-infected cell showing an assembly compartment.  Figure 34C shows four slices 
moving through the cell from top to bottom (left to right).  In all cases the dextran is in the 
nucleus, not just at the top or the bottom.  These data suggest that the nuclear 
membrane adjacent to the assembly compartment is modified such that the dextran can 
penetrate into the nucleoplasm. The alteration of nuclear permeability only in the region 
of the assembly compartment provides another piece of evidence linking the viral 
cytoplasmic activity to viral nuclear activity.  Additionally, a viral-induced change in 
nuclear permeability may explain how a cytoplasmic factor, such as BiP, can interact 
with the nuclear egress complex to participate in the highly interconnected assembly-
egress continuum.  
 
The experiments in this chapter provide evidence that BiP and an intact 
assembly compartment are required for nuclear lamin phosphorylation and 
rearrangement, providing evidence that viral cytoplasmic and nuclear activity are 
intricately linked. The data also suggest a stable and elastic interaction between the 
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assembly compartment and the nucleus.  Furthermore, alterations of the nuclear 
membrane in infected cells occur in the area adjacent to the assembly compartment. 
These alterations include rearrangement of the nuclear lamina, alteration and disruption 
of the outer nuclear membrane, and an increase in nuclear permeability to large 
molecules.  In addition, the perinuclear space is also increased in infected cells, which is 
likely the result of the reduction in SUN proteins during infection. In summary, the data of 
this chapter provide evidence for an assembly-egress continuum, providing a means for 
nucleocapsids to egress the nucleus, access the assembly compartment and become 
mature virions. 
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CHAPTER 6: Discussion 
  
Several characteristics of the human cytomegalovirus replication cycle make it 
conducive to activating cellular stress responses of its host cell.  With its prolonged 
replication cycle, HCMV must keep its host functioning for an extended period of time.  As 
the virus replicates, it must keep metabolic processes active under stress conditions that 
would normally shut them down, such as the exhaustion of key cellular resources and the 
overloading of cellular organelles.  Thus, HCMV modulation of cellular stress signaling 
pathways is a critical step for successfully producing viral progeny.  Growing evidence 
shows that HCMV infection modulates many cellular stress signaling pathways (50, 106, 
169-171, 237, 369).  
By circumventing the effects of cellular stress signaling, the virus maintains needed 
cellular metabolic and synthetic functions and avoids apoptosis.  These data suggest that a 
major goal of the virus is to make the host cell ignore signs of severe stress.  This is 
demonstrated in this thesis, where complete depletion of BiP during HCMV infection has 
very little adverse effect on HCMV-infected cells, though it is very deleterious to uninfected 
cells.  Just as the viral infection can circumvent the inhibition of viral protein synthesis by 
stresses that activate the UPR, such as thapsigargin or hypoxia (135, 171), it can also 
maintain protein synthesis after the depletion of BiP by the SubAB toxin.  In uninfected cells, 
hypoxia, thapsigargin and BiP depletion activate the unfolded protein response.  Activation 
of the UPR effector PERK and the corresponding phosphorylation of eIF2α results in an 
inhibition of global translation. However, although both PERK and eIF2α are 
phosphorylated during infection, translation is not inhibited (136).  HCMV can overcome the 
UPR-induced inhibition of translation.     
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 The maintenance of translation is not the only aspect of UPR signaling modulated 
by HCMV.  As mentioned earlier, although IRE1 is activated and ATF6 translocates to the 
Golgi during infection, cleavage of ATF6 and the splicing of XBP1 does not occur (136).  
These two transcription factors induce a wide range of factors that under normal conditions 
restore cellular homeostasis, but in the context of a viral infection could be detrimental.  
HCMV counteracts the detrimental effects of these targets by inhibiting the production of 
the transcription factors responsible for their induction.  The virus must therefore selectively 
induce any factor with beneficial effects that it requires for infection.  Accordingly, the ER 
chaperones BiP and GRP94 are both induced during infection (136).  The experiments 
described in this thesis have focused on the specific viral induction of BiP, and the role that 
it plays in an HCMV infection.   
In the studies presented here, the expression of the ER chaperone BiP is closely 
regulated during HCMV infection.  This results in a temporally precise increase and 
decrease in BiP levels, which increase by 36 hpi, peak by 60 to 72 hpi, and decrease 
thereafter. During ER stress, the increased level of BiP protein correlates with increased 
transcription from the BiP promoter and a corresponding increase in BiP mRNA.  During 
HCMV infection, the level of BiP mRNA is also increased.  The increase in BiP mRNA 
occurs early in infection, beginning as early has 4 hpi and peaking from 12 to 60 hpi.  The 
data suggest that the increase in BiP protein is, at least in part, due to an increase in BiP 
mRNA.   
 Since increases in BiP mRNA occur by both transcriptional and post-transcriptional 
mechanisms (200),  the activity of the BiP promoter was investigated during infection.   
Activation of the BiP promoter occurs early in infection, between 4 and 8 hpi.  This early 
activation of the BiP promoter corresponds with the increase in BiP mRNA.  HCMV’s 
activation of the BiP promoter early in infection implicates either proteins that enter with 
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virions or the immediate early proteins.  Data presented herein show that newly 
synthesized HCMV MIEPs, and not incoming virion proteins, activate the BiP promoter.  
Furthermore, this activation is independent of the ERSEs normally required for the stress 
induction of the BiP promoter. 
Although the increase in BiP mRNA is sustained throughout infection, the three fold 
activation is minimal compared to the increase that occurs in response to ER stress.  
Treatment with thapsigargin results in a greater than 100 fold increase in BiP mRNA when 
compared to unstressed cells.  This result suggests that HCMV may utilize additional 
mechanisms to obtain the robust increase in BiP protein.  BiP protein levels can be 
increased by altering the stability of the BiP protein or by increasing the translation 
efficiency of BiP mRNA (102, 180, 357).  The translational efficiency of BiP mRNA is 
regulated by the presence of an IRES, located in the 5’ UTR of the BiP mRNA (211).   
A recent study has shown that a related virus, HSV, activates the BiP IRES during 
infection (300).  Similarly, the studies presented herein show that HCMV also activates 
translation form the BiP IRES.  Activation occurs between 8 and 24 hpi, the same time 
during infection that the increase in BiP protein is first detected.  Several cellular proteins 
have been shown to activate the BiP IRES.  Of interest is SSB, also called La autoantigen, 
which activates the IRES during both poliovirus and HCV infections (5, 224).  Analysis of 
SSB protein during infection revealed that SSB is induced early in infection, peaking at 24 
hpi, the same time that the BiP IRES is robustly activated.  Accordingly, knockdown of SSB 
reduces BiP IRES activity and protein level at 24 hpi, confirming a role for SSB in activating 
the BiP IRES during HCMV infection. 
 The specific regulation of BiP by HCMV suggests that BiP may play a critical role 
during an HCMV infection.  The peak of BiP protein levels in infected cells corresponds to a 
period of intense virion structural protein and glycoprotein synthesis/processing and virion 
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assembly.  EM analysis of infected cells depleted of BiP using the SubAB toxin shows that 
viral activity in the cytoplasm ceases after only 12 hours.  A similar result is seen in cells 
depleted of BiP using an shRNA.  This is significant because it indicates that the toxin's 
effects on viral replication are due to the depletion of BiP and not to an uncharacterized 
effect of the toxin.  It is also important to point out the differences between these two 
depletion approaches.  The toxin depletes very rapidly and completely due to its cleavage 
efficiency.  With the shRNA, depletion of BiP is slow and not as complete; the lowest levels 
of BiP occur 48 to 72 hours after lentivirus infection. Thus, HCMV, which is added 24 hours 
after the lentivirus vector, has sufficient levels of BiP to initiate the infection before the levels 
drop to the point where the effects on cytoplasmic egress can be seen. The fact that the 
same effect can be seen after only a few hours of toxin treatment indicates how quickly the 
loss of BiP can be manifested.  This is particularly evident in live cell analysis of cells 
treated with toxin, in which the effects of BiP depletion is observed as early as 30 minutes 
after addition of toxin.   
In addition to the lack of viral activity in the cytoplasm of BiP-depleted cells, 
nucleocapsids were also accumulated just outside of the outer nuclear membrane.  This 
would suggest that in the absence of BiP, the nucleocapsids can depart from the nucleus, 
although we cannot rule out the possibility that this process may be debilitated.  However, 
the accumulation outside of the outer nuclear membrane suggests that without BiP, 
movement away from the outer nuclear membrane is inhibited; correspondingly, the 
cytoplasmic processes of tegumentation, envelopment, and egress do not occur.  These 
data suggest that HCMV precisely controls the expression of BiP, which aids in a number of 
functions needed by the virus, including cytoplasmic viral egress. 
During infection, BiP is relocalized to two distinct cytoplasmic localizations.  One 
pool is located in condensed structures in the periphery of the cytoplasm which also contain 
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other ER markers, thus appearing to originate from the ER.  It is likely that this pool of BiP is 
performing its known ER functions as well as its virus-induced ER function of interacting 
with HCMV proteins US2 and US11, which mediates the degradation of major 
histocompatibility complex class I (117, 349).  
The second structure containing BiP is the assembly compartment, which is a 
complex perinuclear structure.  The assembly compartment has been reported to be a 
modified compartment made of many vesicles derived from the cellular secretory system, 
early endosomes, or the trans-Golgi network.  It is not believed to be derived from the ER, 
ER-Golgi intermediate compartment, cis- or medial Golgi, or lysosomes.  Components of 
the secretory apparatus become reoriented in the assembly compartment in conjunction 
with virion maturation (60, 302, 309, 351).  In agreement with its role in virion maturation, 
the assembly compartment also contains many different virally encoded tegument, 
envelope, and nonstructural proteins (60, 122, 303, 309, 343).  Microscopically, the 
assembly compartment has a cylindrical appearance with a height that is similar to that of 
the nucleus (68); its perinuclear location and the adjacent enlarged, kidney-shaped nucleus 
gives HCMV-infected cells a distinct morphology (311).  It has been suggested that the 
many vesicles that make up the assembly compartment each hold tegument proteins which 
can be deposited onto nucleocapsids as they move through the space between the vesicles 
(68).    
BiP’s localization in these two cytoplasmic compartments is detectable by different 
antibodies.  Antibodies to the C-terminal end of BiP cannot detect or immunoprecipitate BiP 
localized in the assembly compartment.  This is especially true for antibodies to the KDEL 
sequence at the very C-terminus of the protein, suggesting that C-terminal epitopes are 
blocked when BiP is in the assembly compartment.  This is supported by the 
immunoprecipitation reactions in which antibodies against the C-terminus of BiP do not 
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coprecipitate pp28.  Such blockage of the KDEL ER localization signal by a viral protein 
would explain how BiP can be diverted from its normal ER localization to the assembly 
compartment.  
The data show that BiP is located in a ring at the outer edge of the cylindrical 
assembly compartment where it colocalizes with pp28, but not with gB.  gB is located in an 
inner ring of the assembly compartment. The outer ring of BiP fits well with the current 
model  that suggests that the assembly compartment is made up of concentric rings of 
vesicles, each with specific tegument proteins that are sequentially picked up by 
nucleocapsids as they move from the outside to the center of the assembly compartment 
(68).   In this scenario, BiP's protein binding and chaperone functions could aid in depositing 
tegument proteins on nucleocapsids, a mechanism of action that is supported by the finding 
that BiP is in the tegument layer of purified virions (363).  
 The essential role that BiP plays once relocalized to the assembly compartment 
may explain the EM data which shows that viral cytopathic effects in the cytoplasm of 
infected cells disappears after depletion of BiP using either the SubAB toxin or short hairpin 
RNAs.  A similar situation occurs in infections with HCMV containing a mutation in the 
TRS1 gene (2, 23), suggesting that BiP and TRS1 may have shared or coordinate 
functions.  The TRS1 gene product has been reported to have several functions during 
HCMV infection.  Transient expression analyses suggest that it is a transcriptional activator, 
and other studies have suggested that it promotes oriLyt-dependent DNA replication (264, 
265, 292, 331).  Additionally, as discussed earlier, both TRS1 and its homolog IRS1 
prevent the phosphorylation of eIF2α (50, 106).   More importantly for the BiP study is the 
suggestion that TRS1 has a role in virion assembly (2, 23).  Our observations that BiP and 
TRS1 associate in the assembly compartment, and that a fraction of TRS1 copurifies with 
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the assembly compartment, suggest that there is a functional relationship between BiP and 
TRS1 which is needed for assembly compartment integrity.  
In addition to an interaction with TRS1, BiP also interacts with pp28 in the assembly 
compartment.  The pp28 protein (UL99 ORF) is a very abundant constituent of the 
tegument layer (227, 363); it is a true late protein that is myristoylated and phosphorylated 
(142, 155, 303, 323).  It is essential for the production of infectious virions, and mutation of 
the UL99 open reading frame resulted in nonenveloped and noninfectious cytoplasmic 
particles (30, 142, 323).  This phenotype is similar to what was seen in cells depleted of BiP.  
Thus, the association of BiP and pp28 appears to contribute to the same steps in virion 
maturation.  Studies have demonstrated higher-molecular-weight forms of pp28 in infected 
cells, and both FRET assays and subcellular fractionation of infected cells suggested that 
pp28 multimerization occurs in the assembly compartment (308).  Given BiP's chaperone 
function, it is possible that the close association between BiP and pp28 contributes to the 
multimerization of pp28. 
 It has been suggested that the formation of the assembly compartment causes the 
condensation of other cytoplasmic structures (254).  These studies noted that the normal 
organelles become located toward the periphery of the cell relative to the assembly 
compartment.  This is similar to what we report by examining BiP's ER localization in 
infected cells.  Thus, there is a connection between the formation of the assembly 
compartment and the BiP-containing condensed ER structures.   Although the mechanisms 
of assembly compartment formation and cytoplasmic ER condensation are unclear, our 
data suggest that the integrity of these structures is dependent on BiP, since BiP depletion 
causes both structures to dissociate.  Furthermore, the HCMV-induced nuclear 
morphological changes characteristic of infection also disappeared upon BiP depletion, 
suggesting that events that occur in the cytoplasm are intricately linked to events that alter 
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the nucleus.  All of this appears to be highly interconnected as part of an assembly-egress 
continuum that provides the means for nuclear nucleocapsids to egress the nucleus, 
become fully tegumented and move on into the cytoplasm for envelopment and cellular 
egress.  The intricate relationship between viral activity in the cytoplasm and nucleus is 
demonstrated by live cell imaging, in which a single assembly compartment becomes 
distorted in order to remain in its association with two nuclei as the distance between the 
nuclei increases.  The close association of the different aspects of the continuum is further 
supported by both data presented herein and existing data, suggesting that disruption of 
any one aspect of the continuum disrupts the entire process (2, 11, 167).    
The process of assembly and egress of HCMV virions requires significant 
morphological alterations of the nuclear and cytoplasmic architecture.  The manifestations 
of this include enlargement of the nucleus, formation of the kidney shaped nuclei, alteration 
of the nuclear membrane, rearrangement of the nuclear lamina and formation of the 
cytoplasmic assembly compartment.  For example, BiP is integral in the formation and 
integrity of the assembly compartment and its depletion not only causes assembly 
compartment disruption, but also disrupts nuclear remodeling as well as the cytoplasmic 
phenotype of an HCMV infection.  This signifies that the viral induced morphological 
changes are reversible.  Results presented in this thesis show that the depletion of BiP and 
the disruption of the assembly compartment reverse the characteristic rearrangement of the 
nuclear lamina in infected cells.  Under BiP depleted conditions, not only is the nuclear 
lamina rearrangement lost, but the nuclei regain a more normal shape and size.  Similarly, 
disrupting nuclear egress by inhibiting the activity of pUL97 and PKC results in a loss of 
assembly compartment integrity (11).  Thus, as suggested above, disruption of one aspect 
of the assembly-egress continuum disrupts the entire process, restoring infected cells to a 
more normal morphology. 
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 HCMV-mediated lamina rearrangement requires phosphorylation of the lamins in a 
manner that may mimic nuclear lamina rearrangement following metaphase.  However, 
HCMV appears to modify this process through the utilization of a viral specific kinase, UL97, 
in a viral specific nuclear egress complex which includes the HCMV proteins pUL50 and 
pUL53, plus the cellular proteins p32, lamin B receptor and PKC (231).  pUL50 is anchored 
in the INM and believed to associate with the nuclear lamina (230).  pUL53 binds pUL50, 
and it is proposed that these proteins attract the kinases which phosphorylate the lamins for 
rearrangement (38, 218, 230).   
 The connection between BiP and the lamina rearrangement process manifests later 
in infection, after the formation of the assembly compartment, when the depletion of BiP 
results in the loss of lamin A and C phosphorylation on serine 22 and the loss of viral 
specific lamina rearrangement.  These data suggest that BiP and the integrity of the 
assembly compartment positively affect lamin phosphorylation and rearrangement.  These 
events correlate with an interaction between BiP and pUL50; thus the effects of BiP on 
lamin phosphorylation, and lamina rearrangement, appear to be due to a direct affect on 
the function of the pUL50 containing nuclear egress complex.  These data also show that 
BiP has an integral role in both viral cytoplasmic and nuclear activity and implicate it as a 
critical factor in the assembly-egress continuum.  
 An interaction between BiP in the assembly compartment and pUL50 anchored in 
the inner nuclear membrane is complicated by the outer nuclear membrane lying between 
the two.  However, results suggest several alterations of the nuclear membranes that may 
facilitate the interaction.  First, EM data indicate that the nuclear periphery near the 
assembly compartment is very thin compared to other regions of infected nuclei, and 
compared to mock-infected nuclei.  In addition, the data suggest that some regions of the 
outer nuclear membrane are disrupted during infection.  Such changes would favor 
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increased access of BiP in the assembly compartment to pUL50 in the inner nuclear 
membrane.   
 The findings that the nuclear membrane in the region of the assembly compartment 
is significantly altered, and potentially disrupted, are supported by the observation that 
155,000 molecular weight dextran, loaded into mock- and HCMV-infected cells, appears 
inside the nuclei of infected cells, whereas it does not enter uninfeced nuclei.  The dextran 
detected in infected cell nuclei was especially concentrated at sites adjacent to the 
assembly compartment.  This result suggests that the nuclear membrane adjacent to the 
assembly compartment is more permeable to large molecules.  Such permeability also 
suggests a means for the BiP-pUL50 interaction.   Overall, the data suggest that the 
nuclear membrane, especially in the region of the assembly compartment, is significantly 
altered and more permeable to large molecules, features that would support interactions 
between assembly compartment proteins, for example BiP, and nuclear proteins such as 
pUL50. 
In addition to the above alteration of the nuclear membrane, the distance between 
the inner and outer nuclear membranes increases in infected cells.  This correlates with a 
decrease in the levels of SUN-domain proteins during the course of an HCMV infection.  
The loss of SUN-domain proteins has been shown to result in the separation of the inner 
and outer nuclear membranes (59).  Specifically, dimers of SUN-domain proteins, anchored 
in the inner nuclear membrane, interact in the perinuclear space with KASH-domain 
proteins which are anchored in the outer nuclear membrane.  This interaction tethers the 
inner and outer nuclear membranes and maintains a relatively uniform distance between 
the two (59).  The loss of SUN-domain proteins relieves the tethering and allows the inner 
and outer nuclear membranes to disassociate from one another and function separately 
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(59).  One result of this is that large nucleocapsids in the process of nuclear egress can 
push the two membranes apart and fit between them, in the perinuclear space.   
 One of the most intriguing questions about the assembly-egress continuum is how 
the virus mediates the enlargement of the nucleus and its change to a kidney shape 
wrapped around the assembly compartment.  Studies of nuclear envelope breakdown 
(NEBD) suggest that the cellular motor dynein attaches to the nuclear membrane and 
moves toward the centromere, generating tension on the nucleus and creating folds in the 
nuclear envelope (16, 301); the stress eventually causes tearing and breakdown of the 
nuclear membrane.   
Data presented in this thesis show that in cells with impaired dynein function, the 
nuclear shape and size is normal.  Furthermore, inhibition of dynein causes the assembly 
compartment components to disperse throughout the cytoplasm.  This confirms recent data 
suggesting that dynein is integral in assembly compartment formation (132), and provides 
further evidence that viral activity in the cytoplasm is intricately linked to viral-induced 
morphological changes.  Thus, the virus may use a modified version of NEBD, in which 
dynein binds assembly compartment components and the nuclear membrane and moves 
toward the microtubule organizing center that will form the center of the assembly 
compartment.  This pulling of the nuclear membrane toward the MTOC can account for the 
concave nuclear shape formed around the assembly compartment and may promote tight 
association between the assembly compartment and the nucleus.   During normal NEBD, 
the stress of dynein’s pulling results in tearing of the nuclear membrane and nuclear 
breakdown.  In infected cells nuclear breakdown does not occur, but the nuclei do enlarge.  
A potential explanation for this is that nuclear enlargement is facilitated by the addition of 
new nuclear membrane to relieve the stress.  This is a feasible possibility given the recent 
observation of a dramatic increase in fatty acid synthesis for membrane formation that 
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occurs in HCMV infected cells (242).  In addition, it is very likely that the dynein-mediated 
reformation of the nucleus and the rearrangement of the nuclear lamina are interrelated.  In 
an HSV-1 infection, an interaction between dynein and UL34, the HSV-1 homolog of UL50, 
has been reported (399).  While an interaction between pUL50 and dynein has yet to be 
reported with HCMV, these observations suggest the intriguing possibility of an integrated 
mechanism involving BiP, pUL50 and dynein in assembly compartment formation and 
nuclear restructuring. 
 Assimilating the data presented herein with current models in the literature creates 
the following model, represented in Figure 35.  The nuclear periphery in mock-infected cells 
(Figure 35A) consists of a uniform inner and outer nuclear membrane, held in place by the 
interaction in the perinuclear space between SUN- and KASH-domain containing proteins.  
The SUN proteins, located in the inner nuclear membrane, interact with the nuclear lamins, 
which form the rigid nuclear lamina just inside of the nuclear membrane.  The nuclear 
periphery in HCMV-infected cells is drastically altered.  Based on the model of Das et al. 
(68), the assembly compartment is shown as concentric rings made up of specific 
organellar components and virion structural components, for example tegument proteins.  
BiP is located in an outer assembly compartment ring, adjacent to the nucleus.  The 
nuclear membrane near the assembly compartment is modified, with disruption of the outer 
nuclear membrane and both increased permeability and separation between the inner and 
outer nuclear membranes.  All of these changes would increase the access of the proteins 
in the assembly compartment to nuclear proteins.  This may account for the ability of BiP 
and pUL50 to interact.  The model shows the nuclear egress complex as recruited by 
pUL50 and pUL53 (Figure 35B, #1). The model also shows the rearrangement of the 
nuclear lamina in the region of the assembly compartment (Figure 35B, #2).  This 
rearrangement, as well as the prerequisite phosphorylation of the lamins, requires BiP and  
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Figure 35.  Model of assembly-egress continuum 
 
(A) Nuclear periphery in mock-infected cells. (B) Assembly-egress continuum in HCMV-
infected cells. The model is based on the data presented and previous models (68).  See 
text for detailed explanation of assembly-egress events.  INM, inner nuclear membrane; 
ONM, outer nuclear membrane; MTOC, microtubule organizing center; LBR, lamin B 
receptor; PKC, protein kinase C 
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an intact assembly compartment.  The data suggest that the interaction between BiP and 
pUL50 mediates signaling between the assembly compartment and the nucleus to direct 
lamina rearrangement adjacent to the assembly compartment. The model also shows the 
dynein-mediated formation of the assembly compartment and remodeling of nuclear shape 
(Figure 35B, #3).  This appears to be facilitated by microtubules radiating from the 
microtubule organizing center within the assembly compartment.   
All of this coordinately forms the assembly-egress continuum which provides a 
means for nucleocapsids to navigate through the lamina (Figure 35B, #4) and access the 
nuclear membranes near the assembly compartment.  The nucleocapsid then egresses 
from the nucleus into the perinuclear space (Figure 35B, #5).  As suggested by the model 
of Das et al. (68) the nucleocapsids move through the layers of the assembly compartment 
(Figure 35B, #6) and emerge tegumented (Figure 35B, #7) and possibly enveloped.  
Perturbation of any of the above described events in the assembly-egress continuum 
disrupts the entire process and restores the viral-induced nuclear and cytoplasmic 
morphological changes to a more normal appearance.  Thus, the individual steps that 
constitute the assembly-egress continuum during HCMV infection require that all other 
factors of the assembly-egress continuum remain intact in order to maintain the intricate 
relationship between viral cytoplasmic and nuclear activity, and support virion maturation 
and egress.      
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APPENDIX: Abbreviations 
 
ο degrees 
µg microgram 
µl microliter 
µM micromolar 
ADP adenosine diphosphate 
AP assembly protein 
ASFV African swine fever virus 
ATCC American Type Culture Collection 
ATF3 activating transcription factor 3 
ATF4  activating transcription factor 4 
ATF6  activating transcription factor 6 
ATP adenosine triphosphate 
BAP BiP-associated protein 
BDV Borna disease virus 
BiP immunoglobulin binding protein 
BS3 bis(sulfosuccinimidyl) suberate 
BSA bovine serum albumin 
BVDV Bovine viral diarrhea virus 
C Celsius 
Ca2+ calcium 
CaCl2 calicum chloride 
CHOP C/EBP-homologous protein 
cm centimeter 
CO2 carbon dioxide  
CPE cytopathic effects 
CRE ATF/cAMP response element 
CREB1 cAMP response element binding 
protein 1 
CTF-NF1 CAAT-binding transcription factor-
nuclear factor 1 
DAPI 4’6’-diamidino-2-phenylindole 
ddH2O distilled deionized water 
DEN-1 Dengue virus type 1 
DEN-2 Dengue virus type 2 
DMEM10 Dulbecco’s Modified Eagle Medium 
supplemented with 10% serum, 
glutamax and antibiotics 
DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
DR5 death receptor 5 
DsRed red fluorescent monomeric protein 
E2F1 E2 transcription factor 1 
EBV Epstein-Barr virus 
EDEM ER degradation-enhancing α-
mannosidase-like 
EDTA ethylenediaminetetraacetic acid 
EEA1  early endosome antigen 1 
EGCG epigallocatechin gallate 
EGFR epidermal growth factor receptor 
eIF2α eukaryotic initiation factor 2α  
EM electron microscopy 
ER endoplasmic reticulum 
162 
ERAD ER-associated degradation 
ERSE endoplasmic reticulum stress 
element 
FKBP23 FK506-binding protein 23 
GADD34 growth arrest and DNA damage 
gene 34  
GADD153 growth arrest and DNA damage 
gene153 
GDP guanosine diphosphate 
GFP  green fluorescent protein 
GLS Golgi-localization signal 
GRP78 glucose regulated protein 78 
GRP170 glucose regulated protein 170 
GTP  guanosine triphosphate 
HCl hydrochloric acid 
HCMV human cytomegalovirus 
HCV hepatitis C virus 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
HHV-5 human herpesvirus 5 
HIV human immunodeficiency virus 
hpi hours post infection 
HRD1 HMG-CoA reductase degradation 1 
HSP70 heat shock protein 70 
HSPG heparin sulfate proteoglycan  
HSV-1 herpes simplex-1 
HTLV-1 human t-lymphotrophic virus 
IF immunofluorescence 
IFNAR1 interferon alpha receptor 1 
INM inner nuclear membrane 
IP immunoprecipitation 
IRE1 inositol-requiring enzyme 1 
IRES internal ribosome entry site 
JEV Japanese encephalitis virus 
JNK c-Jun amino-terminal kinases 
KASH Klarischt, Anc-1, Syne homology 
kD kilodalton 
Keap1 Kelch-like ECH-associated protein 1 
LB Luria-Bertani 
LE-HFF lifetime extended-human foreskin 
fibroblasts 
LMP latent membrane protein 1 
M  molar 
MCF MLV mink cell focus-forming murine 
leukemia viruses  
MCMV mouse cytomegalovirus 
MCP major capsid protein 
mCP minor capsid protein 
mCP-BP minor capsid protein-binding protein 
Met-tRNAi methionyl-initiator tRNA 
mg milligram 
MHC1 major histocompatibility complex 1 
MHV mouse hepatitis virus 
MIEP major immediate early protein 
ml milliliter 
mM millimolar 
163 
Mo-MuLV Moloney murine leukemia virus 
MOI  multiplicity of infection 
MTOC microtubule organizing center 
Na2HPO4 sodium phosphate 
NaCl sodium chloride 
NaF sodium fluoride 
NEBD  nuclear envelope breakdown 
NF-Y nuclear factor Y 
ng nanograms 
nm nanometer 
Nrf2 NF-E2-related factor-2  
NS4B non-structural protein 4B 
NSAP1 NS1-associated protein 1 
NSP4 non-structural protein 4 
ONM outer nuclear membrane 
ORF open reading frame 
OsO4 osmium tetroxide 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDI protein disulfide isomerase 
PERK PKR-like ER kinase 
PFK-1 phosphofructosekinase-1 
pfu plaque forming unit 
PI3K phosphoinositide-3 kinase  
PKC protein kinase C 
PKR protein kinase R 
PMSF phenylmethylsulfonyl fluoride 
PP1 protein phosphatase 1 
PRMT1 protein arginine methyltransferase 1 
PtdCho phosphatidylcholine  
PUMA p53-upregulated modulator of 
apoptosis 
RAMP4 ribosome-associated membrane 
protein 4 
RIPA radioimmunoprecipitation assay 
rpm revolutions per minute 
RT room temperature 
RT-PCR reverse transcriptase-polymerase 
chain reaction 
S1P site-1 protease 
S2P  site-2 protease 
SAPK stress-activated protein kinases  
SARS severe acute respiratory syndrome 
SCP smallest capsid protein 
SCR control siRNA containing non-
specific, scrambled sequence 
SERCA sarco/endoplasmic reticulum 
calcium ATPase-2 
shRNA short hairpin RNA 
SREBP2 sterol-regulating element binding 
protein 2  
SubAB subtilase cytotoxin 
SUN Sad1/UNC84 homology 
TBST tris buffered saline-Tween 20 
TCID50 50% tissue culture infectious dose 
TFII-I transcription factor II-I 
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TGN trans-Golgi network 
TRB3 tribbles homolog 3  
TRITC tetramethylrhodamine 
UPR  unfolded protein response 
UTR untranslated region 
UV ultraviolet 
VSV  Vesicular stomatitis virus 
WNV  West Nile virus 
WT  wildtype 
XBP1 X-box binding protein 1 
YY1 Yin Yang-1
 
